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Abstract
Hepatitis C Virus (HCV) is a positive stranded RNA virus, grouped into the family of
Flaviviridae. The HCV genome encodes a single polyprotein, which is co- and post-
translationally cleaved into ten structural and non-structural (NS) proteins by cellular
and viral proteases. The coding sequence is flanked by 5’ and 3’ untranslated regions
(UTRs), which contain essential cis-acting elements, regulating translation and RNA
synthesis, e.g. an internal ribosome entry site (IRES) for cap-independent translation.
HCV RNA replication involves the synthesis of a negative strand replication intermedi-
ate, serving as a template for the generation of multiple strands of genomic RNA. This
process requires a concerted action of several viral nonstructural proteins, cis-acting
replication elements and host factors, and is poorly understood at the molecular level.
The first part of this study aimed to characterize the viral non-structural proteins com-
prising the replicase complex in vitro and their mode of action during (-)-strand RNA
synthesis. Since the natural 3’(+)-end is a poor template for the viral polymerase NS5B,
supporting roles of the viral protease/helicase NS3 and the phosphoprotein NS5A were
hypothesized. Optimal conditions for NS3 activity were established by an in vitro heli-
case assay. By combining the individual proteins with different RNA templates, it was
observed that initiation and processivity of NS5B were stimulated by active NS3, but
not by inactive mutants. Inhibition of NS3 helicase activity did not impair the stim-
ulatory effect on NS5B, but led to an altered mode of initiation. Addition of purified
NS5A further augmented the effect of NS3. In conclusion, this work demonstrates that
NS3 and NS5A can improve RNA dependent RNA polymerase activity on a natural
template, thereby providing an experimental model to study the molecular mechanisms
governing initiation of RNA synthesis.
Liver -specific microRNA (miR)-122 is an important host factor of HCV replication,
and recognizes two conserved target sites within the first 45 nt of the HCV 5’ UTR, close
to the IRES. Previous studies suggested a role of miR-122 in RNA stability, translation,
and RNA synthesis. The mechanisms, by which miR-122 exerts these functions, remain
enigmatic. Insertion of a heterologous IRES element, allowing for miR-independent
translation of the non-structural proteins, was sufficient to enable replication in miR-
122-deficient Hep3B cells, suggesting a substantial role of miR-122 in IRES-dependent
translation. The miR-122 binding region is engaged in a strong secondary in the comple-
mentary negative strand. Additionally, we found that a similar structure was predicted in
the positive strand, which would interfere with IRES formation. We therefore hypoth-
esized that miR-122 binding in this region might prevent such alternative structures,
thereby facilitating IRES-mediated translation.
Indeed, mutations in the miR-122 binding region, but not the IRES sequence, which
were designed to stabilize or destabilize the IRES, enhanced or decreased initial transla-
tion, respectively, independent of miR-122. Translation enhancement was independent
from RNA stability, but short-lived, suggesting additional roles of miR-122, e.g. recruit-
ment of host proteins facilitating steady state translation. Moreover, structural analysis
suggested that the HCV IRES folds into a number of conformers in solution, which can
be modified by miR-122 under certain conditions.
Apart from the 5’ UTR, HCV also contains several seed-matches for miR-122 in the
coding sequence of NS5B, and the 3’ UTR, with unknown functional significance. Two
novel sites were identified to be conserved over a number of genotypes. The functional
characterization of these miR-122 binding sites was evaluated by insertion of point mu-
tations, abrogating miR-122 binding to single and multiple sites, revealing a previously
unappreciated role in virion assembly or release. However, assembly of the mutants
could not be rescued by a corresponding mutant miR, suggesting a specific need for wild
type miR-122.
Conclusively, this study provides evidence for miR-122 involvement in almost every
intracellular stage of HCV infection, and defines translation enhancement by suppression
of RNA structures interfering with IRES activity as a key function of miR-122.
2
Zusammenfassung
Das Hepatitis C Virus (HCV) ist ein positiv (+)-Strang RNA Virus, welches zur Fam-
ilie der Flaviviridae geza¨hlt wird. Das HCV Genom kodiert fu¨r ein einziges Polypro-
tein, das co- und post-translational mit Hilfe viraler und zellula¨rer Proteasen in zehn
Struktur- und Nichtstrukturproteine (NS) gespalten wird. Der offene Leserahmen wird
am 5’ und 3’ Ende von nicht-translatierten Regionen (NTR) flankiert, welche essen-
tielle Signale fu¨r Translation und Replikation enthalten, wie z.B. eine interne ribosomale
Eintrittsstelle (IRES), welche cap-unabha¨ngige Translation ermo¨glicht. Wa¨hrend der
Replikation der HCV RNA entsteht ein negativ-Strang Intermediat, welches als Ma-
trize fu¨r die Produktion weiterer positiv-Stra¨nge dient. Zudem ist eine konzertierte
Interaktion viraler NS-Proteine, verschiedener RNA Elemente und Wirtsproteine no¨tig,
welche auf der molekularen Ebene noch weitestgehend unverstanden ist. Der erste Teil
dieser Arbeit hatte die Charakterisierung der NS-Proteine in vitro, sowie die Unter-
suchung ihrer Funktion wa¨hrend der RNA Synthese zum Ziel. Da das natu¨rliche Ende
des (+)-Stranges keine effiziente Initiation der viralen Polymerase NS5B erlaubt, war eine
zentrale Hypothese, dass die Protease/Helikase NS3, sowie das Phosphoprotein NS5A
diesen Vorgang unterstu¨tzen ko¨nnten. Mittels einem in vitro Helikase Assay wurden
zuna¨chst die optimalen Bedingungen fu¨r dieses Enzym getestet. Durch die Kombination
verschiedener NS-Proteine konnte gezeigt werden, dass die aktive Helikase sowohl die
Initiation, als auch die enzymatische Aktivita¨t der Polymerase steigern konnte, wa¨hrend
katalytisch inaktive Mutanten hierzu nicht in der Lage waren. Die chemische Inhibition
der Helikase hatte keinen Einfluss auf die Steigerung der Prozessivita¨t von NS5B, fu¨hrte
jedoch zu einem vera¨nderten Initiationsverhalten. Hinzugabe von NS5A konnte den NS3
vermittelten Effekt noch versta¨rken. Somit konnte gezeigt werden, dass NS3 und NS5A
die Polymeraseaktivita¨t auf einem natu¨rlichen Template steigern ko¨nnen. Zudem stellt
diese Methode auch ein experimentelles Modell fu¨r weitere Untersuchungen der Prozesse
wa¨hrend der Initiation der (-)-Strang Synthese dar.
Die leberspezifische mikroRNA (miR)-122 ist ein wichtiger Wirtsfaktor fu¨r HCV Rep-
likation und erkennt zwei Zielsequenzen in den ersten 45 nt der HCV 5‘ NTR, direkt
vor der IRES. Vorhergehende Studien konnten bereits zeigen, dass die miR-122 RNA
Stabilita¨t, Translation und Replikation positiv beeinflusst. Die Mechanismen dieser
Funktionen sind jedoch noch ungekla¨rt. Die Einfu¨hrung einer fremden IRES, welche
die Translation miR-122 unabha¨ngig macht, ermo¨glichte die Etablierung von Replika-
tion in miR-122-defizienten Hep3B Zellen. Daraus ließ sich eine substantielle Rolle der
miR-122 in der IRES-abha¨ngigen Translation ableiten. Die miR-Binderegion ist im kom-
plementa¨ren 3‘(-) Ende in einen stabile Sekunda¨rstruktur eingebunden. In silico Analy-
sen zeigten die Ausbildung einer a¨hnlichen Konformation im positiv Strang, welche die
Ausbildung der IRES sto¨ren wu¨rde. Daher wurde angenommen, dass die Bindung der
miR-122 diese Strukturen unterdru¨cken, und dadurch die IRES Aktivita¨t stimulieren
ko¨nnte. Tatsa¨chlich konnten Mutationen in der miR-Binderegion, welche die IRES Kon-
formation stabilisieren oder destabilisieren, die initiale IRES Aktivita¨t unabha¨ngig von
miR-122 erho¨hen oder erniedrigen. Die Steigerung der Translation war in diesem Fall
nicht abha¨ngig von der RNA Stabilita¨t, ließ jedoch sehr schnell nach, weshalb weit-
ere Funktionen der miR-122, wie z.B. Rekrutierung von Wirtsfaktoren eine zusa¨tzliche
Rolle spielen ko¨nnten. Zudem ergab die experimentelle untersuchung der RNA Struktur,
dass die HCV IRES in Lo¨sung ein Ensemble von Konformeren ausbildet, welches unter
bestimmten Bedingungen von miR-122 beeinflusst werden kann.
Neben den beiden Bindestellen in der 5’ NTR existieren noch weitere in der kodieren-
den Region und der 3‘ NTR, deren Funktion unbekannt ist. Außerdem wurden noch zwei
zusa¨tzliche Bindestellen im offenen Leserahmen identifiziert, welche in vielen Genotypen
konserviert sind. Die funktionelle Relevanz wurde durch Einfu¨hrung von Punktmuta-
tionen in den Bindestellen untersucht, welche die Assoziation der miR-122 verhindern.
Dies fu¨hrte zu der Beobachtung, dass diese Bindestellen wichtig fu¨r Virusassemblierung
oder Egress sind. U¨berraschender Weise konnte die korrespondierende miR-Mutante
diese Funktion nicht wiederherstellen. Dies ko¨nnte fu¨r eine miR-122 Wildtyp-spezifische
Rolle sprechen.
Zusammenfassend konnte diese Studie zeigen, dass miR-122 in jedem intrazellula¨ren
Schritt der HCV Infektion eine wichtige Rolle spielt. Weiterhin konnte die Steigerung der
Translation, durch die Unterdru¨ckung interferierender Strukturen, als Schlu¨sselfunktion
der miR-122 identifiziert werden.
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1.1. The Hepatitis C Virus
The existence of hepatitis C virus (HCV) was first anticipated in 1975, when Feinstone
et al. 1 proposed an infectious agent, which, despite causing similar symptoms in some
cases, showed no reactivity with Hepatitis A nor B antibodies (accordingly termed non-A
non-B hepatitis). Hence, it was suspected to be a new type of viral hepatitis. Addition-
ally, one report suggested person-to-person transmission without the necessity of blood
transfusion2. In 1978, studies in chimpanzees demonstrated that the disease was indeed
caused by a transmissible agent. However, its identity remained enigmatic for more than
a decade, until the identification of the viral genome was published in 19893.
1.2. Incidence and Associated Diseases
Presently, over 170 million people (or 3% of the world’s population) are estimated to
carry the pathogen4. The virus owes much of its success to its extreme inherent vari-
ability, accounting for the emergence of seven currently known genotypes (gt), and a
vast number of subtypes. Significant disparities between geographical regions in inci-
dence and genotype prevalence (fig. 1.1) can be observed. The routes of infection
range from sexual contact over direct blood-to-blood (needle-sharing/reuse, nocosomial,
blood-transfusion) to graft-derived transmission (organ transplantation), or contami-
nated medical products (shistosomatosis prophylaxis)5. Hence, high-risk individuals are
men who have sex with men, injecting drug users, and patients in hospitals with poor
hygienic standards. Potentially due to the wide overlap of risk groups, co-infection with
HIV is rather common6. Only 20 - 30% of acute infections can be cleared spontaneously.
Acute hepatitis C rarely involves any severe symptoms in immunocompetent persons7.
However, in up to 80% of patients the infection progresses to a persistent state, which
makes HCV the leading etiologic agent for chronic liver disease. Quasispecies emerge
shortly after infection, rapidly adapting to the host’s immune response8. Viral persis-
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Figure 1.1.: Incidence of HCV infections in different geographical regions. HCV is
distributed throughout the world. The most prevalent genotypes in America, Europe, Russia
and China are 1 and 2. In contrast, genotype 4 is most common in Africa and the middle
eastern regions. Genotype 4 is most often found in the Indian population. Representation
based on data from Messina et al. 4
tence can induce severe fibrosis and cirrhosis of the liver in 20% of the cases. This
condition is frequently accompanied by steatosis (fatty liver disease), particularly in
patients with genotype 39. Eventually, the infection can culminate in hepatocellular
carcinoma (HCC)10,11, in 1 - 3% of cases per year. HCC is a particularly aggressive
form of liver cancer with poor survival rates. The severity of disease is strongly influ-
enced by gender, age, and lifestyle. Moreover, there is evidence that also extra-hepatic
malignancies can be HCV related, including the reported involvement of HCV in B-
cell non-Hodgkin’s lymphoma12. Each year, HCV associated diseases account for over
500,000 deaths worldwide4.
1.3. Treatment and Vaccination
To date, there is no approved vaccine against HCV. The standard of care treatment was
at first limited to long-term high doses of PEG-ylated interferon (IFN)α in combina-
tion with the guanosid-analogon ribavirin, which blocks viral replication by an unknown
mechanism13. However, apart from severe side effects, elimination of the virus could only
be achieved in less than 50% for the predominant genotype 1 (80% for genotype 2) of
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chronically infected patients. In the past decade, the approval of several highly effective
direct acting antivirals (DAA), such as NS3 protease (VX95014, Boceprevir15), NS5A
(Daclatasvir16) and RdRP inhibitors (Sofosbuvir17) , with average sustained virological
response rates of nearly 100% for genotype 2, and above 95% for gt1, has significantly
improved the therapeutic success18. Still, the high genetic variability and plasticity, re-
sulting in the occasional appearance of resistance mutants, complicates the development
of a 100% effective therapeutic for all genotypes. Importantly, the most effective novel
therapies are very costly, and therefore their availability is limited, especially in less de-
veloped regions. Another promising approach is the targeting of essential host-factors.
In fact, cyclophilin A inhibitors19–21 and locked nucleic acid (LNA)-based decoys for
miR-12222–24 have progressed to phase 2 clinical studies. However, due to the success of
recent DAAs, they have not advanced into clinical use, yet.
1.4. Molecular Biology of HCV
HCV belongs to the family of Flaviviridae, and is a member of the genus Hepacivirus.
The recently discovered non-primate hepatitis virus (NPHV)25 and the GBV-B (G.-
Barker-Virus, named after the first patient, in which it was discovered) are the most
closely related viruses in this clade. Other genera of the Flaviviridae are Flavivirus (e.g.
Yellow Fever Virus), Pegivirus (GBV-A, GBV-C), and Pestivirus (e.g. Bovine Viral
Diarrhea Virus). The infectious viral particle of HCV measures around 40 - 100 nm in
diameter, and is surrounded by a host-derived lipid bi-layer, protruded by viral trans-
membrane proteins (fig. 1.2 E1, E2). After complete assembly, ApoE and ApoB,
proteins involved in VLDL-lipoprotein formation, are acquired26. The genome of HCV
Figure 1.2.: Lipo-viral particle of HCV. In addition
to the double-layer lipid envelope, HCV is associated with
lipoproteins, including ApoE and B. The E1 and E2 surface
proteins are responsible for host cell recognition and fusion
and protrude the lipid membrane. The proteinous capsid en-
closing the genomic RNA is assembled by multiple copies of
the core protein.
is a positive single-stranded ((+)ss)RNA of roughly 9600 bp3. The genomic RNA is
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protected by a capsid shell, formed by multiple copies of the viral core protein. The
monocistronic transcript is translated into a polyprotein precursor of approximately
3000 aa in length27, which is co- and post-translationally cleaved by cellular and viral
endoproteases into ten individual proteins28,29.
The structural components of the infectious virion are core, E1, and E2. p7 and the
non-structural (NS) proteins NS2, 3, 4A, 4B, 5A and 5B, are likely not incorporated
into the virus particle. Instead, they perform crucial activities in the viral life cycle. In
fact, NS3 - 5B have been shown to be essential and sufficient for the amplification of
viral RNA29. The uncapped genomic RNA also contains various sequence and struc-
tural features, which are critical for efficient translation, replication and assembly. A
highly structured internal ribosomal entry site (IRES) of 389 nt is located at the 5’ end,
in the untranslated region (UTR) of the positive strand30. Parts of these structures
interact with regulatory elements within the coding region (i.e. SL5B) to modulate the
aforementioned processes (fig. 1.3B). Most likely, the 5’ region also contains signals
for the translation-replication switch, similar to the polio IRES, since translation and
replication are incompatible processes31. Especially the first 120 nucleotides and the
complementary sequence contain structures (SLII and SLIIz’), which are important for
both, protein and RNA synthesis (fig. 1.3A,C).
1.5. The Viral Life Cycle
HCV infection relies on several membrane receptors, which are bound in a defined se-
quence. After penetration of the cell, the viral life cycle is completely cytoplasmic, and
is accompanied by substantial membrane rearrangements in the cell, which represent the
viral replication compartment.
1.5.1. Attachment and entry
Viral entry requires a concerted action of several membrane receptors. Host cell con-
tact is initiated by capturing of cellular glycoproteins, glycosaminoglycans, and VLDL-
receptors by viral E1-E2 proteins and host-acquired low-density-lipoproteins. This pre-
liminary binding enables specific interactions of HCV with its entry-receptors. Among
these are CD81 and Scavenger receptor B1 (SR-B1)32,33. Claudin-1 (CLDN1) and oc-
cludin (OCLN), which are exclusive to laminar tight junctions in liver tissue, are also
involved in the final steps of this process34,35(fig. 1.4A). Epidermal growth factor re-
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Figure 1.3.: The genome structure of HCV. The genome is a monocistronic (+)-strand
RNA molecule. The 5’ end encodes for the structural proteins involved in particle formation,
whereas the the non-structural proteins are located at the 3’ end. The replicase complex is
formed by NS3-5B. A | The 5’UTR of HCV, containing the IRES element (domains II-IV)
and two miR-122 binding sites in domain I. B | The 3’ cis-acting elements within the coding
region of NS5B (5BSL3) and the 3’UTR. VR: variable region. C | 3’(-) structure SLI’ - SLIIy’
are essential for replication.
ceptor -kinase signaling36 induces clathrin-mediated uptake of the viral particles into
endosomal vesicles37,38. Upon acidification of the endosomal compartment, the HCV
glycoproteins undergo structural changes to promote membrane fusion39. This induces
disassembly of the HCV core complex and liberation of the viral genome into the cyto-
plasm.(fig. 1.4B)
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Figure 1.4.: The life cycle of HCV. A | Entry of HCV is mediated by the interaction
of host cell receptors with the E1:E2 complex. B | After uptake of the viral particle in
a clathrin-dependent manner, membrane fusion is initiated and the capsid disintegrates to
release the RNA into the cytoplasm. C | At the ER, ribosomes are recruited by the 5’ IRES,
to translate the polyprotein. D | The mature proteins associate with the ER membrane and
form the membranous web, consisting of a number of vesicular structures. Especially the
DMVs are suggested to serve as platform for genome replication. Some NS5A containing
vesicles of unknown function are in contact to microtubuli (mt). E | The transcribed RNAs
are subsequently packaged into newly formed capsids. This process is in close coherence with
core-beset lipid droplets. The particles then bud into the ER and follow the exocytotic pathway
through the Golgi, where post-translational glycosylation of E1- E2 is carried out. F | The
transport vesicle fuses with the plasma membrane to liberate the virion.
1.5.2. Translation and Processing of the Viral Polyprotein
The genomic RNA of HCV does not feature a 5’ cap structure, which is usually needed
for ribosome attachment. Instead, the virus relies on an IRES, which also eliminates
the need for most canonical initiation factors and ribosomal scanning. The open reading
frame encodes a polyprotein precursor, which needs to be separated during and after
translation(fig. 1.4C). The translation product is cleaved successively by the cellular
10
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Figure 1.5.: Processing of the viral polyprotein. A | Representation of the complete
HCV polyprotein. The scission of the large polyprotein is at first dependent on the host
signal peptidase (asterisk), residing at the ER. After hydrolysis at the p7-NS2 junction, N2-3
is autocatalytically cleaved. All remaining proteins are released by the NS3 protease. Later,
the signal-peptide peptidase catalyzes the maturation of core. B | The NS proteins and viral
genomic RNA are recruited into DMVs, formed mainly by NS4B. NS3 might unwind secondary
structures of single stranded templates or double stranded replication intermediates to facilitate
polymerase initiation.
serine-protease signal peptidase, and the viral NS2/3 protease. Autocatalytic cleavage of
the NS2/3 precursor ultimately activates the NS3/4A viral protease, which is responsible
for the completion of polyprotein processing40,41,29. The 23-kDa immature form of the
core protein is cleaved by the signal peptide peptidase42 to produce the mature 21-kDa
protein43,44 (fig. 1.5A).
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1.5.3. Membranous Web Formation and RNA Replication
After translation of the viral proteins, they induce the formation of a membrane compart-
ment, the so-called membranous web (MW). It is composed of several types of vesicular
structures. The double-membrane vesicles (DMV) are the most abundant type (fig.
1.4D). The non-structural proteins NS3 to NS5B, and the viral RNA are sequestered
into these vesicles, which are thought to be the primary foci of replication activity45–48.
This was convincingly shown by Paul et al. 49 , since 4B-containing membrane fractions
consist predominantly of DMVs and exhibit RNA amplification capacity. The exact
organization of the replicase within these structures, however, is still not unequivocally
shown. In all likelihood, the participating fraction of proteins and RNA are enclosed by
the double membranes45,50 (fig. 1.5B). The first step of RNA replication is the synthesis
of a negative strand RNA replication intermediate, serving as a template for progeny
positive strand genomes. However, the individual contribution of the involved proteins
(and host factors), as well as the initiation mechanism of (-)-strand synthesis have yet to
be clarified. Each of the involved NS proteins is thought to have multiple essential roles
in initiation and continuation of RNA replication. Moreover, it becomes increasingly
clear that their activities are not limited to replication51,52. The positive and negative
strand RNA is amplified in asymmetrical quantities. While the (-)-strand synthesis is
rather inefficient, the generated amount of (+)-strand is around 10-fold higher. This
allows the virus to efficiently propagate its genome, while keeping double-stranded repli-
cation intermediates to a minimum, which are potent triggers for the innate immune
response. The mechanistic details, as to how the amplified RNA leaves these compart-
ments to initiate subsequent rounds of translation, or virion morphogenesis are not yet
defined.
1.5.4. The Viral Replicase
The replicase of HCV consists of NS3 to NS5B and a single strand of RNA. The exact
processes and interactions within the replication compartments of HCV remain elusive.
However, there have been ongoing efforts to biochemically characterize the involved
proteins. While many major functions have been meticulously described, especially the
intermolecular interactions necessary for efficient replication initiation were difficult to
address, due to the lack of appropriate model systems.
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NS3/4A
NS3/4A is a multifunctional 68kDa protein. Its N-terminal serine metallo-protease do-
main is mainly responsible for polyprotein maturation. The protease adopts a β-barrel
fold, and coordinates a stabilizing Zn+ ion. The catalytic triad is composed of His 57,
Asp 81 and Ser 13953. Full functionality of the protease is only achieved in presence of
its co-factor NS4A, as it comprises one β-strand within the barrel, anchors the protein
to the membrane and can interact with other NS proteins54. In addition to polyprotein
processing, the enzyme exhibits a specificity for important proteins of major pathways
of the antiviral recognition network, which make it a key component for immune eva-
sion. Cleavage of the mitochondrial antiviral-signaling protein (MAVS) on mitochondria-
associated membranes (MAMs) efficiently blocks signaling of the dsRNA sensor RIG-I
(retinoic acid inducible gene I), and consequently detection of viral replication interme-
diates55,56. In parallel, viral RNA induced TLR3 signaling is impaired by scission of the
cytoplasmic adapter protein TRIF57. Additionally, cell viability is enhanced via prote-
olytic degradation of the T-cell protein tyrosine phosphatase, which augments cytokine-
independent growth signaling58. Importantly, the NS3/4A holo-enzyme also possesses
Figure 1.6.: Structural and functional
features of the NS3 helicase domain. The
helicase domain of NS3 .4A92 is comprised of 3
sub-domains. It is connected to the protease
portion by an unstructured linker. The struc-
ture shows a short stretch of bound ssDNA and
an ATP-analogon within the nucleotide binding
site. Each step along the substrate is facilitated
by a major conformational change, which is ini-
tiated by the break-down of an ATP molecule
in an ATPase pocket between domains I and II.
an active NTPase and helicase domain, of the DExD-box family. It could be involved in
double-strand unwinding prior to every replication cycle. Dissolution of each nucleotide
bond requires the conversion of one ATP, which is processed by the intrinsic ATPase
subunit. Other nucleotides can be utilized as well, albeit with lower efficiency59. The
generated energy drives an inter-domain shift, which slides the enzyme forward on its
substrate in a ratchet-like manner60,61. The enzyme exhibits low preference in binding-
affinity to nucleic acids, and can readily unwind DNA and RNA duplexes. Accordingly,
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in vitro assays have shown its capability of unwinding dsRNA and secondary structures
of ssRNA molecules resembling the 3’ stem-loops of the HCV genome, and indicated an
essential role in HCV replication and assembly62,59,63. These experiments also suggest
that the protease fraction enhances nucleic acid binding and helicase activity. However,
functional evidence for the mode of action of the helicase in the HCV life cycle is still
lacking. For HCV and the related CSFV, a role in modulating the activity of the viral
polymerase has been reported based on in vitro experiments64,65.
Binding of NS4A induces a structural change of the protease subunit, which is also
required for optimal NS3 helicase activity62 and vice versa66. Also NS5B can serve to
stimulate helicase activity. The same study could also show that the active complexes
are in a 1:1 stoichiometry67. While a role in the translation/replication switch has been
proposed68, presently no conclusive studies have been published to further elucidate the
role of NS3/4A in viral RNA replication.
NS4B
NS4B is a small integral membrane protein, which is involved in different functions
during viral RNA synthesis. While most of the protein is buried in the membrane, and
is therefore hydrophobic, a number of defined charged residues in the terminal domains
are critical for protein function69. NS4B is chiefly responsible for the generation of the
membranous web, where replication takes place70,71. Its C-terminal domain is oriented
towards the cytoplasm, as indicated by Proteinase K assays. The N-terminus displays
a dual topology, with a considerable fraction pointing towards the luminal side of the
replication vesicle72. Its precise function in the HCV life cycle has not been determined so
far. Based on multiple interactions with other replicase members73,74, it is assumed that
the protein might serve as a hub for the assembly of the viral ribonucleic acid associated
protein (RNP) complex. A nucleotide binding domain with an alleged hydrolase activity
has also been detected, but its functional relevance is unclear75. Recently, an involvement
in particle production has also been reported76.
NS5A
NS5A is an RNA binding phospho-protein77,78, which is tethered to the lipid membrane
via an N-terminal amphiphatic helix. It consists of three domains, two of which are
natively unfolded79,80. Only domain 1 possesses a defined tertiary fold and forms homo-
dimeric or oligomeric complexes81–83. The protein is implicated in nearly all steps of
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the intracellular life cycle of HCV, from translation84,85 over replication86,74 to virion
assembly51,87,88. Moreover, due to its numerous host-interaction partners, it severely
alters the cellular homeostasis89–91. Some studies have also established a link to immune
evasion92,93.
Due to its complex post- translational modification pattern, which is most prominently
represented by a basal (p56) and a hyper-phosphorylated (p58) state94–96, it is until now
hardly possible to say how the “native” NS5A affects replication. Furthermore, both
phosphorylation species apparently influence different steps in HCV infection. p56 is
presumably augmenting replication, while p58 favors assembly and release97. Partially
or abnormally phosphorylated proteins might be severely affected in its activity. So
far, it is not entirely clear, which potential phosphorylation sites are actually modified
in each of the two forms. It is therefore a challenging task to reproduce the native
pattern in most common expression systems98, which makes this protein particularly
hard to study in vitro. Some of the key enzymes responsible for specific phosphorylation
states have been identified. The main contribution to generate the hyper-phosphorylated
form comes form the casein kinase Iα96. A well-described serine cluster in domain 3
seems to be the target region for the protein97. Moreover, the important host-factor
phosphoinositol-4 kinase IIIα has been implicated to reduce hyper-phosphorylation, by
a so far undefined mode of action99. Several other kinases have also been found to impact
NS5A phosphorylation and activity, adding to the complexity of regulation100,101,95.
NS5B
NS5B is the viral RNA-dependent RNA polymerase (RdRp) of HCV, and its catalytic
site strongly resembles the respective domain of HIV reverse transcriptase102. Like most
other proteins of the RdRP-class, it possesses a right-hand fold, with the typical finger,
palm and thumb domains. The RNA template is coordinated in a narrow cleft between
finger and thumb102. Besides those similarities, NS5B also shows some unusual features.
In most cases, RdRPs can acquire two distinct conformations, open and closed, which
significantly affects the size of the RNA-binding pocket. In the open conformation,
RNA duplexes comprised of template and primer can efficiently be incorporated, and
only this binding event induces the transition to the closed state103. For NS5B, there
is only evidence for minor conformational changes after RNA binding, due to numerous
inter-domain contacts, which restrict the flexibility of the structure. The native state of
the NS5B catalytic domain is thus rather comparable to the closed conformation of model
RdRPs, which only allows for binding of template RNA and a single initiating rNTP104.
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It might be attributed to this fact that de novo initiation is currently assumed as the main
form of replication. This mode of initiation requires a di-nucleotide primer105. Whether
NS5B generates this di-ncleotide at the site of initiation, or whether it can also use other
templates, is not known. The process of incorporating the initiating nucleotide is the
rate-limiting step of RNA synthesis105. At the C-terminus, NS5B possesses a membrane
anchor and a linker, containing a β-hairpin, which can fold into the RNA-binding pocket.
The function of this domain has yet to be elucidated. The anchor is essential for protein
function in cell culture48, but deletion of the 21 aa trans-membrane helix (∆C21) (up to
60, including the linker) do not impair enzymatic activity in vitro, and greatly improve
solubility of the protein during purification106. The ideal template for initiation is a
stable structure, in proximity of a short single stranded 3’ trailer sequence, or at least
one free cytidylate107. These conditions are found at the 3’(-) end, allowing for efficient
(+)-strand synthesis. However, the 3’(+) end is engaged in a stable stem without a single
stranded region, therefore (-)-strand synthesis is significantly less efficient. In this case,
the activity of the viral helicase might be needed for initiation107. Upon transition from
initiation to processive elongation dramatic conformational changes take place, which
have only recently been visualized108. There are marked structural differences between
individual strains. These might also be indicative for the strong genotype-associated
variances of in vitro replication capability109,107,104,110.
1.5.5. Cis-Acting Replication Elements
Apart from the proteins composing the replicase, genome amplification is additionally
governed through sequence and structural signals in the RNA template. The 3’ fraction
of the (+)-strand harbors various so-called cis-acting replication elements (CRE, fig.
1.3). These are composed of complex hairpin structures. One is located in the coding
region of NS5B, called 5BSL3, and features a clover-leaf fold of three hairpins111. The
central element, 5BSL3.2, interacts with the second of the terminal three-stem-loop
structure, called the X-tail112, and other upstream sequences113. It is also reported
to influence IRES activity114. The primary sequence of the 3’ X-tail is nearly 100%
conserved in all known strains of HCV, and nucleotide exchanges are rarely tolerated.
The kissing-loop interaction of X-tail and 5BSL3 is essential for efficient replication112,115.
They are separated by a variable region and a PolyU/UC stretch at the start of the 3’
UTR116, which positively regulates replication, but can tolerate deletion of large patches,
without a complete abolishment of infectivity117,118. It is a hub for viral and host protein
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association119,78,120,121, but also a strong activator of antiviral signaling122,123.
1.5.6. Assembly and Release
Packaging of the viral RNA takes place on the surface of lipid droplets, which are
covered with the capsid protein core124. The core protein is the only building block
of the proteinacious capsid. It has RNA binding capabilities125,126, and also interacts
with the envelope glycoprotein E1:E2 heterodimer, via the cytoplasmic domain of E1127.
Unlike the envelope proteins of other flaviviruses, they are not proteolytically processed
during their passage through the secretory pathway128. Both proteins contain multiple
glycosylation sites129,130. Little is known about the small p7 peptide, which can form an
ion channel131. Apart from the fact that it is necessary for assembly132 and can prevent
degradation of the glycoprotein E2133, the exact function of the viroporin has not been
clarified. NS2 is a cysteine protease, and a part of the intermediate NS2-3 protease. It
is also involved in particle production, but is not included in the mature virion134,135.
After assembly of intact capsids, the particle enters the secretory pathway136. By
budding of the capsid into the ER-lumen, likely mediated through interaction of core
with the E1:E2 complex, the virion acquires its membrane. In the course of egress,
the viral membrane picks up lipoproteins ApoE and B, and is likely associated with
VLDL137, which remain associated to the virion and are needed for the subsequent
infection event. During its passage, the viral particle is packaged into a secretory vesicle,
which releases the infectious virion by membrane fusion138. This process is, like viral
entry, clathrin-dependent137 (fig. 1.4F).
1.6. Cell Culture Systems for HCV Replication
The establishment of an efficient cell culture model for HCV took more than a decade
after initial characterization of the virus. In those years, HCV was challenging to prop-
agate and detect in cell culture, so most investigations relied on infected primary hep-
atocytes, which only survive several weeks under cultivation and detection of RNA by
PCR-based methods139,140. Later, also susceptible cell lines were discovered, which could
sustain HCV infection for prolonged periods of time141. The major turning point was
the subgenomic replicon system, developed by Lohmann et al. 142 , which is based on a
truncated open reading frame, containing the replicase components NS3-5B. The core
to NS2 fragment was replaced by a neomycin phosphotransferase (neo), conferring re-
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sistance to the antibiotic G418, for selection in cultured cells. The first replicons were
bicistronic (fig. 1.7B), with the selection marker under control of the HCV IRES and
a second EMCV IRES element driving translation of the HCV non-structural proteins.
The coding sequence was derived from a genotype 1b consensus (Con1)142. Modifications
Figure 1.7.: Reporter replicons for HCV. A | Monocistronic replicon with firefly reporter.
The conserved GDD motif of the polymerase is indicated. Mutation of this amino acid triplet
abolished replication capacity of the replicon. B | Bicistronic replicon with an EMCV IRES
controlling non-structural protein synthesis. C | Full length reporter virus (JcR2A) with a
renilla luciferase gene preceding the core coding region.
of the replicon system allow insertion of a reporter (e.g. Luciferase) instead of (or in
combination with) a selection marker. Additionally, the replicon system can also be used
in a monocistronic context, with a recognition site for the host ubiquitin protease 3’ of
the reporter gene143–145 (fig. 1.7A). The construct is flanked by the native non-coding
regions to allow for efficient replication and translation. Usually, these sequences are in
vitro transcribed to generate a replication competent RNA, which is then transfected
into target cells by electroporation. A conserved GDD-motif in the catalytic center of
the RdRP can be deleted (∆GDD) or mutated (GND), to generate a replication deficient
negative control (marked in fig. 1.7A). These RNAs faithfully emulate the intracellular
stages of HCV replication, including membranous web formation.
Most isolates need to acquire a number of adaptive mutations to replicate efficiently
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in cell culture146. These mutations boost replication, but completely abrogate infectious
particle formation147. The discovery of the Japanese fulminant hepatitis (JFH)-1 strain
(gt2a), which thrives in cultured cells without any need for adaptation, made it possible
to generate an even more effective replicon system148.Today, this represents one of the
most frequently used model systems in HCV research, due to its high replication effi-
ciency. Replicon systems for many other genotypes have been developed in recent years,
allowing for the investigation of genotype-dependent differences149.
Moreover, JFH-1 also produces virions in cell culture, albeit to low numbers. This was
the basis for the generation of a chimeric construct (core-NS2 of the J6 strain (also gt2a))
to allow production of infectious particles in cell culture to unprecedented titers150. The
resulting virus has been modified and a Renilla luciferase reporter was introduced. This
construct is called JcR2A, and allows for easy detection of full-length HCV replication
and infection (fig. 1.7C).
Selection of Con1 replicon transfected Huh-7 cells gave rise to replicon-containing
clones. By curing these cells with antiviral regimens, two cell lines (Huh-7 LUNET,
Huh-7.5) were obtained, which are significantly more permissive for HCV propagation
than the parental cell line151. Apart from these highly susceptible cell lines, other liver
and non-liver cells are capable of HCV replication when they are supplied with miR-
122, which has been identified as a crucial host factor of HCV translation and replica-
tion152,153. A recently established model system are Hep3B cells. This hepatic cancer
cell line has been transformed by chronic HBV infection, and lacks detectable expression
of miR-122154. Therefore, these cells do not support efficient HCV replication natively.
However, stable transduction, or transient transfection by electroporation renders these
cells permissive for viral replication155. Similarly, HepG2 cells have been reported by one
group to become permissive for HCV upon supplementation of miR-122156. In addition
to hepatocytes, several non-hepatic cells have been coaxed into susceptibility by simple
transfection of miR-122. Among them are Hec1B (ovary), 293T (fibroblast), MC-IXC
(neuronal) and RERF-LC-AI (lung)157.
1.7. miRNA in Viral Infection
Viral RNA replication is not only dependent on a number of viral, but also host factors.
Apart from various protein factors, many HCV hijacks the cellular RNA interference
machinery for its own propagation. Many other viral infections also modulate the host
miRNA system, by targeting crucial components of the RNAi machinery (reviewed in
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Skalsky and Cullen 158). Several members of the Herpes- and Polyomavirus families even
encode for their own miRNAs159. A relative of HCV, the Kunjin strain of West Nile
Virus is currently the only RNA virus known to generate a functional miRNA from
the 3’ UTR of its genome160. Overall, the small non-coding RNA fraction is of major
importance for a large number of viruses.
1.7.1. RNA interference and short non-coding RNAs
The basic process of RNA-induced inhibition of translation is called RNA interference
(RNAi), and was first discovered in studies on petunia161, and further insight was gained
in Caenorhabditis elegans. It was discovered that delivery of small RNA fragments with a
complementary sequence to regions of cellular mRNAs, resulted in decreased levels of the
targeted transcript and the encoded protein162. Shortly after this revolutionary observa-
tion, the occurrence of small interfering RNAs (siRNA) in plants, shed light on possible
functions of RNAi. It was observed that cauliflower mosaic virus infection is counter-
acted by generation of short fragments of viral RNA, which bind to their respective
complements, and eventually lead to its degradation163. It was assumed that this ability
of generating anti-viral RNAs had been lost in higher animals, until recent studies could
show siRNA-mediated host defense mechanisms are existent164. However, the majority
of cellular short RNA is generated from endogenous sources, and has important functions
in cellular homeostasis. MicroRNAs are 21 - 24 nt long non-coding transcripts, which are
capable of post transcriptionally regulating the translation of their target genes. MiR-
NAs are located either in intronic or exonic regions, as single transcripts or in clusters
under a common promoter, which are transcribed to polycistronic primary miRNAs.
They are usually generated by RNA polymerase II, in some cases by RNA polymerase
III (PolII, PolIII). These capped and polyadenylated transcripts are several hundred
base pairs in length, and form bulged, hairpin structures with a short terminal loop.
These structural features are recognized by the ribonuclease III-like protein Drosha, and
its co-factor DiGeorge Syndrome Critical Region Gene 8 (DGCR8), forming the micro-
processor complex165–167. The pri-miRNA is cleaved by Drosha at around 22 nt from the
terminal loop. DGCR8 functions as molecular ruler to ensure the correct length of the
fragments. The resulting stem loop is now called precursor miRNA (pre-miRNA). In few
cases, nuclear maturation of miRNA precursors can be Drosha/DGCR8-independent168.
Yet, the final products of both ways have the same distinct features, most importantly a
2 nucleotide overhang at its 3’ end, and a 5’ phosphate. After export to the cytoplasm,
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the pri-miRNA is bound by Dicer, another member of the ribonuclease III family. After
binding, the terminal loop is removed169,170. The only known exception is pri-miR-451,
which is directly processed by AGO2171. The resulting short RNA duplex has now 3’
overhangs on both strands. Subsequently, the strand with the higher thermodynamic
stability on its 5’ end, or passenger strand (miR*), is released and usually degraded.
The guide strand, becomes the active miR. Target specificity is primarily mediated by
the 5’ nucleotides 2 to 8, which compose the so-called seed region. Further pairing
of the 3’ nucleotides determines the stability of the hybrid. Since not all nucleotides
are complementary, the miRNA:mRNA duplex has a bulged appearance. Studies have
shown, that target sites are significantly over-represented in the 3’ untranslated regions
of cellular mRNAs. Before binding to a target mRNA, the double-stranded RNA is
being incorporated into the RNA-induced silencing complex (RISC). The core proteins
essential for the assembly of the initial complex are Dicer, one member of the Argonaut
protein family, mostly AGO2, and TRBP172,173. The final RISC can be comprised of
many factors, even though only AGO bound to a small RNA seems to be sufficient for
functional mRNA silencing. Unlike in siRNA-mediated decay, the imperfect binding
of miRNAs does usually not trigger AGO2-driven immediate destruction of the target
transcript, but initially blocks translation. The definitive mechanism is not yet fully un-
derstood, but several hypotheses are discussed. One model suggests a block of ribosomal
initiation, due to interference of AGO2 with eIF4F cap-binding174, and/or recruitment
of deadenylases by GW182175, which is known to directly interact with AGO2. In addi-
tion to the translational repression or degradation of target mRNAs, miRNAs can also
function via epigenetic transcription regulation in the nucleus and direct receptor bind-
ing176–179. In the next step, Dicer dissociates from the complex, and the residual RISC
is sequestered in cytoplasmic aggregates, the processing bodies (P-body)180. These foci
contain proteins of the degradosome, and completely lack ribosomes, thereby promoting
degradation and subverting translation. The whole process is summarized in fig. 1.8.
On the mRNA level, the overall changes are rather modest, which has lead to the term
”regulatory fine-tuning”181. The reduction of mRNA and protein levels depends strongly
on numerous factors, such as the number of binding sites, the degree of sequence com-
plementary, potential counter regulatory events182, and possible synergistic effects183,184.
Many mRNAs have multiple binding sites and are targeted by more than one miRNA.
By today, over 1000 human miRNAs have been discovered, and the number is rising.
Estimations that up to 80% of all genes are regulated by this particular mechanism185–187
underscore the importance of maintaining a delicate balance of proteins in the cell.
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Figure 1.8.: MicroRNA biogenesis and function. In animals, PolII transcribed hair-
pins are cut by the nuclear microprocessor complex, comprised of Drosha and DGCR8, and
transported to the cytoplasm via exportin 5/RanGTP. Dicing and unwinding is followed by
embedding of the mature miRNA into the RISC, which is essential for the inhibition of trans-
lation and re-localization to P-bodies.
1.8. HCV:miR-122 interaction
miR-122 is liver specific, and with roughly 60000 copies per cell the most abun-
dant miRNA in hepatocytes188,189. It is involved in a great number of cellular pro-
cesses. The functional spectrum includes roles in iron and lipid metabolism190–192, anti-
tumor193,194,192 and anti-viral195 activities as well as immune modulation196. The viral
genome harbors two highly conserved binding sites for the mircroRNA in the first 40
nucleotides of the 5’ UTR, which have been found to be of vital importance for the
virus152. Numerous studies have found that in cellular genes the 3’ UTR show a sig-
nificant enrichment of functional binding sites, and translation is reduced upon RISC
binding (reviewed in Bartel 197). In contrast, HCV translation and replication are mas-
sively increased upon miR-122 interaction198,199. Indeed, the miR-122 is an important
dependency factor for HCV, and might be the reason for the liver tropism of the virus.
So far it has been reported that most cell lines lacking miR-122 do not support replica-
tion, with few exceptions. In one study it was observed that Hec1B support low-level
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replication of HCV in absence of miR-12212, which is in line with some reports claiming
extra-hepatic manifestations of the disease200,201. Also, Hep3B cells were shown to allow
for replication of a bicistronic replicon155. Even though an ever growing amount of de-
scriptive evidence for the importance of the miR-122:HCV interaction is generated, the
molecular mechanisms are still elusive. A general stabilization effect of miR-122 on the
HCV RNA has been described, which has been connected to host nuclease resistance.
The binding model of miR-122 to the 5’ portion of HCV predicts an unusual 3’-overhang
of the miR, effectively masking the native 5’-terminus of the viral genome202. Therefore,
it has been postulated, this might act as a physical shield against the recognition of
5’-3’-exonucleases. Specifically, Xrn1203 (and recently also Xrn2204) were identified as
likely effectors, degrading unprotected HCV RNA. The stability hypothesis is currently
thought to explain most of the effects on the HCV life cycle, although there is mounting
evidence that the other modes of action are at least similarly important. Especially the
failure of efficient knock-down of the exonuclease Xrn1, which is thought to be the key
player in HCV RNA degradation, to rescue replication in absence of miR-122 has cast
some scrutiny on this view205. Moreover, miR-independent replication of a bicistronic
construct further underscores the notion that a combination of events is necessary to
fully explain the impact of miR-122 on the viral life-cycle155. While ongoing replication
is not affected by miR-122206, the initiation phase seems to be influenced. A recent
study claimed that this might be due to displacement of translation-enhancing factors
(e.g. PCBP2), leading to a greater fraction of RNA available for replication207. Another
option that was explored in some detail, was the stimulation of protein synthesis. Re-
porter systems and replicon based studies, in cells or in vitro 208,198 have all concluded
that HCV IRES-dependent protein production is increased in presence of miR-122. More
specifically, the kinetics of 40S attachment are accelerated, which is a crucial step on
the way to initiation complex formation209. The molecular basis for this effect has not
yet been discovered.
1.9. Host and Viral Modes of Translation Initiation
Cellular mRNAs are commonly translated in a cap-dependent fashion. The cap struc-
ture is an important recognition site for the protein complexes that are required for
ribosome attachment and translation initiation. This modification is applied to the
mRNA during its nuclear maturation process. While this is the standard mechanism of
translation, alternative routes exist, which rely on direct, internal ribosome recruitment
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to the initiation site.
1.9.1. Cap-dependent Versus IRES-mediated Translation
The cap structure is composed of a C7-methylated guanosine (m7G) which is attached to
the 5’-end via a triphosphate bridge. This is a common feature of all processed messenger
RNA, which are exported from the nucleus into the cytoplasm. It protects the RNA
from premature degradation, and additionally serves as a hub for protein recruitment210.
In the nucleus, a cap-binding complex is assembled, composed of IMPα, and the cap-
binding proteins CBP20 and CBP80. In addition, proteins of the spliceosome, the exon-
junction complex (EJC), and polyA-binding proteins associate to the message. After
translocation to the cytosol, a cascade of events is triggered, leading to the assembly of
an initiation complex. First, a binary complex of the scaffolding factor eIF3 and the
40S ribosome is recruited to the cap via the CBP80/20-dependent Translation Initiation
Factor (CTIF)211,212. At this point, the ternary complex co-associates to form a 43S
pre-initiation particle213. Since these steps are all taking place in close proximity of the
cap structure, the ribosome must be placed at the initiation codon by scanning the RNA
template. For this step, the eIF4F complex is utilized, which contains the RNA helicase
eIF4A214. Upon ATP hydrolysis, this factor moves the 43S complex along the message.
Once in place, the eIFs are removed from the pre-initiation complex. This leads to
the assembly of the 80S ribosome, with the help of eIF5 and 5B. The pioneer round
of translation is about to begin215. This distinct step in the life of messenger RNAs
is mainly important for quality control. Aberrantly spliced mRNAs, which contain
a stop-codon in the ORF, are recognized by interaction of the SURF protein complex
(SMG1,Upf1,eRF1+3), which associates to stalled ribosomes and a downstream EJC216.
Then, endo- and exonucleases are recruited and degrade the faulty message, a process
known as nonsense-mediated decay (NMD). If the mRNA is correctly processed, the first
ribosome dislodges all EJCs in its course217, and also a specific type of polyA-binding
protein (PABPN1), which is only present during this pioneer round of translation218.
These modifications of the mRNP are therefore referred to as translation-dependent
mRNP remodeling. At the cap, a translation-independent change is mediated by IMPβ,
which binds to IMPα, stably connected to the CBPs218. Interaction of these proteins
releases the CBP complex, which is then replaced by eIF4E, also present in the eIF4F
particle. The other included eIF4-protein, eIF4G, interacts with polyA-binding proteins
to circularize the mRNA, and also recruits the 43S complex to initiate subsequent rounds
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of translation. Now, polysome assembly and steady state translation can begin. Most
DNA viruses are replicating in the nucleus, and can therefore make use of the host’s
capping machinery. Poxviruses are an exception, as they encode their own capping
enzymes. Influenza viruses have to acquire their cap from host mRNAs employing a
process termed cap-snatching. However, a large number of RNA viruses use a different
strategy. Attachment of the uncapped RNA to the ribosome is in these cases mediated
by an IRES. Several virus families make use of such a structured RNA element. There
are currently four known types of RNA-virus IRES elements, which are grouped based
on their structural properties and usage of initiation factors. Type I is present in entero-
, rhino-, and polio virus219,220. Some members of the cardio- and apthoviruses of the
Picornavirdiae family mediate translation from a type II IRES, sharing the archetype
structure of EMCV221. Both of the previously mentioned IRESes rely on many canonical
eukaryotic initiation factors (eIF), including eIF4A and G, but they contain distinct
structural features. In contrast, HCV possesses a type III IRES, which is only dependent
on eIF3 and the ternary complex (eIF2:GTP:tRNAmet), similar to the related GB virus-
B and -C, and classical swine fever virus. Curiously, a DNA virus, Human Herpesvirus-8,
also shares this type of IRES222. The initiation element of Cricket paralysis virus is the
epitome of a type IV IRES, which is independent of initiation factors223, including the
ternary complex, and is located within an intergenic region224.
Not only virus messages, but also some host mRNAs have been described to contain
functional IRES elements in addition to the cap225–228. Similarly, HIV-1 produces capped
mRNAs, which also harbor IRES elements. These are employed during the late stages
of productive infection, when the host cell is going into translational arrest229. 5’ UTRs
with an IRES are usually longer, more structured and might contain several upstream
AUGs, making them poor templates for efficient cap-dependent translation. However,
both types of initiation can concur on the same message226. The circumstances under
which either mode is used are not always clear, but for cellular genes, their regulation
seems to be mostly dependent on environmental influences (e.g. starvation) or cell cycle
phase. For instance, the IRES of the X-linked inhibitor of apoptosis protein evades stress-
induced translation repression by using eIF5B, instead of eIF2α230,225, a mechanism also
exploited by HCV231. While most IRES elements are upstream of the initiator AUG,
some are located in the coding region, therefore producing a shortened protein. In
the case of p53, this truncated version acts as potent inhibitor of the cap-translated
version, and induces cellular proliferation232,233. Overall, the cellular IRES still remains
a mystery in many ways. In contrast to their viral counterparts, they are less structurally
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stable and do not share common sequence features. One common feature is the use of
specialized RNA-binding proteins, IRES-specific cellular transacting factors (ITAFs),
which are non-canonical modulators of translation. These factors serve to recruit other
proteins, or to structurally rearrange the RNA. Importantly, they can substitute the
functions of canonical initiation factors. Almost all known IRESes circumvent the need
for the cap-binding protein eIF4E234,235. The scanning step is also omitted in most
cases, since the ribosome is assembled in close vicinity of the initiation codon. The
detailed mechanisms, and whether the assembled RNP is static, or as dynamic as in
cap-dependent translation remains to be investigated.
1.9.2. The HCV IRES and its Modulation by Host Factors
The HCV IRES structure is located in the 5’UTR of the viral genome, as well as a
part of the core coding region236, and is divided into three functional domains (II-IV,
fig. 1.9A). Domain I is not included in the classical definition of the IRES, however,
it is able to modulate translation. All domains feature extensive secondary structures,
which are crucial for IRES function. Moreover, interactions between different parts of
the IRES further increase its three dimensional complexity. The primary sequence of
the IRES element is highly conserved among all genotypes. Only few positions can be
exchanged without causing severe impairment of IRES activity. Genotypes 3a and 4a
have exchanges at nucleotides 175 and 224, which retain the structure via non-Watson-
Crick base pairing, but might impact the thermodynamic stability. For gt3a, the domain
III substructures c and d are also deviating from the sequence of other genotypes. This
might account for a weaker IRES activity observed for gt3 sequences, compared to 1 and
2. Reported variations in domain IV are all located in the core coding region237.
1.9.3. Functional properties of the HCV 5’ UTR and IRES domains
The role of domain I (nt1-47) has been controversially discussed. While some claimed
a positive role in protein synthesis238,239, others found it to be dispensable for IRES
activity240, or even exert repressive effects on the translation of a downstream open
reading frame241,242. In agreement with the latter, deletion of domain I enhances trans-
lational activity not only in vitro, but also in vivo 243. Importantly, studies on the HCV
replicon system have shown that this region also harbors functional elements that facil-
itate replication244. It was later recognized that the 3’ terminus of the complementary
(negative) strand is responsible for this function245. Importantly, most assumptions on
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the roles of this domain were made before the discovery of two seed-binding motifs for
the liver-specific microRNA (miRNA or miR)-122153, which can significantly increase
the translation/ replication capacity of the virus by a presently undefined mode of ac-
tion246(fig. 1.3A). In recent years, the modulatory role of domain I in viral translation
has therefore regained a lot of significance. In particular, the purportedly unstructured
region separating SLI and II is in the focus of attention .
IRES domains II and III promote assembly of the 40S and 48S ribosomal complexes,
respectively247 (fig. 1.9A). Domain II is absolutely required for efficient IRES activity in
liver cells248,249. Besides the primary sequence and secondary structure, also the tertiary
fold is of great import. The twisted L-shaped architecture of SLII is crucial for ribo-
some assembly, and compounds targeting the kink region effectively abolish translation
activity250,251. In HCV, as well as the related Classical Swine Fever Virus (CSFV), it me-
diates the displacement of eIF2 to facilitate attachment of the 60S ribosomal subunit252.
Moreover, this domain is able to structurally modify the ribosome to optimize activity,
stability and entry position via a GCC motive at the tip of the stem-loop223,253,254, a
feature that sets this type of IRES apart from all others. Deletion of domain II also
influences the structure and ribosome binding capability of the downstream domains255.
Domain III is mostly responsible for host factor recruitment, it comprises binding
motifs for numerous ITAFs and the eIF3 complex256, the only additional host initi-
ation factor known to aide HCV translation, apart from the eIF2-containing ternary
complex. Under stress conditions, when eIF2α is phosphorylated and thereby inacti-
vated, eIF5B can be used as substitute. The activity of domain III depends on the
formation of an internal pseudoknot at the 3’ base, close to the initiation codon30,249,236.
The structural setup confers a high binding affinity for the eIF3 N-terminal RNA bind-
ing domain257,256,258, which allows the HCV IRES to compete with preformed eIF3:40S
complexes259. The eIF3:40S complex is necessary for cap-dependent translation activ-
ity. The HCV IRES binds the 40S subunit independently before recruiting eIF3 and
the ternary complex. Therefore, this function of the HCV IRES might also provide a
means for virus-induced host cell shut off. Moreover, multiple contact sites with the 40S
ribosomal subunit were identified at sub-domains IIIc and IIId by toe printing analysis,
the adjacent pseudo knot, and the initiation codon by different groups255,247 (fig. 1.9A).
Domain IV includes a stem containing the initiator AUG, which negatively regulates
translation efficiency260. The domain extends into the core coding region261. The se-
quence folds into a pseudoknot element262, which positions the ribosomal E-site directly
at the start codon, without the need for a scanning step. The primary sequence seems
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to be critical for 40S binding, resulting in extreme conservation among genotypes263.
Figure 1.9.: The internal ribosomal entry site of HCV. A | Sequence of events prior
to translation initiation. (1) The first step of translation initiation is the recruitment of the
small subunit of the ribosome. For capped RNAs, eIF3 is needed for 40S attachment and 48S
particle formation. (2a) Here it is recruited separately, together with the ternary complex,
eIF2:GTP:tRNAmet, under normal conditions. (2b) During cell stress, eIF2α is inactivated
through phosphorylation, and HCV switches to eIF5B instead. (3) 80S assembly is initiated
by eIF3. Then, domain II mediates the release of initiation factors. The structure of SLII as
well as of the ribosome is altered in the process, to position the ribosome correctly and activate
translation. B | Factors that modulate HCV translation, and their respective binding position
in the 5’ or 3’ UTR.
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1.9.4. Cellular and viral proteins involved in IRES mediated
translation
Several protein factors have been found to modulate HCV IRES dependent translation.
As mentioned above, eIF3 and 2, and under certain circumstances eIF5B, are the only
canonical initiation factors known to be associated with HCV. In contrast, the complete
eIF4 complex, including the scanning factor eIF4A are thought to be dispensable for
IRES activity264. In the 5’ and 3’ genome flanking regions, a number of ITAFs are
bound (fig. 1.9B).
NSAP-1265, La antigen266, NFAR90/45267,268, polycytidylic acid binding protein
(PCBP)269,270, heterogeneous ribonucleoprotein L (hnRNPL)271,272,267,273 or UNR (up-
stream of N-ras)273,274 are known interactors, which are in most cases known to enhance
translational activity. Also, the polypyrimdine tract binding protein, PTB, binds to
multiple sites in the viral 5’ and 3’ UTR275,276,273. The role of PTB has been subject
to great controversy277–280, but is now believed to inhibit, rather than stimulate trans-
lation, instead favoring RNA replication281. Of note, UNR and PTB have also been
implicated in activation of a cellular IRES element in the APAF-1 message, acting as
a molecular chaperone282. Interestingly, UNR itself can be translated via internal ini-
tiation, in this case PTB is also described as a negative regulator283. Also, a member
of the heat-shock protein family, HSP90, has been reported to associate with eIF3 to
stimulate translation284.
While viral non-structural proteins are absent during the first round of HCV trans-
lation, at later stages of the viral life cycle it is likely that they can act as regulatory
factors. Examples are NS3, which has been shown to inhibit translation and favor repli-
cation by dislodging La68, or interaction with YB-1285. Additionally, some evidence has
been provided that NS5A can act positively on global translation, at least in part by
recruiting eIF4E85,89,286. Interestingly, also activation of the antiviral double stranded
RNA-dependent protein kinase (PKR) and its interaction with viral NS5A seems to be
beneficial for HCV translation activity under certain circumstances287. Concomitantly,
the kinase is potently triggered by domain II-IV of the HCV IRES84,288. Conversely,
others have found that the IRES inhibits PKR function289, which might be due to dif-
ferent cell type specific modes of regulation287. PKR is triggered by exogenous stressors
(e.g. dsRNA intermediates during viral infections), and in turn shuts off translation
by phosphorylating eIF2α. Phosphorylated eIF2α cannot participate in ternary com-
plex formation, resulting in translational arrest290. HCV escapes this genuinely antiviral
29
1. Introduction
mechanism by usage of eIF5B, resembling a mode of translation initiation usually found
in bacteria231.
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2.1. An in vitro replication assay for HCV
To date, the mechanisms of initiation of viral RNA synthesis remain largely elusive. The
vital contribution of the non-structural proteins NS3 (especially its helicase function)
and NS5A to RNA replication have been described in the replicon model. However,
mutations which perturb the function of a single protein are hardly interpretable in
the cellular context, due to the complex network of interactions present in this setting.
Hence, the isolation and reconstitution of replicase complexes in vitro is the method
of choice in order to address the contribution of individual protein functions. Working
in vitro systems for the HCV replicase have been established for synthetic templates,
but few data are available on biologically relevant RNAs. Especially the determinants
for the initiation of de novo (-)-strand synthesis, which is the primary step for every
replication cycle, are not clear.
Therefore, the first part aimed to develop an in vitro assay using purified replicase
proteins, to reproduce critical steps of HCV replication initiation in a test tube. This also
requires a reliable expression system for the involved non-structural proteins. Initially,
the focus was set on the optimization of protein expression in bacteria or mammalian cells
and the characterization of protein function. In this approach, the isolated components
of the viral replicase should be used to determine individual contributions of the non-
structural proteins on the polymerase activity of NS5B. In particular, the functional
involvement of the viral helicase NS3, but also potential activities of NS5A should be
investigated.
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2.2. Dissecting the roles of miR-122 in the HCV life
cycle
In the second part, we were addressing the question, as to how miR-122 influences HCV
at different stages of its life cycle. This issue is under vigorous debate. RNA stability,
replication and translation efficiency have all been hypothesized as possible modes of
action. The stability hypothesis is currently thought to explain most of the effects on
the HCV life cycle, although there is mounting evidence that the other modes of action
are at least similarly important. Especially the failure of efficient knock-down of the
exonuclease Xrn1, which is thought to be the key player in HCV RNA degradation, to
rescue replication in absence of miR-122 has cast some scrutiny on this view. Thus,
this work aimed to quantify the different contributions of miR-122 to translation, RNA
synthesis and RNA stability and comprehend the underlying molecular mechanisms.
One possibility under investigation was, whether binding of the RISC complex could
act as an RNA chaperone to induce a structural shift in the 5’ UTR of HCV, which regu-
lates translation efficiency. The functional HCV IRES consists of three highly structured
domains, II - IV, which are essential for translation291. We envisioned that by prevent-
ing the formation of a translation attenuating stem in domain I, miR-122 binding could
create a bias towards the local structure, which is described as domain II of the HCV
IRES. By means of site directed mutagenesis within the two 5’ binding sites, we wanted
to determine the impact of miR-122 on translation and replication. Moreover, the IRES
with and without bound miR-122 was subjected to structural analysis by biochemical
(SHAPE) and biophysical (NMR) methods.
Apart from the two prominent 5’ miR-122 binding sequences, two more sites have
already been described: one in the coding region of NS5B, and another one in the
variable region of the 3’ UTR. In addition, further conserved miR-122 binding sites were
searched by comparing the full length RNA sequences of several genotypes. To date,
the contribution of these sites to the viral life cycle has not been investigated in great
detail. Therefore, this work finally aimed to interrogate the functional relevance of the
additional sites in the coding region and 3’ UTR.
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3.1. Chemicals and Expendables
Table 3.1.: Overview of chemicals
Name Supplier
Agarose Sigma Aldrich (Darmstadt, Germany)
Ethidium bromide Carl Roth (Karlsruhe, Germany)
Ampicilin Sigma Aldrich (Darmstadt, Germany)
Acetic acid Carl Roth (Karlsruhe, Germany)
Glycerol Carl Roth (Karlsruhe, Germany)
β-Mercaptoethanol Sigma Aldrich (Darmstadt, Germany)
Calcium chloride Carl Roth (Karlsruhe, Germany)
Chloroform Carl Roth (Karlsruhe, Germany)
Ethylenediaminetetraacetic
acid (EDTA)
Sigma Aldrich (Darmstadt, Germany)
Ethanol Carl Roth (Karlsruhe, Germany)
Methanol Carl Roth (Karlsruhe, Germany)
Glycerol Carl Roth (Karlsruhe, Germany)
Hydrochloric acid Carl Roth (Karlsruhe, Germany)
Isopropanol Carl Roth (Karlsruhe, Germany)
Potassium acetate Carl Roth (Karlsruhe, Germany)
LB Medium/Agar Carl Roth (Karlsruhe, Germany)
Magnesium chloride Carl Roth (Karlsruhe, Germany)
3-(N-
Morpholino)propansulfonic
acid (MOPS)
Sigma Aldrich (Darmstadt, Germany)
NaCl Carl Roth (Karlsruhe, Germany)
Di-Sodium carbonate Carl Roth (Karlsruhe, Germany)
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o-Nitrophenyl-β-D-
galactopyranosid
Sigma Aldrich (Darmstadt, Germany)
Polyethylenimine Sigma Aldrich (Darmstadt, Germany)
Paraformaldehyd Sigma Aldrich (Darmstadt, Germany)
Tris(hydroxymethyl)aminomethane
(TRIS)
Carl Roth (Karlsruhe, Germany)
Triton-X 100 Sigma Aldrich (Darmstadt, Germany)
Tween20 Carl Roth (Karlsruhe, Germany)
Sodium dodecylsulfate Sigma Aldrich (Darmstadt, Germany)
Dithiothreitol Sigma Aldrich (Darmstadt, Germany)
Dimethylsulfoxide Sigma Aldrich (Darmstadt, Germany)
2-methylnicotinic acid Sigma Aldrich (Darmstadt, Germany)
1,1’-carbonyldiimidazole Sigma Aldrich (Darmstadt, Germany)
Phenol Sigma Aldrich (Darmstadt, Germany)
Urea Sigma Aldrich (Darmstadt, Germany)
Polyacrylamide (19:1, 30%) Carl Roth (Karlsruhe, Germany)
Coelenterazine Promega (Mannheim, Germany)
Luciferine Promega (Mannheim, Germany)
Table 3.2.: Overview of expendable materials
Name Manufacturer
Eppendorf reaction tubes (1.5 ml, 2.0 ml) Eppendorf (Hamburg, Germany)
Multiply-µStrip Pro 8 PCR tubes Sarstedt (Nrmbrecht, Germany)
Polyproylen tubes (15 ml, 50 ml) Sarstedt (Nrmbrecht, Germany)
Pipet tips (10µL, 100µL, 1000µL) Greiner (Frickhausen, Germany)
Glass pipet (2 ml, 5 ml, 10 ml) Costar (Corning NY, USA)
Sterile syringe BRAUN Melsungen AG (Melsungen, Ger-
many)
Sterile syringe filter (0.22µm, 0.45µm) Millipore (Billerica, USA)
Cell culture flasks Becton-Dickinson (Heidelberg, Germany)
Cell culture dishes Falcon BD (Heidelberg, Germany)
Multiwell culture plates Falcon BD (Heidelberg, Germany)
96-well white flat-bottom NUNC (Roskilde, Denmark)
Scalpel Swann-Morton (Sheffield, UK)
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Microscopy glass slides Menzel (Braunschweig, Germany)
Cover slips Menzel (Braunschweig, Germany)
Latex/ Nitrile gloves Kimberly-Clark (Dallas, TX, USA)
BioMax MR Film Kodak (Rochester, NY, USA)
BioMax MS Film Kodak (Rochester, NY, USA)
BioMax Light Film Kodak (Rochester, NY, USA)
Glassware Schott (Jena, Germany)
Phosphorscreen BioRad (Hercules, CA, USA)
Table 3.3.: Kits and commercial systems
Name Manufacturer
PhusionFlash High Fidelity Master Mix Thermo Fischer Scientific (Waltham, MA,
USA)
Restriction enzymes NEB (Ipswich, MA, USA)
DNA Ladder EcoRI λDNA Invitrogen (St. Leon-Rot, Germany)
T4 DNA Ligase NEB (Ipswich, MA, USA)
Extract II Gel Extraction Kit Machery & Nagel (Freiburg, Germany)
NucleoBond PC 100 Plasmid Extraction
Kit
Machery & Nagel (Freiburg, Germany)
NucleoBond PC 500 Plasmid Extraction
Kit
Machery & Nagel (Freiburg, Germany)
Penicillin-Streptomycin (100x) Gibco-BRL (Karlsruhe, Germany)
DMEM Gibco-BRL (Karlsruhe, Germany)
OPTIMEM Gibco-BRL (Karlsruhe, Germany)
Trypsin-EDTA PAA Laboratories (Pasching, Austria)
jetPEI Polyplus Transfection SA (Illkirch-
Graffenstaden, France)
Lipofectamine2000 Thermo Fischer Scientific (Waltham, MA,
USA)
Effectene Qiagen (Hilden, Germany)
Grace Insect Cell Medium Gibco-BRL (Karlsruhe, Germany)
RNAsin Promega (Mannheim, Germany)
SensiMixPlus SYBR Invitrogen (Darmstadt, Germany)
siRNA negative control Sigma Aldrich (Darmstadt, Germany)
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dNTPs Invitrogen (Darmstadt, Germany)
rNTPs Invitrogen (Darmstadt, Germany)
SuperScript III RT Invitrogen (Darmstadt, Germany)
Western Lightning ECL PerkinElmer (Waltham, MA, USA)
QuantiGene ViewRNA ISH Cell Assay
Kit
Affymetrix (Santa Clara, CA, USA)
Fluoromount-G Sigma Aldrich (Darmstadt, Germany)
3.2. Plasmids
Table 3.4.: Basic plasmids
Name Description
pAPM-L1221 Lentiviral vektor for shRNA expression,
puromycin resistance gene
pBSK-3’-JFH-dg T7 expression plasmid for in vitro assay
template
pFKT7-JFH-1-3’ 7 expression plasmid for in vitro assay
template
pET16 Plasmid for IPTG inducible protein ex-
pression
pET21 Plasmid for IPTG inducible protein ex-
pression
pFastBac-DualGFP Baculovirus plasmid for protein expres-
sion in Sf9
pFK-i389-LucubiNS3-3’-dg-JFH Monocistronic luciferase-Replicon, JFH-1
NS3-3’, HDV ribozyme at 3’end.
pFK-i341-PiLucNS3-3’-dg-JFH Bicistronic luciferase-Replicon, JFH-1
NS3-3’, Polio IRES driven luciferase,
HDV ribozyme at 3’end.
pFK-JCR2a-dg-WT Full-length J6/JFH-1 luciferase reporter
virus
pTM-NS3-3’ T7 promoter-driven protein expression
plasmid
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pMD.G2 Lentiviral plasmid, which encodes for the
surface protein (env)
pCMV∆31 Lentiviral plasmid, which encodes for the
replication machinery (gag/pol)
pWPI-BLR Lentiviral protein expression plasmid with
EIF1A promoter
pUC19 High copy plasmid, used for generation of
in vitro transcripts
3.3. Technical Equipment and Software
Table 3.5.: Overview of centrifuges, PCR cycler and other technical appliances
Name Manufacturer
Biofuge Pico Heraeus (Hanau, Germany)
Gelelectrophoresis system Qiagen (Hilden, Germany)
Electrophoresis Power Source Qiagen (Hilden, Germany)
NanoDrop Light Thermo Fischer Scientific (Waltham, MA,
USA)
Sorvall RC5C Plus Centrifuge Thermo Fischer Scientific (Waltham, MA,
USA)
GlassLine Refrigerator Liebherr Holding GmbH (Kirchdorf an der
Iller, Germany)
Freezer -20◦C Gram (Sarstedt, Germany)
Freezer -80◦C Thermo Fischer Scientific (Waltham, MA,
USA)
ThermoMixer Eppendorf (Hamburg, Germany)
Precision 2864 Water Bath Thermo Fischer Scientific (Waltham, MA,
USA)
Vortexer Bibby Scientific Limited (Staffordshire,
UK)
Analysis balance M4600 Delta Range Mettler (Giessen, Germnay)
pH-meter 766 Calimatic Knick (Berlin, Germany)
TPersonal 48 Thermal Cycler Biometra (Gttingen, Germany)
37
3. Materials
BioRad CFX96 BioRad (Hercules, CA, USA)
UV GelDoc 2000 Intas (Ahmedabad, India)
PipetBoy acu integra INTEGRA Biosciences (Fernwald, Ger-
many)
Pipets (10µL, 100µL, 1000µL) Gilson (Hamburg, Germany)
Dispenser Multipipette Eppendorf (Hamburg, Germany)
Leica DM-IL HC microscope Leica Camera AG (Solms, Germany)
Leica DM-IL microscope Leica Camera AG (Solms, Germany)
Leica DFC 420C CCD camera Leica Camera AG (Solms, Germany)
Leica DM 6000B microscope Leica Camera AG (Solms, Germany)
HERAsafe sterile work bench Thermo Fischer Scientific (Waltham, MA,
USA)
HERAcell 240 incubator Thermo Fischer Scientific (Waltham, MA,
USA)
Magnetic stirrer L-71 A. Harfenstein (Wrzburg, Germany)
Shaker HS250 IKA Labortechnik (Staufen im Breisgau,
Germany)
Lumat LB 9508 Tube Luminometer Berthold Technologies (Bad Wildbad,
Germany)
Mithras LB 940 Plate Luminometer Berthold Technologies (Bad Wildbad,
Germany)
Gene Pulser II Electroporation System BioRad (Hercules, CA, USA)
Table 3.6.: Software
Name Developer
Creative Suite 6 Adobe (Dublin, Ireland)
Kile Kile Development Team
Prism 5 GraphPad (La Jolla, CA, USA)
CFX Manager BioRad (Hercules, CA, USA)
CLC Main Workbench v6.5 CLC bio (Mhltal, Germany)
Primer3 Lincoln Stein
VARNA Ponty and Leclerc 292
SAFA Das et al. 293
LEICA Suite Leica Camera AG (Solms, Germany)
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Office Suite 365 Microsoft (Redmond, WA, USA)
3.4. Oligonucleotides
All primers were designed using either the integrated tool of CLC Main Workbench v5,
or VectorNTI v11. The oligonucleotides were purchased from Sigma Aldrich (Darmstadt,
Germany). Refer to supplementary tab. C.2 to tab. C.1 for a complete list of used
primers.
RNA oligonucleotides were ordered at MWG (Ebersberg, Germany). Sequences of
hsa-miR-122-5p and -3p were acquired from miRBase. However, an additional 3’ U
was added based on the review of Jopling 188 , which stated this sequence as the most
abundant variant in hepatocytes. For the inactive mutant miR-122 A4U, the adenine at
position 4 was changed to uracil, and the complementary exchange was performed on the
3p-strand. Duplexes were generated by mixing of 5p- and 3p-strand, 2 min denaturing
at 95◦C, and cooling to room temperature on the bench top.
3.5. Bacteria and Cell Lines
The bacterial strain used or plasmid amplification was E. coli DH5α from Invitrogen
(Darmstadt, Germany). BL21 E. coli were used for IPTG inducible protein produc-
tion. DH10Bac (Thermo Fischer Scientific, Waltham, MA, USA) were used for bacmid
generation, to produce baculovirus.
Table 3.7.: Overview of used cell lines
Name Type
HEK293T Adherent human epithelial cell line, expresses SV40 large T-
antigen
Hep3B Human hepatoma cell line with HBV integrate, no miR-122 ex-
pression
HepG2 Human hepatoma cell line, no miR-122 expression
Huh7 “Lunet” Human hepatoma cell line, HCV cured
Huh7.5 Human hepatoma cell line, highly permissive Huh7 subclone
Sf9 Insect cell line for baculovirus based protein production
BSRT7 Baby Hamster Kidney cell line, expressing T7 polymerase
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4.1. Cloning
4.1.1. Polymerase Chain Reaction (PCR)
The PhusionFlash Master Mix (Thermo Fischer Scientific, Waltham, MA, USA) was
used for PCR-based DNA amplification. 0.5µM of the respective primers were mixed
with up to 500 ng of template, and diluted with water to a final volume of 10µl. Then,
10µl of the master mix was added and the PCR was performed according to the manu-
facturer’s instructions.
Deletions of sequences within a given template were generated via fusion PCR. This
two-step method makes use of two primer pairs: one pair of “outer” primers was designed
as usual at the very ends of the template with an incorporated restriction site, as desired.
Two “inner” primers were placed directly 3’ adjacent to the desired mutation site with
a 5’ complementary overhang of approximately 15 nt. With the corresponding inner and
outer primers, two PCR fragments were generated with complementary sequences at the
respective overlap region. Via these sequences, the amplification products of the first
PCR were fused in a second step, using the outer primer pair.
4.1.2. Restriction of DNA Templates
For analytic purposes, ≈500 ng of DNA were used in the reaction. 1u per µg of restriction
enzyme (NEB, Ipswich, MA, USA) was used, and the mixture was incubated for 1 h at
37◦C, or as indicated for specific enzymes. In case of plasmids to be used for ligation,
1 u of calf intestine phosphatase (NEB, Ipswich, MA, USA) was added after 30 min, and
the mixture was incubated for another 25 - 30 min at 37◦C. This step was performed to
remove the 5’-phosphates from the cleavage sites, to counteract spontaneous re-ligation
of the vector.
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4.1.3. Agarose Gel Electrophoresis
Depending on the expected size of the DNA fragment, 1 to 2% agarose gels were prepared
in TAE buffer (40 mM TRIS,1 mM EDTA, 40 mM acetic acid) with 10µL of a 10 mg/ml
ethidium bromide (EtBr) solution per 100 ml. The DNA was complemented with loading
dye. The gel was run at 100 V for 25 to 45 min. 10µL DNA ladder mix were loaded
on at least one lane, to estimate the sizes of the analyzed fragments. UV-analysis was
performed using the INTAS UV system (Intas Ge iX Imager, Ahmedabad, India), and
images were printed for each gel.
4.1.4. Gelextraction
If gel electrophoresis was used to purify DNA fragments, bands of the desired size
were excised with a clean scalpel on an UV transilluminator, at low energy UV light
(λ=365 nm), to minimize double-strand breaks. The gel pieces were transferred to 1.5 ml
reaction tubes, and the enclosed DNA was extracted with the column-based MN Ex-
tractII kit (Macherey-Nagel, Du¨ren, Germany), as instructed by the manufacturer.
4.1.5. Ligation
1 u of T4 DNA ligase (NEB, Ipswich, MA, USA) per 20µL of rection mix was employed
for ligation of DNA fragments with compatible ends. Usually, molar ratios of 1:5 to 1:3
(Vector:Insert) were used, to ensure a high insertion rate, whilst avoiding multiple inser-
tions. For each reaction, approximately 100 ng of vector were used in order to achieve
a satisfactory transformation rate, later in the process. The corresponding amount of
insert was calculated by the following formula:
minsert(ng) =
mvector(ng) · linsert(kbp) · 5
lvector(kbp)
Finally, the reaction was incubated for 2 h at room temperature, or alternatively over
night at 16◦C, and further on used for transformation of competent bacteria.
4.1.6. Transformation of Chemically Competent Bacteria
DH5α E. coli were thawed on ice, and 100µL of the bacteria suspension were mixed with
10µL ligation mix. After 10 min incubation on ice, the bacteria were transformed for
45 s at 42◦C in a water bath, and cooled on ice. 900µL of lysogeny broth (LB) medium
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were added, and the culture was grown for 1 h at 37◦C in a shaker incubator. For the
amplification of a purified plasmid, the suspension was added to 4 ml of LB-Amp, and
grown over night at 37◦C in a shaker incubator. In case of a freshly ligated construct,
the culture was collected for 3 min at 3,000 rpm, the pellet was taken up in 200µL of LB
and streaked on an LB agar plate, supplemented with ampicillin. Clones were picked
with a sterile pipet tip after incubation at 37◦C, 4 ml of LB-Amp were inoculated and
grown at 37◦C under agitation.
4.1.7. Transformation of Electrocompetent Bacteria
0.2 cm electroporation cuvettes were pre chilled on ice for 30 min before use. 1 ml LB
medium was prepared per reaction in a reaction tube. 40µl electrocompetent E. coli
cells were then thawed on ice. Next, 1-3µl of salt free DNA-solution was transferred
into a pre-cooled eppendorf tube and mixed with 40µl of bacteria, and transferred into
the electroporation cuvette. The mixture was incubated for 1 min on ice. The pulse
settings were set to 25µF, 2.5 kV and 200 Ω. After electroporation, 1 ml of LB-Medium
was added and the bacteria were transferred to a fresh eppendorf tube, incubated 20-
60 min at 37◦C and seeded on appropriate selective LB-Agar. The remaining cells were
cryo-conserved by adding 15% glycerol and frozen at -20◦C.
4.1.8. Isolation and Analysis of Plasmid DNA from Bacteria
Plasmid extraction was conducted using a column-based approach. Depending on the
desired amount of isolated DNA, 4 ml up to 500 ml of transformed E. coli culture were
used as input. For small-scale extractions the Miniprep kit was applied, larger volumes
were processed with the Maxiprep kit (Macherey-Nagel, Dren, Germany). In both cases,
the manufacturer’s protocols were used. The obtained plasmids were subjected to an-
alytical restriction, to estimate the success of the ligation. If the correct band pattern
was produced, the samples were sequenced by the commercial service provider GATC,
Freiburg.
4.1.9. Glycerol Stocks
For long term storage, transformed bacteria were grown in sterile LB medium, containing
antibiotics, and collected by centrifugation. The pellet was resuspended in 500µL LB
medium and 500µL sterile 86% glycerol. Then the cultures were stored at -80◦C.
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4.2. Cell Culture
The human HEK293T, HepG2, Huh7.5, Huh7 ”‘Lunet”’, and Hep3B cell lines were
used for the different applications. Under normal culturing conditions, all cell lines were
grown in polysterene culture dishes (Falcon BD, Heidelberg, Germany), in Dulbecco’s
Modified Eagle Medium (DMEM), complemented with 10% FCS, 1% sodium pyruvate
and 1% penicillin/streptavidin. The cells were grown to confluency in an incubator
(37◦C, 5% CO2), and splitted as required. All cells were counted prior to transfection
or electroporation, using a Neubauer chamber.
4.2.1. Transient Transfection of RNA and DNA
Electroporation of cells
Cells were trypsinized, washed and resuspended in cytomix (120 mM KCl, 0.15 mM
CaCl2, 10 mM K2HPO4/KH2PO4 (pH 7.6), 25 mM Hepes, 2 mM EGTA, 5 mM MgCl2)
including freshly added 2 mM ATP and 5 mM glutathione. The final concentration
was 1.5·107 (for Hep3B or Huh7.5 ) or 1·107 (for Huh7) cells per ml. 6·106 cells were
electroporated with 10µg of replicon RNA. Depending on the experiment 50 pmol wild
type or mutant miR-122 duplex RNA were added per 10µg of electroporated RNA. As
a control for short term translation assays, 5µg of a capped Renilla transcript were also
added. Cells were then seeded onto 6-well plates, incubated at 37◦C, and subsequently
lysed (1% Triton-X-100, 25 mM Gly-Gly, pH 7.8, 15 mM MgSO4, 4 mM EGTA, 1 mM
DTT added directly prior to use) and frozen at the desired time points. Luciferase
activity of the lysates was measured in a tube luminometer.
Tranfection with Polyethylenimine
After trypsin treatment, 5·105 cells were plated in a 6-Well plate (Falcon BD, Heidelberg,
Germany) either 24 h prior to transfection. The aspired confluency ranged between
60 and 80%. For transfection with polyethylimine (PEI, Polyplus Transfection SA,
Illkirch-Graffenstaden, France), 1µg of the expression vectors were taken up in 100µL
OPTIMEM medium and complemented with 10µL PEI. The used cell numbers, DNA
concentrations and reagent volumina for different well sizes were chosen according to
the supplied protocol. After brief vortexing, the mixture was incubated 20 min at room
temperature. The medium in the wells was changed to 2 ml serum-free OPTIMEM, to
minimize cytotoxic effects. The tranfection mix was then added drop-wise, and the plate
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was gently tilted for homogeneous distribution. The cells were then incubated (37◦C,
5% CO2) until harvest and analysis for gene expression.
Transfection with Lipofectamine2000
After trypsin treatment, cells were plated either 24 h to reach an aspired confluency
ranged between 60 and 80% at the time of transfection. Depending on the scale of
transfection the volume of Lipofectamine2000 (Thermo Fischer Scientific, Waltham, MA,
USA), specified by the manufacturer’s protocol was diluted in OPTIMEM in a reaction
tube. In a separate tube, 5µg of plasmid was added to the same volume of OPTIMEM.
After 5 min incubation at room temperature, both solutions were mixed and incubated
again for 20 min before addition to the cells. After 6 h the medium was changed, to
prevent cytotoxic effects. The cells were then incubated (37◦C, 5% CO2) until harvest
and analysis for gene expression.
Transfection with Effectene
After trypsin treatment, cells were plated either 24 h to reach an aspired confluency
ranged between 60 and 80% at the time of transfection. The protocol was employed as
described by the manufacturer. 5µg of plasmid DNA was first mixed with Enhancer
and transfection buffer for DNA condensation, and kept at room temperature for 25
minutes. Effectene Reagent (Qiagen, Hilden, Germany) was then added and the mixture
was incubated for 10 minutes to allow Effectene:DNA complexes to form. The complexes
were mixed with DMEM medium, and added directly to the cells. The cells were then
incubated (37◦C, 5% CO2) until harvest and analysis for gene expression.
Transfection with MirusLT1
For pTM based protein expression in Huh7 Lunet, producing T7 polymerase, Mirus
LT1 was used as transfection reagent. 6-Well plates were used and treated according to
manfacturer’s instructions. 24h post transfection cells were harvested and processed.
Transfection with CaPO4
After trypsin treatment, HEK293T cells were plated either 24 h, or at least 4 h prior
to transfection, to ensure proper settling. The aspired confluency ranged between 60
and 80%. 10-20µg DNA were diluted in 450µl sterile H2O, and supplemented with
50µl of 2.5 M CaCl2. Then, 500µl 2x HBS-Buffer (Thermo Fischer Scientific, Waltham,
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MA, USA) were added and the mixture was incubated at room temperature for 20 min.
The solution was added drop-wise to the cells. After 2 h the medium was screened for
precipitates, indicating a successful transfection. The medium was changed 4 h post
transfection. The cells were then incubated (37◦C, 5% CO2) until harvest of the super-
natant for lentivirus transduction.
4.2.2. Generation of Lentiviruses and Stable Cell Lines
Retroviral plasmids were transfected with CaPO4 into a HEK293T packaging cell line.
The vectors for virion production were pMD.G2, which encodes for the surface pro-
tein (env), pCMV∆31 for the replication machinery (gag/pol), and the pWPI construct
containing the gene of interest, which carries a packaging signal. The used ratio of
pCMV∆31, pWPI and pMD.G2 was 3:3:1. After 4-6 h the medium was changed. The
efficiency of transfection was evaluated by microscopic analysis of the precipitate forma-
tion in the medium. The supernatant of the cells containing the assembled lentivirus
was collected after 48 and 72 h, filtered through a 0.45µm syringe filter, and stored at
-80◦C until use. Target cells were seeded to a final density of 30-50% confluency at the
time of transduction in a 12-Well plate. Over a period of two days, the recipient cells
were treated three times with 0.5-1 ml of filtered supernatant from the producer cells. 6 h
after the last transduction, the medium was changed and the selection compound was
added. Untransduced cells were used as a control, to ensure the efficiency of selection.
4.3. Protein Production and Detection
4.3.1. Baculovirus-production for Expression of HCV
Non-Structural Proteins in Sf9 Cells
For baculovirus production, the bac-to-bac protocol from Thermo Fischer Scientific
(Waltham, MA, USA) was used. In brief, the NS3-5B expression cassette was cloned
into the pFastBac-DualGFP vector, and amplified in DH5α E. coli. For recombination
into the baculovirus bacmid, 1 ng of plasmid was transformed into DH10Bac E. coli and
selected on LB agar plates containing kanamycin, gentamicin, tetracycline, Bluo-gal,
and IPTG. White colonies were picked and transferred into a 3 ml liquid culture. The
bacmid DNA was extracted, and the correct insert was determined by PCR. Empty
bacmids would lead to a 300 bp product, while the correct insert should show a band at
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9000 bp. The bacmid was transfected into Sf9 cells, using Cellfectin II (Thermo Fischer
Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. The cells
were incubated at 28◦C and checked for GFP expression after 24 up to 72 h. At 72 h post
transfection, the supernatant was clarified by filtration through a 0.2 mum syringe filter,
and stored at 4◦C. Fresh Sf9 cells were inoculated with the virus stock, incubated at
28◦C and checked regularly for GFP expression. The amount of produced HCV protein
was determined by western blot.
4.3.2. Preparation of HCV Non-Structural Proteins Expressed in E.
coli
E. coli BL21 were electroporated, as described above, with a pET-plasmid carrying the
gene-of-interest and an ampicilin resistance gene. An agar plate was streaked with a
seeding tool from a glycerol stock and single clones were picked to inoculate a 5 ml
ampicilin starter culture. After over night growth, the culture was used to inoculate a
500 ml culture, which was grown to an OD600 of 0.6-0.7. Then the cultures were cooled
to room temperature. For NS5A expression, 3% ethanol were added. After 20 min, the
expression culture was induced with 0.1 mM IPTG (fig. 4.1) and incubated at 20◦C.
For NS3, the culture was pelleted after 4 h, for NS5A the incubation was carried out
over night. After centrifugation, the pellets were kept on ice and resuspended in lysis
Figure 4.1.: IPTG induction control. SDS polyacrylamide
gel stained with coomassie brilliant blue. The arrow head indicates
the expected size for his-tagged NS3. Whole cell lysates were lysed
in Laemmli buffer and loaded before (-) and after (+) over night
induction with IPTG.
buffer containing lysozyme, benzonase and a protease inhibitor. The pH of the buffer
was chosen based on the isoelectric point of the desired protein. Since the solubility is
strongly decreased at that pH, the conditions were adapted to higher values, up to pH
8.8 with Tris/HCL.
After lysis for 30 min on ice, the suspension was sonicated 6 times for 30 s. Afterwards,
the soluble and insoluble fraction were separated by centrifugation. The supernatant was
filtered and transferred into a new falcon. It was then adjusted to 500 mM NaCl and
10 mM imidazole. After brief incubation at 4◦C, 1 ml NiNTA slurry was added, followed
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by another incubation at 4◦C for 45 min. The beads were washed twice with buffer
containing 50 mM imidazole, and then loaded onto a gravitational flow column. After
another wash with 5 ml 50 mM imidazole, the stringency was increased to 75 mM or
100 mM imidazole for NS3 or NS5A, respectively. The protein was eluted in one fraction
with 200 mM L-histidine. All samples were analyzed by SDS PAGE, to check for purity
and quantity of the obtained protein.
4.3.3. Western Blot
For protein analysis, the cells were lysed by addition of Laemmli loading buffer (2% w/v
SDS, 10% glycerol, 50 mM DTT, 0.01 w/v bromophenol blue). This was followed by
denaturization at 95◦C for 5 min. The proteins in the samples were then separated on
a 10% SDS PAGE gel, and blottet onto a methanole activated PVDV membrane over
1.5 h at 2 mA cm−2, using the semi dry method. For this purpose, two filter papers, the
membrane, the gel, and another two filter papers were soaked with semi dry blotting
buffer (25 mM TRIS, 250 mM glycin, 0.1% SDS, pH 8.3), stacked, and placed onto the
transfer system. Alternatively, wet blotting was performed with a current 350 mA for
1-2 h, or 100 mA over night at 4◦C. In succession to the blotting process, the membrane
was blocked with 5% low fat milk powder in PBS (MPBS) for 30 min. Then the pri-
mary antibody (1:1000 - 1:500 in MPBS+0.5% Tween20) was applied and incubated
for at least 1h, at room temperature, or over night at 4◦C, followed by 3 washes with
PBS-T and addition of the second antibody (1:10000 in MTBS-T), coupled to horse
radish peroxidase (HRP). The following 1 h incubation was carried out at room temper-
ature. Finally, the blot was washed (2x PBS-T, 1x PBS) and chemiluminescence was
measured in an Intas Ge iX Imager (Intas, Ahmedabad, India) , after addition of the
HRP substrate.
4.4. In Vitro Assays
4.4.1. Helicase Assay
The helicase activity of purified NS3 and NS3/4A was assessed in a DNA-based un-
winding assay. A 54-mer, a 30-mer, and a capture oligonucleotide , complementary to
the 30-mer, were purchased from Sigma-Aldrich (Darmstadt, Germany, tab. 4.1). The
30-mer was radiolabeled with T4 PNK (NEB) in the supplied buffer, using 10µCi γ-32P-
ATP per pmol substrate. The excess nucleotides were removed by trap filtration in an
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Illustra MicroSpin G25 column (GE Healthcare). An equimolar amount of the 54-mer
was added, and the mixture was heated to 95◦C and slowly cooled to room tempera-
ture to anneal the oligos. 0.8 pmol of each enzyme used in the following reaction were
Table 4.1.: Oligonucleotides used for helicase assay.
Name Sequence
54-mer GACTACGTAC TGTTAACCGC CGCCCAGGTG TGAGGAGTAC
CAGGCCAGAT CTGC
30-mer TGGTACTCCT CACACCTGGG CGGCGGTTAA
capture TTAACCGCCG CCCAGGTGTG AGGAGTACCA
preincubated 5 min at room temperature. After addition of H2O, 10x unwinding buffer
and the labeled dsDNA, the proteins were allowed to form active complexes at 37◦C
for additional 5 min. Then, the capture oligo was added in 30-fold excess, to prevent
reannealing. After taking a sample (no ATP, 0 min), 5 mM ATP were added to start the
reaction. Samples were prepared for 1, 5, 10, 20, and 30 min reaction time. After the
denoted period, the helicase activity was abolished by addition of 1 reaction volume stop
solution (20 mM EDTA, 0.5% SDS). 10µL of glycerol loading dye were added to each
20µL of sample. As positive control, 0.1 pmol labeled dsDNA in unwinding buffer were
denatured at 95◦C in the presence of 3 pmol capture oligo. All samples were stored at -
20◦C. 15µL of each sample were loaded onto a 12% native PA gel, and run at 3-4 V·cm−1.
The bands were visualized on a phosphoimager ( BioRad, Hercules, CA, USA), and the
quantitation analysis was performed with the provided QuantityOne software (BioRad,
Hercules, CA, USA).
4.4.2. RdRP assay
First, 2.5µL RdRP buffer (20 mM Tris pH7, 25 mM KCl, 1 mM EDTA, 1 mM DTT +
12.5 mM MgCl2), 0.25µL 100mM DTT, 0.5µL RNAsin and 9µL RNAse-free H2O were
mixed on ice (“RdRP Mix”). In a seperate tube, the NTP mix was prepared, containing
2.5µL 10x cold rNTPs (10mM GTP/ATP/UTP, 100µM CTP), and 1µL α−32P-CTP
(1µl = 10µCi). The proteins were preincubated with the RdRP Mix for 15 min at RT.
Meanwhile, the RNA was denatured for 2 min at 95◦C, then flash-cooled for 2 min on
ice. The RNA was then added to the RdRP Mix and incubated at 37◦C for 5 min. The
polymerization reaction was started by addition of the NTP mix, and incubated at the
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desired temperature for 1 h. The reaction was terminated with 1 mM aurintricarboxylic
acid in 1x TE buffer.
For the scintillation counter-based assay, the reaction was precipitated in 1 ml 5%
TCA, and incubated on ice for 30 min. The mixture was filtered through a 10 mm round
Whatman filter on a vacuum device.The precipitated oligonucleotides were retained in
the filter, while unincorporated nucleotides were removed by 5 washes with 0.1%TCA
solution. The filter was then transferred into a scintillation tube and covered with Ultima
Gold scintillation reagent (PerkinElmer, Waltham, MA, USA). The counts per minute
were detected in a Beckman LS 6000 Liquid Scintillation Counter (Beckmann Coulter,
Brea, California, USA). An empty filter was used as negative control.
For the gel based assay, the RNA was subsequently isolated by phenol:chloroform
extraction and isopropanol precipitation. The resulting pellet was dissolved in 10µL
formamide loading dye and denatured for 5 min at 65C. 5µL were loaded on a pre-
heated 6% polyacrylamide gel, containing 8 M urea. The gel was run at 20 W for 2 h,
fixed in 10% methanol/acetic acid and dried. The produced RNA products were de-
tected by autoradiography using phosphor screens. The bands were visualized on a
PMI phosphoimager (BioRad, Hercules, CA, USA) and the quantitation analysis was
performed with the provided QuantityOne software (BioRad, Hercules, CA, USA).
4.5. RNA Synthesis, In Vitro Transcription and
Structure Determination
4.5.1. In Vitro transcription
In vitro transcripts for electroporation were generated from 10µg pFK-plasmid in IVT
buffer with 16 mM MgCl2, 4 mM rNTPs, 1.7µg BSA (NEB) and 10µl of homemade T7
polymerase. The reactions were performed 4 h or over night at 37◦C. The RNA was
purified by phenol:chloroform extraction and isopropanol precipitation. RNA integrity
was assessed by agarose gel electrophoresis. For capped transcripts, m7G analog (Sigma
Aldrich, Darmstadt, Germany) was added to a final concentration of 20 mM.
4.5.2. In Silico RNA Structure Calculation
For in silico folding of the 5 terminal 120 nt of HCV, the online versions of mfold,
RNAFold and RNAalifold were used without constraints. For RNAalifold analysis, 3
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full-length sequences of each genotype were obtained from HCVdb.org. Visualization
was performed with VARNA.
4.5.3. Gel Purification of RNA
RNA of the 5’UTR fragments was in vitro transcribed and purified, as described above.
Approximately 20 - 30µg were loaded on a 5% Urea gel (20x20 cm), and run for 1 h at
20 W. Bands were visualized by UV shadowing and extracted with an RNAse-free spat-
ula. The gel piece was crushed using a scalpel and transferred into a clean eppendorf
tube. Then, 500µl of extraction buffer was added and the RNA was eluted for 48 h at
4◦C on a rotator. The supernatant was transferred into a new tube, the remaining gel
was rinsed with another 250µl of buffer, and the supernatant was pooled with the previ-
ously collected sample. RNA was extracted by phenol:chloroform, and precipitated with
isopropanol at -20◦C. After two EtOH washes, the pellet was resuspended in deionized
water.
4.5.4. SHAPE
SHAPE assays and synthesis of NAI were performed as reported by Spitale et al. 294 , with
minor modifications. Briefly, in vitro transcripts were denatured at 95◦C, and refolded
in presence of miR-122-5p or -3p at 37◦C for 15 min. Different MgCl2 concentrations
(0, 1 and 6.6 mM) were tested. NAI or DMSO were added and incubated for another
10 min, before phenol:chloroform extraction. Purified RNA was subjected to reverse
transcription (RT) with a 32P-labeled primer, and the cDNA was analyzed on a urea PAA
gel, followed by autoradiography using phosphor screens. The bands were visualized on a
phosphoimager (BioRad, Hercules, CA, USA) and subsequently assigned and quantified
with SAFA293.
4.5.5. NMR
RNA fragments were produced by in vitro transcription, as described before. For NMR
sample preparation, 50 100µg of linearized template was used per ml of reaction, in
a total volume of up to 10 ml. The RNA was diluted in 5 volumes 8 M urea. The
resuspended RNA was purified by FPLC, and dialyzed against water for 24 h, to remove
salts. The water was exchanged five times during the course of dialysis. Salt-free samples
were subjected to lyophilization. The lyophilized RNA was resuspended in RNAse free
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H2O at a concentration of 2 mg/ml, and denatured at 95
◦C before flash-cooling on ice.
The transcript was concentrated to around 1 mM in 75µl using Amicon centrifugation
concentrators (Merck Millipore, Darmstadt, Germany). After concentration, an equal
amount of 2x folding buffer (20 mM HEPES, 200 mM NaCl, 10 mM MgCl2) was added
and the samples were transferred to 3 mm Shigemi tubes (Shigemi Inc, Allison Park, PA,
USA). The samples were incubated for 15 minutes at 37◦C, before measurement in an
850 or 950 MHz Bruker spectrometer (Billerica, MA, USA) at the desired temperature.
1D and 2D NMR spectra were visualized and evaluated with Bruker Topspin software.
4.6. Direct and indirect detection of HCV RNA
4.6.1. HCV RNA detection by qRT-PCR
For first-strand cDNA synthesis, 10µM gene specific primers, and dNTPs were added
to 1µg of total RNA, and filled up to 10µL with DEPC treated H2O (tab. 4.2). This
mixture was incubated for 5 min at 65◦C and then chilled on ice for at least 2 min,
before adding 10µL the reverse transcriptase mix (tab. 4.3). To start the reaction, the
Table 4.2.: Composition of the RNA
mix for first-strand cDNA synthesis
Component Amount
RNA (1µg/µL) 1µL
Primer 1µL
dNTPs (10µM) 1µL
H2O to 10µL
Table 4.3.: Composition of the RT mix
for first-strand cDNA synthesis
Component Amount
RT buffer 2µL
MgCl2 (25 mM) 4µL
DTT (0.1 M) 2µL
RNAseOUT 60 u
SuperScript III 200 u
sample was placed into a thermo cycler. The following program was applied:
25◦C
10 min
50◦C
50 min
85◦C
5 min
4◦C
∞
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Comparative quantification of DNA was performed with quantitative PCR (qPCR),
using SYBRGreen. The obtained data is presented in cycle threshold (CT) values.
This unit defines the first cycle the specific fluorescence signal is above background
level. Comparison in abundance of two or more templates is only possible, if they are
amplified at the same rate, and no side products are made. cDNA of template-negative
cells, and H2O controls were employed to detect unspecific priming, or contaminations,
respectively. 40 cycles withe the following PCR program were performed:
95◦C
1 min
95◦C
30 s
55◦C
60 s
72◦C
60 s
40 x
4◦C
∞
To compare the relative expression of different mRNAs, the ∆∆CT -method was used,
with human GAPDH mRNA as calibrator (set to 1). Then, the difference between
the CT values of the control and miRNA of interest was used to calculate the relative
amounts in different cell lines.
At the end of each run, a melting curve analysis was performed, to detect possible side
products or primer dimers. Upon denaturing of the DNA dimers, the complex with the
dye is destroyed, and the fluorescence signal disappears. The decrease of fluorescence is
plottet against the temperature. Therefore, for a single product, only one sharp peak
should be visible. More peaks would indicate additional products of different length.
4.6.2. HCV RNA detection by Northern blot
6·106 electroporated cells were immediately put on ice, spun down and resuspended in
cold PBS with 5 mM aurintricarboxylic acid (PBS-ATA) as input control (0 h). For later
time points, 6·106 (1-24 h) or 3·106 (48-72 h) were seeded on a 10 cm dish, and incubated
at 37◦C for the desired time. a fraction of cells At later time points, cells were scraped
into put on ice immediately, spun down and resuspended in cold PBS-ATA.
Cells were lysed with 750µl of GITC solution. Genomic DNA was sheared by pipet-
ting. Then, 1/10 volume 2 M NaAc (pH 4.5) and 1 volume acidic phenol were added.
After addition of 1/5 volume chloroform, the mixture was vortexed and incubated on ice
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for 15 min. The phases of the milky solution were separated again by 10 min centrifu-
gation at 13,000 rpm, 4◦C, and the RNA-containing upper phase was transferred into
a new tube, avoiding carry-over from the interphase. Now the RNA was precipitated
by addition of 1 volume isopropanol. After 30 min incubation at -20◦C, the RNA was
pelleted by centrifugation for 15 min at 14,000rpm, 4◦C. Finally, the pellet was washed
once with 70% ethanol, and dissolved in an appropriate volume of water. The RNA was
quantified by NanoDrop (Thermo Fischer Scientific, Waltham, MA, USA) measurement,
and stored at -70◦C. Denaturing glyoxal agarose gel electrophoresis was performed for
Northern blot analysis. 1-1.5% agarose (depending on the size of the RNA) was dissolved
in H2O, then NaPO4 pH 7.0 to final concentration of 10 mM was added. During sam-
ple preparation, up to 10µg RNA in a volume of 10µl were mixed with 4.1µl 100 mM
NaPO4 pH 7.0, 6µl 6M deionized glyoxal, and 20.5µl DMSO, incubated at 50
◦C for 1 h,
cooled on ice, and mixed with 10.9µl glyoxal loading buffer. 25µl of the sample were
loaded onto the gel. Electrophoresis was performed in 10 mM NaPO4 pH 7.0 at 4 V/cm
gel. To keep the pH constant, the buffer was constantly mixed by magnetic stir bars
after the sample had migrated into the gel.
RNA was transferred to positively charged nylon membranes (Hybond-N+; Amersham
Biosciences, Freiburg, Germany) with 50 mM NaOH (0.2 bar under pressure for 1h,
vacuum transfer machine (Keutz, Giessen, Germany) and cross-linked by UV-irradiation.
To block unspecific binding of the probe to the membrane, it was incubated for 15 min
at 68◦C in 10 ml hybridization solution containing 100µg heat denatured salmon sperm
DNA. Positive-strand HCV RNA was detected by hybridization with α−32P-labeled
negative sense riboprobe complementary to nt 5979 to 6699 of the HCV JFH-1 isolate
in hybridization solution at 68◦C ON. Hybridization with a β-Actin-specific riboprobe
was used to monitor equal sample loading in each lane of the gel. Membranes were
washed twice with 2x SSC/0.1% SDS for 15 min at 68◦C, and then washed three times
with 0.2x SSC/0.1% SDS for 15 min at 68◦C, briefly dried and signals were detected by
autoradiography. As standards for the positive-strand RNA defined quantities (109, 108,
and 107 RNA molecules per 25µl) of the corresponding in vitro transcripts were used.
4.6.3. Strand-specific HCV RNA detection by in situ hybridization
The QuantiGene ViewRNA ISH Cell Assay Kit (Affymetrix, Santa Clara, CA, USA;
Cat. No. QVC 001) was used for in situ hybridization. Cells were fixed with 4% PFA,
rinsed with PBS and then permeabilized with 70% EtOH at 4◦C for 1 h. After washing
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with PBS, the supplied QS protease was applied for 5 min at RT in a 1:4000 dilution.
Then the cells were rinsed and 1:100 probe set (in Probe Set Diluent QF prewarmed to
40◦C) was added for 3 h at 40◦C. Excess probes were removed with the supplied Wash
Buffer. Next, cells were incubated with PreAmplifier Mix (PreAmplifier Mix 1:25 in pre-
warmed Amplifier Diluent QF) for 30 min at 40◦C. After thorough washes with Wash
Buffer, the Amplifier Mix Solution (Amplifier Mix 1:25 in pre-warmed Amplifier Diluent
QF) was applied for 30 min at 40◦C. After another wash with Wash Buffer, the final
Label Probe Mix Solution (Label Probe Mix 1:25 in pre-warmed Label Probe Diluent
QF) was added for 30 min at 40◦C. Then the cells were washed with PBS and subjected
to immunofluorescence staining as described below.
4.7. Immunofluorescence Assay
Cells were grown on a cover slip, placed into each well of a multi-well plate, and trans-
fected the following day. 24 h post transfection, the cells were washed twice with PBS.
Afterwards, they were fixated with 4% para-formaldehyde (PFA) for 15 min, and washed
again. To disrupt the plasma membrane, and allow intracellular immunostaining, the
cells were treated with Triton X-100 for 5 min. Then, 10 min blocking with 3 mg/ml BSA
in PBS, were followed by 1-2 h incubation with primary antibody (1:100 in PBS+3 mg/ml
BSA). 50µL of antibody solution were pipetted on a piece of parafilm, and the cover
slip was placed on the droplet. Subsequently, the slides were washed and blocked again,
and exposed to the secondary, labeled antibody (1:1000), for another hour in the dark.
Finally, glass slides were prepared with a drop of DAPI-solution, and the cover slip
was gently placed on top. The cover slips were fixed with fluoromount (Sigma Aldrich,
Darmstadt, Germany), and the slides stored at 4◦C in the dark until use.
4.7.1. Luciferase Assay
For assaying the firefly luciferase activity from reporter replicons, cells were washed
once with PBS, lysed directly on the plate in ice cold lysis buffer (350µl/6-well) and
frozen. Upon thawing, lysates were resuspended by pipetting and 100µl were mixed in
a measuring tube with 360µl of assay buffer (with freshly added 1 mM DTT and 20 mM
ATP). After the addition of 200µl of a 200µM luciferin solution in 25 mM Gly-Gly,
the luciferase activity was measured in a tube luminometer (Lumat LB9507; Berthold,
Freiburg, Germany) for 20 s. All luciferase assays were done in duplicate measurements.
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For renilla measurements, 20µl of lysate were mixed with 100µl assay buffer with-
out ATP/DTT, but supplemented with 1,43µM coelenterazine (Promega, Mannheim,
Germany), and measured for 10 s.
Dual-luciferase assays from the same tube were performed with 40mul of lysate. Fire-
fly activity was recorded after mixing with 100µl assay buffer with ATP/DTT, and
70µl/ml of 1 M luciferin stock solution. Luminiscence was measured for 10 s. Then,
renilla quencing buffer was added and the sample was measured again for 10 s, after a
delay of 60 s, to allow sufficient quenching of the firefly activity.
4.8. Detection of miRNA by RT-PCR
4.8.1. Stem-loop qRT-PCR
This method for the amplification of small RNAs was first described by Chen et al. 295 .
The main advantages of this approach is the generation of qPCR compatible products
even from a small pool of RNA. The procedure is based on primers of about 60 nt in
length, with a stem-loop structure. Primer design was performed with the online tool
“miRNA Primer Designer” (http://www.leonxie.com/miRNAprimerDesigner.php), and
a reference miRNA gene (miR-23b) was selected based on the results of Lamba et al. 296 .
Six nucleotides at the 3’ end confer specificity for a mature miRNA, the rest of the
primer is kept constant. First a mix of multiple stem-loop primers, adjusted to 10µM
each, dNTPs and H2O (primer mix, tab. 4.4) were incubated at 65
◦C for 5 min. After
chlling on ice, the RT mix (tab. 4.5) was added, to a final volume of 19µL. At last,
1µg of RNA was added. In contrast to a conventional RT-PCR, a pulsed RT program
Table 4.4.: Composition of the primer
mix for stem-loop cDNA synthesis
Component Amount
dNTPs (10µM) 1µL
Stem-loop Primer Mix 1µL
H2O 11.25µL
Table 4.5.: Composition of the RT mix
for stem-loop cDNA synthesis
Component Amount
Buffer 4µL
DTT (0.1 M) 1µL
RNAsin (40U/µL) 0.5µL
SuperScript III (200U/µL) 0.25µL
was used.
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16◦C
30 min
30◦C
30 s
42◦C
30 s
50◦C
1 s
60 x
85◦C
5 min
4◦C
∞
Comparative quantification of DNA was performed with quantitative PCR as de-
scribed before. To compare the relative expression of different miRNAs, the ∆∆CT -
method was used, with human miR-23b as calibrator (set to 1). As for the conventional
qPCR, at the end of each run, a melting curve was produced, to detect possible side
products or primer dimers.
4.9. Pull-Down Assays
4.9.1. Immunoprecipitation
Cells were washed twice with PBS and scraped in 1 ml sterile PBS. 10% were spun down,
resuspended in 50µl Laemmli buffer, and used as input. After centrifugation (10 min
at 8000g, 4◦C), the supernatant was discarded, and the pellet was resuspended in 1 ml
lysis buffer, followed by incubation on ice for 15 min. To aid lysis, the suspension was
vortexed briefly and pipetted up and dwn with a 100µl pipette. Then, the cell debris
and nuclei were removed by a centrifugation at 10000 g for 10 min. The lysate was
transferred into a fresh tube and 2-8mul of antibody was added, then incubated under
rotation for 2 h at 4◦C. In the meantime, 10µl Protein G-coated beads were washed with
1 ml lysis buffer (1 min at 3000g, 4◦C). The buffer was removed before lysate was added,
and mixed with the beads by pipetting. Then, the mixture was incubated over night at
4◦C under rotation. The next day, beads were washed three times with lysis buffer, and
the protein was eluted by boiling for 10 min in 50µl of Laemmli buffer. Beads were spun
down and the supernatant was transferred to a fresh tube carefully to avoid carry-over
of beads. The samples were then analyzed by western blotting.
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4.9.2. Biotin-miRNA Pull-down
Pull-down of a biotinylated miRNA was performed, based on the protocol of Wani and
Cloonan 297 . In brief, 200 pmoles biotin tagged miRNA were electroporated together
with 10µg of an HCV replicon. Two electroporations were pooled on a 15cm dish
and incubated at 37◦C for 72h. On the day of harvest, streptavidin-coated magnetic
dynabeads were washed (Wash buffer: 5 mM Tris-Cl pH 7.5, 0.5 mM EDTA, 1M NaCl),
NaOH treated (Solution A: 0.1 M NaOH, 0.05 M NaCl followed by Solution B: 0.1M
NaCl) to remove RNAses, and blocked with 1 mg/ml BSA and tRNA in sterile H2O
at room temperature for 2 h on a rotating mixer. The cells were scraped and washed
twice with cold, sterile PBS. The pellet was resuspended in 300µl lysis buffer (10 mM
KCl, 1.5 mM MgCl2, 10 mM Tris-HCl pH 7.5, 5 mM DTT, 0.5% NP-40) containing 1x
complete protease inhibitor and 40 U/mlRNAsin. The suspension was frozen at -20◦C
and thawed at room temperature to increase lysis efficiency. The lysate was cleared
by centrifugation at 4◦C, and the supernatant was transferred to a new tube. NaCl
was added to a final concentration of 1 M. The blocked beads were washed three times
with bead wash buffer, and the lysate was then added. The mixture was incubated at
room temperature for 30 min under rotation. Afterwards the beads were washed three
times (10 mM KCl, 1.5 mM MgCl2, 10 mM Tris-Cl pH 7.5, 5 mM DTT, 0.5% NP-40,
40 U/ml RNAsin ,1x Complete Mini protease inhibitor, 1 M NaCl) and then resuspended
in 1 ml TRIZOL reagent. Protein and RNA were extracted following the manufacturers
instructions.
4.9.3. Electrophoretic Mobility Shift Assay
The RNA of interest was dephosphorylated (CIP) and 5’ end labeled with γ−32P using
T4 PNK. Then the labeled RNA was incubated with purified protein under suitable
binding conditions The 25µl reaction mix contained 1x Binding buffer, RNA (50,000
cpm) and the purified protein (serial dilutions from excess to less than equimolar). The
mixture was incubated for 30 min at 37◦C. After incubation, 5µl EMSA loading dye was
added. 5µl of the the sample was loaded onto a 5% native polyacrylamide gel. The rest
was frozen at -20◦C.
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5.1. Purification of HCV Replicase Components
The first aim of this study was to determine potential roles of NS3 and NS5A in the ini-
tiation of HCV RNA synthesis. Prior to determining the roles of different non-structural
proteins in HCV replication, it was necessary to establish a robust and reliable assay
to address the contribution of each protein alone. This can only be achieved in vitro,
since the cell culture system inheres a high degree of complexity, in which a variety of
host factors can significantly influence the outcome of an experiment. Hence, a highly
reduced and controlled model system is better suited to identify the individual functions
of a single viral protein, as well as functions which rely on the action of cellular co-
factors. Additionally, requirements of the RNA template can be addressed more easily.
The 3’ terminal 450 nucleotides, including the 5B-CRE structure of the JFH-1 positive
strand RNA was used as a basic template. The RNA templates were generated by in
vitro transcription. An authentic 3’ end is essential for the replicase assay, because it
represents the natural initiation site for NS5B. Therefore, the transcripts were either
generated on a PCR-based template, or using a plasmid (pFKT7-JFH-1-3’) with a suit-
able restriction site at the end of the template. It has been determined that the ideal
template consists of a short single stranded 3’ end, followed by a stem-loop structure.
Such an architecture is present at the 3’ (-) terminus, which is also readily recognized by
NS5B in vitro (fig. 5.1A). In contrast, the (+)-strand is a poor template for terminal
initiation of the polymerase, due to its extensive secondary structure. However, the
helicase activity of NS3, or a yet to be determined mechanism involving NS5A, might
facilitate efficient replication. Especially for the helicase this hypothesis is conceivable,
since it could convert the hairpin into a single stranded region, more suitable for NS5B
initiation (fig. 5.1B). To study the viral replicase in vitro, first, a sufficient amount
of protein must be produced and purified. Two strategies were employed to produce
proteins for reconstitution of the functional replicase. Either the in cis expression of all
proteins in an eukaryotic system, which relies on the natural cleavage of the polyprotein.
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This strategy would more closely resemble the natural context of HCV infection, in a
sense that the proteins will undergo most stages of maturation and post-translational
modification. However, due to the large size of the complete ORF and transfection
efficiency, the amount of produced protein might be limiting. Alternatively, the indi-
vidual production of each protein in bacteria was pursued. While especially the natural
phosphorylation pattern of NS5A will likely not be obtained in this system, it has the
advantage of being relatively easy and suitable for large scale protein production (fig.
5.1C).
Figure 5.1.: Working hypothesis and establishment of an in vitro RdRP assay. A |
Initiation of NS5B is highly efficient at the single stranded 3’ end of the (-)-strand of the HCV
genome. B | The hairpin structure at the 3’ end of the (+)-strand of HCV prevents the viral
polymerase to initiate RNA replication. Thus, the helicase activity of NS3 might be required
to unwind the stem, and thereby create a suitable template for NS5B. C | To establish an in
vitro replicase assay, the non-structural proteins NS3, 5A and 5B were purified via different
methods. The optimal conditions for the helicase function of NS3 was tested. In parallel, the
production of RNA template was optimized. Finally, the template-dependent impact of NS3
and 5A on RdRP function was assessed. In the future, this assay could be used to investigate
the roles of individual protein domains or chemical compounds in vitro.
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5.1.1. Tagging of NS proteins and Determination of their
Replication Fitness
To effectively extract complete replicase complexes, common tag has to be introduced
into the non-structural proteins 3-5B. Ideally, the tagged proteins should support replica-
tion in cell culture, since this would verify that all individual components are functional,
and a possible failure to replicate in vitro is not due to aberrant folding or impairment
of protein function. On the other hand, the functionality in the cell culture system is
not necessarily a predictor for the in vitro situation. Deletion of the membrane anchor
of NS5B for instance, abolishes replication in cell culture, but even enhances in vitro
RNA polymerization. The positions for the tags were in part based on a publication
that investigated how viral replication was affected by 15,nt long insertions at random
sites in the open reading frame298. For NS3, a tag can be added at the 5’ terminus,
without significantly impairing the proteins function in replication (fig. 5.2A). A site
in 4B was already described to tolerate a tag insertion, given an additional compensatory
mutation49, and was not tested here. Domain 3 of the NS5A protein is completely dis-
pensable for replication, and thus easy to modify (fig. 5.2B). NS5B proved to be the
most difficult protein to tag, without abrogating replication. According to the study
of Arumugaswami et al. 298 and considering structural properties and accessibility (ide-
ally an unstructured loop at the surface) several positions were tested. Insertions were
introduced after amino acid 42 (1), 246 (2), 248 (3), 264 (4) and 326 (5). In another
approach, the tag was inserted directly after the C-terminal linker region (post-linker,
PL), however, also this strategy could not produce a viable construct (fig. 5.2C). For
the latter position, also a FLAG and an HA-tag were introduced, but neither of these
supported efficient replication. Only one mutant, 4, exhibited low levels of replication
after 72 h, with raw values at around 10-fold over background (fig. 5.2C). It remains to
be evaluated, whether a different tag could improve the replication behavior. Addition-
ally, selection experiments could be conducted, in which the negative effects of the tag
might be compensated by mutations acquired during serial passaging. However, due to
the low replication efficiency of the tagged NS5B variants and the necessity to combine
all tags into a single replicon, which would further dampen efficiency of the system,
different methods of ectopic polyprotein production were explored.
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Figure 5.2.: Replication capacity of hexa-histidine tagged JFH-1 replicons. Upper
panels: schematic structure of the HCV NS proteins NS3 helicase, A | ; NS5A B | and NS5B
C |. Numbers indicate the his-tag insertion site(s). Lower panels: impact of His-tag insertion
on replication efficiency of a subgenomic luciferase replicon with His-tag insertion, compared
to a wt-replicon (WT) and a replication deficient mutant (∆GDD). Replication efficiency is
expressed in relative light units (RLU) in cell lysates of Huh-7 cells 72 h after transfection,
relative to 4 h, to normalize for transfection efficiency.
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5.1.2. Expression of the Complete Replicase Open Reading Frame
in Eukaryotic Cells
The most natural condition to express the proteins of the replicase machinery is in a
context encompassing NS3-5B, which are necessary and sufficient to support RNA repli-
cation. This can only be achieved in eukaryotic cells, since the open reading frame is too
large for efficient expression in bacteria. Apart from this, the eukaryotic system offers
several additional advantages. The two most important are the in cis processing, which
might significantly affect protein folding kinetics, and secondly, post-translational modi-
fication, which relies on host factors not present in prokaryotes. Two different strategies
were tested to achieve high protein yields: Firstly, a mammalian cell line (BSRT7) ex-
pressing T7 polymerase was used in conjunction with a T7 promoter bearing plasmid.
Secondly, the expression with a baculovirus system in insect cells (Sf9). Several trans-
Figure 5.3.: Non-structural protein expression in BSRT7 and Sf9 cells. A | Evalua-
tion of different transfection methods for BSRT7 cells using a GFP reporter plasmid. Shown is
the GFP expression 24 h post transfection. PEI transfection was the most efficient in BSRT7
cells. B | Expression of HCV NS3-5B, harboring an RFP within domain 3 of NS5A. The
expression of the RFP reporter was around 50% of the GFP control. C | Western blot analysis
of NS5A expression in BSRT7 cells. A plasmid encoding the NS3-5B polyprotein from isolate
JFH-1 under transcriptional control of the T7-promoter was transfected into BSR-T7 cells.
Con1 NS5A expressed in Sf9 cells was used as a control. Lysates corresponding to equal cell
numbers were loaded per lane. D | Expression of NS5A in Sf9 cells infected with baculoviruses
carrying the coding sequence for JFH NS3-5B. Na¨ıve Sf9 cells served as negative control. The
same Con1 NS5A expressing Sf9 cell line as in C was used as positive control.
fection methods were compared for their effectiveness in BSRT7 cells. PEI was found
to be the most efficient reagent, with approximately 50% of cells expressing GFP from
a transfected reporter plasmid (fig. 5.3A). However, the much larger plasmid encoding
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the viral proteins, including an RFP within NS5A, could not be delivered to the cells
with the same efficiency. In addition, the expression levels were much lower compared to
control Sf9 cells expressing Con1 NS3-5A (fig. 5.3B, C). The transfection of baculoviral
vectors, containing the replicase cassette and GFP as separate cistrons, and subsequent
inoculation of Sf9 cells only yielded very few GFP expressing cells (not shown). Western
blotting confirmed that only minute amounts of viral protein were produced (fig. 5.3D).
The expression in neither of these systems could produce sufficient amounts of protein
for the desired purpose. Therefore, this approach was not further pursued, and no efforts
were put into purification of replicase proteins using these expression models. Instead,
the strategy was revised, and the proteins of interest were expressed individually in E.
coli.
5.1.3. Expression of Single Proteins in E. coli
The proteins NS3, 5A and 5B were produced in bacteria. NS4B is assumed to be mainly
responsible for membranous web formation, and not RNA replication itself. Therefore,
it should not exert any function in an in vitro assay, and was not purified. Since all
proteins of the HCV replicase complex are either integral membrane proteins, or at
least tightly associated with lipids, the purification strategy was optimized to ensure
maximum yield and purity. Efficient protocols exist for bacterial production of a version
of NS5B, lacking the C-terminal 21 amino acids (NS5B∆C21), which has been shown to
be much more soluble. Also, this truncated variant is more active in vitro, than the full
length enzyme. NS3, 5A and the full-length 5B, however, are more complex to isolate
in a soluble form. NS5A and full-length NS5B aggregate easily upon over-expression
in bacteria. To aid correct folding 3% EtOH were added to the culture medium before
induction, and expression was found to be best in an over night culture at 18◦C. To
increase solubilization and prevent aggregates in the lysis buffer, the pH was adjusted
according to the theoretical pI of the individual proteins based on their amino acid
sequence. The larger the difference between pI and pH, the greater the chance to keep
the protein soluble. For NS5A (pI=5.15) and NS5B (pI=9.04) the buffer was kept at
7.5. In contrast, NS3 has an expected pI of 6.99, so the pH was raised to 8.8.
With these adjustments, satisfactory yields of protein could be obtained. The proteins
were of sufficient purity, with very little contaminating bands (fig. 5.4).
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Figure 5.4.: Bacterial expression and
purification of HCV non-structural
proteins. Around 1µg of eluted protein
was loaded on a 10% PAA gel and stained
with coomassie brilliant blue. Arrow heads
indicate the band for the protein of inter-
est. Protein amounts were approximated
by NanoDrop measurement.
5.1.4. Reconstitution of the Viral Replicase In Vitro
After purification of the replicase proteins, the next goal was to assess the modulatory
effects of NS3 and NS5A on the function of the viral polymerase NS5B. NS3 is a mul-
tifunctional enzyme, which contains a protease, and a helicase/NTPase domain. The
relevant function in the replicase is likely associated to the helicase, which might prepare
the RNA template for efficient NS5B initiation. Therefore, its enzymatic activity was
determined and reaction conditions were tested that would allow enzymatic activity of
polymerase and helicase in the same reaction. In contrast, the phospho-protein NS5A
does not posses any known enzymatic function, but binds to several viral and host pro-
teins, as well as to uridylate-rich RNA. How and if it is involved in initiation of (-)-strand
synthesis is not yet understood. Thus, no further testing was possible beforehand for
this protein.
NS3 Helicase Assay
Before the interaction of the purified replicase components were tested, the NS3 helicase
was subjected to an in vitro assay, to confirm its functionality. Besides the wild type
enzyme, also an ATPase dead mutant (Q460H62) and the helicase domain alone (∆P)
were used. These his-tagged variants of the viral protease/helicase were also expressed
in E. coli and purified via NiNTA chromatography (fig. 5.5A). The enzyme kinetics and
efficacy were determined in a DNA based unwinding assay, adapted from62 (fig. 5.5B).
Furthermore, specificity of the observed effect was probed by inhibition of the helicase
by the small molecule inhibitor manoalide (MNLD). This compound has been described
to inhibit helicase function, ATPase and nucleic acid binding capabilities of HCV NS3
and related cellular helicases63. As expected, a dose dependent effect could be observed
with an IC50 of 1.1µM (fig. 5.5D, E). Thus, manoalide is approximately 15 times more
potent inhibiting NS3 on a DNA duplex compared to the RNA template (IC50=15µM),
tested by Salam et al. 63 . VX950, a potent protease inhibitor, had no effect on total
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helicase activity (fig. 5.5F) or the enzyme kinetics (supplementary fig. C.1). The
small polypeptide NS4A is an essential co-factor of NS3 during natural infection. It
folds into the protease domain, and anchors the enzyme to the membrane. To evaluate
its role in vitro, an NS3/4A fusion-protein was expressed and purified. Previously, it
has been shown, that the pH significantly influences the helicase activity of NS3/4A.
At acidic pH, helicase activity was detected, while neutral pH inhibited protein func-
tion. We could observe the same effect in the established helicase assay (fig. 5.6D-E).
While the NS3 helicase activity was readily detectable at pH6, no unwinding was found
at physiological pH7.5. This phenotype remained unchanged upon addition of either
NS5A or 5B in equimolar amounts. Since NS5B activity is greatly reduced in an acidic
environment299,300, NS3 was used without NS4A at pH7.5 in the subsequent assays. In
order to further optimize assay conditions, a potential temperature-dependence of the
helicase was addressed. At room temperature (25◦C), the DNA duplex was unwound
only very inefficiently. Furthermore, 37◦C, or 41◦C (the physiological temperature inside
the liver) were tested, which both proved to be more suitable for unwinding activity (fig.
5.7A). At early time points 41◦C could increase helicase activity compared to 37◦C, but
the maximum amount of unwound template after 30 min was equal in both conditions.
To mimic cell culture conditions as close as possible, the following optimization experi-
ments were conducted at 37◦C. Next, the cooperative effect of NS5B was addressed. It
has already been shown that NS5B has a stimulatory effect on NS3 helicase activity62.
The reported stimulation was dose dependent, and readily observable at excess concen-
trations of NS5B. Thus, NS5B∆C21 was added to the unwinding reaction. In agreement
with the published data, no stimulation could be observed at equimolar amounts in the
optimized helicase buffer. However, using a buffer optimized for RdRP activity had a
marked effect on NS3, and the unwound DNA fraction after 30 min was decreased by
approximately 50%. Interestingly, this effect could be reversed by adding NS5B in a 1:1
molar ratio (fig. 5.7B and C).
In summary, the NS3 helicase function was greatest using the full length enzyme, but
without NS4A as co-factor. As for the optimal in vitro conditions, elevated temperatures
greater than 25◦C were needed for optimal activity. Since the final replicase assay
depends on full functionality of NS5B, an RdRP buffer was tested for its effect on helicase
function. It was found that this buffer was not ideal for NS3. However, interaction with
the polymerase was sufficient to restore full helicase activity. These data also indicate
that NS3 and NS5B were capable of functional interaction under the chosen in vitro
conditions.
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Figure 5.5.: Expression and determination of activity of NS3 variants. A | Schemat-
ics of the NS3 variants used, and representative SDS-PAGE gel stained with coomassie blue,
demonstrating the successful purification of the proteins. Arrow heads mark the expected
size of each construct. The nature of lower band (*) in the Q460H mutant preparation is
not known. B | Kinetics of NS3 action were determined by a DNA based unwinding assay.
Duplexes of a 54 and a radioactively labeled 30 nucleotide long DNA fragment were incu-
bated with full-length NS3 and a 30-fold excess of a 30 nt capture oligo. The reaction was
started by addition of ATP and incubated for up to 30 min. The reaction was loaded onto
a non-denaturing PAA gel and the ratio of the initial duplex (54:30) and hybrids with the
capture oligo (30:30) was determined by auto-radiography. (n=5) C | Unwinding performance
of the different mutants was tested as described in textbfB. Shown are endpoint values after
30 min at 37◦C . Heat-denatured samples were used as positive control (95◦C ). D | Manoalide
(MNLD) is an inhibitor of NS3 activity and was used to verify a specific effect of the enzyme.
Representative auto-radiography image showing the effect of increasing MNLD concentration
on NS3 helicase activity. The effect of increasing concentrations of MNLD on NS3 unwinding
activity was quantified (n=2), and the IC50 was calculated. E | Comparison of MNLD with the
protease inhibitor VX950, both at 100µM concentration (n=2). Shown are endpoint values
after 30 min at 37◦C . Error bars represent S.D.
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Figure 5.6.: Effect of NS4A on NS3 activity in vitro. A | Coomassie stained SDS-PAGE
of purified NS3/4A. B | pH-dependent performance of an NS3/4A fusion protein. Purified
NS3/4A was subjected to the helicase assay described in fig. 5.5 at different pH values
(n=2).In brief, 30 nt DNA oligo was labeled and hybridized with an unlabeled 54 nt fragment.
The duplex was incubated with the enzyme, excess levels of a 30 nt capture oligo and ATP.
The resulting large (54:30, native) and small (30:30, unwound) duplex were separated by PAA
gel electrophoresis, detected by auto-radiography and quantified. Shown is the amount of
unwound duplex over 30 min at 37◦C. Error bars represent S.D. C | The same assay as in
B was performed at pH7.5, but after addition of equimolar amounts of other non-structural
proteins (NS5A and 5B) to assess, whether possible protein:protein interactions might overcome
pH dependence of NS3/4A.
Figure 5.7.: Optimization of conditions for NS3 activity in vitro. A | To address
the influence of temperature on NS3 unwinding kinetics, the DNA-based helicase assay was
performed at 25◦C, 37◦C and 41◦C (n=2), as described above. In brief, 30 nt DNA oligo was
labeled and hybridized with an unlabeled 54 nt fragment. The duplex was incubated with the
enzyme, excess levels of a 30 nt capture oligo and ATP. The resulting large (54:30, native)
and small (30:30, unwound) duplex were separated by PAA gel electrophoresis, detected by
auto-radiography and quantified. B | The final aim to reconstitute the viral replicase demands
optimal activity of all enzymes in vitro. Therefore the different buffer systems, either optimized
for NS3 (“helicase buffer”, n=2) or NS5B (“RdRP buffer”, n=1) were used in the helicase
assay. NS5B alone was used as a negative control. Shown is the amount of unwound duplex
over 30 min. Error bars represent S.D.
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Impact of NS3 on NS5B RNA Polymerization
After successful validation of NS3 activity, interaction with NS5B, and optimization of
in vitro conditions, it was attempted to unravel the role of NS3 in NS5B-driven RNA
replication. Previously, it has been described that in CSFV NS3 can increase NS5B RNA
polymerization activity through direct interaction at distinct regions65. In vitro, NS5B
has been described to use several modes of initiation: i) primer-dependent/copy-back:
the end of newly made RNA product is annealed to another RNA template and used
as primer to initiate a subsequent round of polymerization. This mechanism produces
RNAs larger than the original template. ii) terminal de novo: First synthesis of a 2-3 nt
primer at the very 3‘ end of the template, then the polymerase switches from initiation
to elongation mode. This mechanism is used to initiate at the 3’ terminus, producing
exactly template-sized RNAs. This is suspected to be the preferred mechanism in the
natural infection. iii) Internal de novo: as in ii), but using an internal single-stranded
region, as it has been shown for picornaviruses301,302.
To test whether HCV NS3 is capable of stimulating NS5B processivity or initiation
capacity, both proteins were incubated to different ratios, and complemented with either
a cytidin homo-polymer, or a natural hetero-polymer, comprising the 3’ end of the
HCV (-) strand, including the known cis-acting replication elements. As readout for
polymerase activity, the incorporation of radio-labeled nucleotides into the nascent RNA
was quantified by liquid scintillation counting104 (fig. 5.8A). The homo-polymer is
unstructured and therefore elongation can progress at maximum velocity. Additionally,
it allows for efficient initiation virtually anywhere on the template. The 3’(-)-strand
sequence also contains an ideal platform for initiation at the 3’ end, but features several
secondary structures. These might be favorable for more specific recognition of the
viral RNA, but also restrict internal initiation on this template. Moreover, since the
intrinsic processivity of NS5B is rather low? , the stems might also slow down or abort
polymerization.
NS3 acts as a 3’-5’ helicase, and could theoretically initiate at a short single stranded
region 3’ of the first stem and unwind the structured template, thereby aiding efficient
initiation or polymerization of NS5B. Indeed, the active wild type NS3 was able to
stimulate incorporation of radioactive nucleotides by approximately 3-fold, whereas the
inactive mutants did not (fig. 5.8B). This dependence on helicase activity suggests a
specific effect, which goes beyond pure stabilization of NS5B, and argues for a function
of active NS3, facilitating NS5B initiation and/or processivity.
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Figure 5.8.: Effect of NS3 variants on NS5B activity in vitro. A | Schematic repre-
sentation of the used assay to study RdRP activity by incorporation of radioactively rNTPs.
NS3 and NS5B∆C21 were pre-incubated on ice in different ratios. Then, either a natural and
highly structured template (in vitro transcribed 3’(-) nucleotides 1-341 of the JFH-1 strain),
or a cytidylate homopolymer was added. The reaction was started by addition of rNTPs con-
taining radioactively labeled CTP and incubated for 60 min at 37◦C. The reaction was TCA
precipitated, and the polymerase products captured on a Whatman filter. Excess nucleotides
were removed by stringent washing, and the radioactivity incorporated into newly formed RNA
products was measured in a scintillation counter. B | Effect of NS3 variants on NS5B per-
formance, using the 3’ terminal 341 nucleotides. NS5B was incubated with full-length NS3 or
inactive variants Q460H and ∆P. C | Effect of NS3 variants on NS5B performance, using a
polyC template. NS5B was incubated with full-length NS3 or inactive variants Q460H and ∆P
(n=3). The values of each experiment were normalized to the activity of NS5B alone. Error
bars represent S.D.
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In contrast, on the polyC template the incorporation of nucleotides was not improved
by NS3 addition, which might mean that NS5B is maximally active on this template,
and no further stimulation is possible. In fact, increasing amounts of the helicase dead
mutants even decreased RdRP activity on this template (fig. 5.8C). Since the active en-
zyme did not show this phenotype, one could speculate that NS5B processivity might be
enhanced actually be pulled along the template by NS3. This mechanism would require
interaction with NS5B, the RNA template and an active ATPase, which mediates the
structural shift necessary for moving along the template. The Q460H mutant is ATPase
defective, while ∆P is supposedly impaired in RNA binding. Therefore, interaction of
these mutants with the polymerase could lead to a functional block, by retention at the
initiation site (Q460H), or sequestration away from the template (∆P).
These data show that NS3 activates NS5B-dependent RNA synthesis through its he-
licase/NTPase function. Likely this involves physical interaction of both proteins. How-
ever, it cannot be deduced from these results, if the generated product was initiated
de novo from the extreme 3’ end, which would be necessary in the natural context,
or by internal initiation, which has also been described to occur in vitro. Therefore,
a qualitative analysis of reaction products was performed using a gel-based system as
readout. Here, the natural 3’ terminal 450 nt of the (+)-strand were used (fig. 5.9A).
The polymerase alone was not able to initiate efficiently on this template (fig. 5.9B).
In concurrence with the liquid scintillation counting assays, the overall RdRP activity
was increased by functional NS3, but not by inactive mutants (fig. 5.9C). Additionally,
a specific increase of the presumed full-length product was observed in presence of NS3
(fig. 5.9A,C,D)), as judged by higher amounts of a radiolabeled product of template size
(450 nt). At different temperatures, the observed phenotype was modulated. Lowering
the temperature, led to a decreased the amount of NS3 needed for maximal stimula-
tion (0.5-fold molar ratio, fig. 5.9C). Moreover, the specific enhancement of de novo
product seemed to be favored over the general RdRP activation. At higher temperature
the opposite effect became evident (fig. 5.9D). Interestingly, in all cases a 2-fold excess
of NS3 led to reduced specific product, compared to equimolar amounts. However, the
effect RdRP stimulation was retained at excess concentrations of NS3, at least at higher
temperatures.
As shown previously, the natural compound MNLD readily inhibits NS3 nucleic acid
unwinding, and to a lesser extent its ATPase activity63. The impact of MNLD on
NS5B is not known. To test the influence of NS3 inhibition on RdRP activity, these
compounds were added to the assay with a NS3:NS5B ratio of 1:1. The compounds
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Figure 5.9.: Effect of NS3 variants on NS5B de novo initiation in vitro. A |
Schematic representation of the gel-based assay, and assignment of obtained bands. The ini-
tial experiments were performed at 37◦C, using different NS3:NS5B ratios. 3’(+) RNA, and
rNTPs with α−32P-CTP were added, and radioactively labeled products were separated by
denaturing PAGE, and visualized by auto-radiography. Bands above 450 nt were considered
copy-back products, template-sized RNAs were assumed to be terminal de novo products.
Lower bands could be a result of internal initiation. The density of a whole lane was used as
value for RdRP activity. The band at 450 nt was normalized to the corresponding lane. B |
Representative auto-radiography image, and quantification of terminal de novo product, and
RdRP activity. C | Effect of NS3 variants on NS5B performance. NS5B was incubated with
equimolar amounts full-length NS3 or inactive variants Q460H and ∆P. General and specific
RdRP stimulation were quantified and normalized to the values obtained with NS5B alone.
D-E | Temperature dependence of NS3-mediated RdRP stimulation. The assay was performed
at 30◦C, to facilitate protein:protein interaction, or 41◦C to mimic conditions in the human
liver. Error bars represent S.D. of three independent experiments.
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were preincubated with the proteins in different concentrations. While a stimulation
of NS5B by NS3 was still visible in all conditions, the nature of the template was
different at inhibitory concentrations, giving ride to large amounts of copy-back product.
Strikingly, the template-sized and all smaller products were effectively eliminated in a
dose-dependent manner (fig. 5.10A). To test for any effect on NS5B alone, a template
with a tri-cytidylate attached to the 3’ terminus was used. NS5B can initiate on its own
at this short single-stranded region. Interestingly, MNLD alone did also affect NS5B
terminal de novo initiation, while a faint band appeared at the size of the suspected
copy-back product (fig. 5.10B). However, this was not as pronounced as in the case of
NS3 addition. Possibly because NS3-mediated stimulation of the general RdRP activity
is required for this effect.
Additionally, biogenic polyamines (i.e. spermidine (SPDN)), inhibited NS3 with IC50
values around 0.5 mM, but stimulated NS5B by up to 6-fold at similar concentrations,
leading to achievement of the maximal enzyme velocity303. For SPDN, the inhibitory
concentration for NS3 has not been tested in our system, so a larger concentration range
form 10µM to 10 mM was covered. As for MNLD, the compound was able to increase
the copy-back fraction. However, addition of NS3 was not essential in this case, as
the compound itself actively stimulates NS5B303 (fig. 5.10C). This means, a general
stimulatory effect on the Vmax of NS5B can be mediated by NS3, even after inhibition of
the helicase. However, the mechanism of initiation seems to be affected, since terminal
de novo product is not efficiently made under these conditions.
In conclusion, we found no increase of the copy-back fraction of newly synthesized
RNA after addition of active NS3, whereas internally initiated or abortive fragments
appeared in concurrence to the template-sized product. The data are in line with a re-
ported 1:1 stoichiometry of functional NS3:5B complexes67. The most specific effects on
de novo initiation were seen at 30◦C, which might be due to more stable protein:protein
and Protein:RNA interactions. Suppression of the helicase activity by chemical inhibitors
led to a loss of de novo product, instead copy-back products were generated in larger
proportions. Additionally, MNLD and SPDN seem to act on NS5B, favoring a primer
dependent mode of initiation. This speaks for two separate functions of NS3: first, at the
initiation step, for which the helicase is needed, and second, a stimulation of processivity
which likely depends mostly on the NTPase activity of NS3.
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Figure 5.10.: Small molecule inhibition of NS3 and its impact on NS5B stimula-
tion.A NS3 and NS5B∆C21 were pre-incubated on ice in different ratios. Then, the nat-
ural in vitro transcribed 3’ 450 nt of the (+)-strand (JFH-1) and different concentrations of
Manoalide (MNLD) were added. As stated above, the reaction was started by addition of
rNTPs containing radioactively labeled CTP and incubated for 60 min at 37◦C. The resulting
labeled fragments were separated by denaturing PAA gel electrophoresis and visualized by
auto-radiography. Densities of the terminal de novo and copy-back product (*) were quanti-
fied relative to the whole lane (n=2). B | The standard heteropolymeric 3’(+) template was
modified with 3 cytidylates at the 3’ end to enable NS5B initiation without NS3. C | Chemical
structure of Spermidine (SPDN). A similar effect as with MNLD is seen for spermidine under
equivalent assay conditions. The copy-back product is marked by an asterisk. The 1 mM value
was not considered due to apparent loss of sample. Error bars represent S.D.
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The Role of NS5A
Next, the role of the viral phospho-protein NS5A was interrogated. NS5A is a key factor
for efficient RNA replication of numerous host factors engaged in RNA synthesis and
biogenesis of the viral replication compartment. However, few facts are known about the
contribution of the interplay of NS3, 5A and 5B. Thus, different ratios of all three NS
proteins were mixed, and the impact on de novo initiation was investigated. A slightly
Figure 5.11.: Modulation of NS5B by NS5A. NS3, NS5A and NS5B∆C21 were pre-
incubated on ice in different ratios. Then, the natural in vitro transcribed 3’ 450 nt of the
(+)-strand (JFH-1) were added as template. As before, the reaction was started by addition
of rNTPs containing radioactively labeled CTP and incubated for 60 min at 37◦C. The resulting
labeled fragments were separated by denaturing PAA gel electrophoresis and visualized by auto-
radiography. A | Auto-radiography images showing the effect of each auxiliary protein alone
(NS3 or NS5A), or B | the combination of NS3 and 5A in different amounts. Numbers above the
lanes indicate the used molar ratios relative to NS5B (NS3:NS5A:NS5B). C | Quantification
of auto-radiography images (n=2). RdRP activity indicates the density of the whole lane.
Densities of the terminal de novo product (450 nt) were quantified relative to the whole lane.
Error bars represent S.D.
increased production of the suspected de novo product could be observed in presence
of NS5A, without the need for NS3. However, this effect was less pronounced than the
helicase-mediated stimulation (fig. 5.11A, C). The NS5A-mediated mechanism seemed
to be distinct from the one exerted by NS3, since an additive effect was noted, when
both proteins were added in equimolar amounts. In this case, a substantial increase of
overall RdRP activity and terminal de novo product formation was noted (fig. 5.11B,
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C, [1:1:1]). This phenotype was only observed in this particular condition. As described
before, 2-fold excess of NS3 reduced the de novo product (fig. 5.11B, C [2:1:1]). A
similar trend was also seen in presence of increased amounts of NS5A, while the decrease
of RdRP activity was somewhat less pronounced (fig. 5.11B, C [2:2:1]). Indeed, excess
NS5A even seemed to attenuate the stimulatory function of NS3 slightly (fig. 5.11B, C
[1:2:1]). This is in line with the previously proposed separate effects on NS5B function.
Also, the strongly increased polymerase activity only in the case of equimolar amounts
of all proteins underscores the need for a well-balanced complex formation.
These data suggest a supporting/modulatory role of NS5A, by enhancing the NS3-
mediated effects, and increasing terminal de novo initiation at optimal molar ratios of
all three proteins. Recruitment and correct positioning of the NS3:NS5B complex would
therefore be a likely mode of action by NS5A in this context.
Remaining Technical Challenges
While the assay worked in principle, many experiments showed a high degree of vari-
ability. The most common issues are summaized in fig. 5.12. A constant source of
uncertainty resulted from a significant quantity of abortive products produced in the in
vitro transcription reaction, as shown in fig. 5.12A. Moreover, a few times, another
unidentified band appeared close to the presumed full length product (fig. 5.12B).
Some protein batches were contaminated with minute amounts of RNAse, which led to
the degradation of most of the sample (fig. 5.12C). The desired reproducibility was not
always achieved when only one component was changed in the reaction, i.e. a different
batch of protein (fig. 5.12D). While all batches of protein and RNA template were
checked for contamination or degradation, respectively (fig. 5.12E, F), this was not
sufficient to predict, whether an individual purification would yield comparable results.
Conclusively, the overall quality of the used components needs to be improved and has to
remain consistent between batches. Gel-purification of the used RNA, and an additional
size exclusion chromatography step for the proteins could be employed to generate high
quality components. Therefore, additional studies will be required beyond the scope of
this thesis to setup a more robust in vitro system.
Overall, these observations support a model of a minimal replicase containing NS3,
NS5B and viral RNA. NS5A could further augment the NS3-mediated effect on de novo
initiation of RNA synthesis. However, the experimental model could not be established
towards sufficient robustness to allow more in depth studies (fig. 5.12). Open questions
remain, in particular concerning the involvement of NS5A in RNA replication, as the
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Figure 5.12.: Persisting technical problems. A | A large number of lower molecular
weight bands appeared in the marker, which was generated by hot in vitro transcription. A
possible reason for this is premature termination of the T7 polymerase. B | A second band
close to the terminal de novo product was detected in several experiments. The nature of this
RNA remains unclear. C | Some protein preparations were contaminated with RNAses. D |
Different protein and/or RNA batches lead to very different results. Shown are two experi-
ments performed in the same way, but with a different NS3 preparation. E | Protein purity
was checked by SDS PAGE, stained with Coomassie Brilliant Blue. F | RNA integrity was
determined by agarose gel electrophoresis. Multiple bands represent different conformations of
the RNA.
protein was produced in bacteria and several studies have pointed out that the post-
translational modification of NS5A is crucial for correct protein function.
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5.2. Dissecting the Roles of miR-122 in the HCV Life
Cycle
The mode of action of miR-122 as a viral dependency factor has been attributed to
a variety of functions. The most recent paradigm on the molecular mechanism is a
physical stabilization of the viral RNA (fig. 5.13A). Other reports have also claimed,
that replication initiation is enhanced (fig. 5.13B), as well as translation of the viral
polyprotein (fig. 5.13C). While these studies have already worked on different leads to
find the true mode of action, most pursued a single hypothesis, and relied on different
cell culture systems. Initially, it was attempted to specify the quantitative contribution
of this small non-coding RNA at different phases of the viral RNA metabolism, and to
subsequently elucidate the corresponding mechanism of each function.
Figure 5.13.: Comparison of HCV replication in different cell lines upon miR-122
supplementation. A | miR-122 protects the HCV 5’ end against cleavage by the host exonu-
clease Xrn1304. B | RNA amplification is enhanced after miR-122 binding207. C | Translation
activity of the viral IRES is increased, and the association of the 40S ribosomal subunit is
bound more efficiently209.
5.2.1. Establishment of a miR-122 Activated Cell Culture System
To investigate the mechanisms responsible for the effects of miR-122 on the HCV life
cycle, a cell line without miR-122 expression was required. HEK293T as a non-hepatic
cell line, as well as HepG2 and Hep3B cells are described to have undetectable miR-
122 levels, and are therefore unable to sustain HCV replication natively. However, by
supplementation of the miRNA, transfected HCV RNA can be efficiently amplified. Ini-
tially, we used a co-electroporation approach of JFH-1 monocistronic reporter replicons
together with synthetic miRNA duplexes (fig. 5.14). None of the tested cell lines could
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reach the reporter activity achieved in the control Huh7.5 cell line. Nevertheless, 293T
and Hep3B replicated >100- or >1000-fold over background levels (∆GDD), respectively
(fig. 5.14B). Since Hep3B cells performed best in the comparison of the different tested
cell lines, as they showed the highest permissivity for HCV after introduction of miR-122.
These cells were therefore selected for subsequent experiments. All attempts to induce
HCV replication in HepG2 were unsuccessful even in presence of miR-122. In contrast,
293T and Hep3B cells could readily support HCV replication (fig. 5.14B). In addi-
tion, the amounts of miRNA present in the na¨ıve and electroporated cells were detected
by qPCR. Only background levels of miR-122 were detected without duplex addition,
whereas the electroporated cells showed levels even higher than Huh7.5 cells after 48 h
(fig. 5.14C). However, it is likely that not all of the miRNA is active, which might be
partly be the reason for the lower replication activity, compared to Huh7.5. By means
of in situ hybridization and western blot, detecting the expression of non-structural pro-
teins, a robust translation and replication could be visualized. No detectable levels of
reporter activity, viral protein or RNA were present during the 72 h time course when
no miR-122 was added (fig. 5.14B, D, E).
In addition, Hep3B cells were transduced with lentiviruses encoding either the wild
type pre-miR-122 stem-loop, or a mutated version with a single nucleotide exchange
within the seed region (A4U), rendering it unable to bind canonical targets. Comple-
mentary mutations in the HCV 5’ UTR (m1,2) will in turn only allow for binding of
miR-122 A4U, and not the wild type replicon (fig. 5.15A). The lentiviral integrate also
contained a puromycin N-acetyl-transferase gene for selection. To confirm the activity of
the introduced miR-122 variants, a known miR-122 target gene (PACT304) and several
controls were tested for regulation by western blot. While the wild type miR was able
to repress PACT expression to around 60%, the A4U version did not alter the expres-
sion levels. The control genes (ACTB, GAPDH) were not affected by over-expression
of either miR-122 variant (fig. 5.15B). The miR-122 expression levels of the cells were
determined by stem-loop RT qPCR. The miR-122 level in the generated cell lines is
approximately half of the amount found in Huh7.5 cells, a hepatic cell line highly per-
missive for HCV. In addition, let7a levels were also tested and found to be unaffected by
overexpression of functional miR-122, arguing for a largely unaffected RNAi system (fig.
5.15C,D). After validation of the functional miRNA expression, different HCV reporters
were tested, either a wild type construct or the m1,2 mutant, bearing the compensatory
mutations U26A and U41A for the A4U miR-122. As expected, neither replicon was
viable in native Hep3B cells. The miR-122 wild type cells only supported the wild type
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Figure 5.14.: Comparison of HCV replication in different cell lines upon miR-122
supplementation. A | Schematic of the monocistronic luc-ubi reporter replicon of the JFH-1
strain. B | Three different cell lines were electroporated with JFH-1 monocistronic replicons in
presence or absence a synthetic miR-122-duplex. Cells were lysed and luciferase activity (RLU)
was measured after 4 h (input control, not shown), and 48 h at the peak of replication activity.
The replication deficient ∆GDD (deletion in the catalytic center of NS5B) mutant served as
negative control. Highly permissive Huh7.5 cells were used as positive control. C | qPCR
quantification of miR-122 in na¨ıve Hep3B cells, compared with cells electroporated with miR-
122 duplex. miR-expressing Huh7.5 cells served as control. D | Replicon RNA was transfected
with or without wild type miR-122, and cells were stained with HCV- specific probes (red).
Nuclei were visualized with DAPI (blue). E | Western blot analysis of viral protein expression
over 72 h. GAPDH was used as loading control.
replicon, whereas the mutant miR-122 exclusively stimulated the corresponding mutant
replicon. The maximal reporter activity and the replication kinetics were comparable in
both cases. Moreover, the initial translation stimulation was achieved also for the A4U
miR-122 binding to m1,2 (fig. 5.15E,F). Therefore, the general mechanism of action
seemed not to be impaired for the mutant miR-122. This means that all relevant func-
tions of miR-122 could be reconstituted by exogenous supplementation of a synthetic
duplex and can be replaced by a mutant miR. Thus, Hep3B cells are a suitable model
system for the study of miR-122 dependent effects on the HCV life cycle.
To characterize the influence of miR-122 on the viral replication capacity, we used a
number of mono- and bicistronic replicons. The major difference between these reporters
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Figure 5.15.: Establishment of Hep3B cells stably expressing miR-122. A | Binding
of miR-122 to a target RNA. Mutation of a single nucleotide within the seed region (A4U)
restricts binding to the natural target site. Conversely, the complementary exchange in the
target leads to abolishment of interaction with wild type, but restores binding of the A4U
mutant. B | Western blot of control genes in cells stably expressing miR-122 WT or A4U.
HSP90, ACTB and GAPDH have no known or predicted target sites for miR-122, and are
not differentially regulated in all cell lines. PACT is a known target of the miRNA and is
downregulated only in cells expressing WT miR-122. All gene expression levels were normalized
to those of HSP90.C | qPCR quantification of miR-122 or D | let7a in native and miR-122
expressing Hep3B cell lines. Huh7.5 were used as a control. Luciferase reporter activity of wild
type or mutant replicons in Hep3B cells clistE with co-electroporated or F | stably expressing
wild type or mutant miR-122.
80
5. Results
was the IRES responsible for translation of the viral proteins (fig. 5.16A). First, the
influence of miR-122 on the translation of the incoming RNA was interrogated using the
luciferase activity at 4 h post electroporation. The most notable effect was observed in
the monocistronic context, where translation of the whole ORF depends on the HCV
IRES, and therefore on miR-122. The luciferase activity was increased over 6-fold, while
all other constructs were much less affected (fig. 5.16B). Next, the replication kinetics
was addressed. Unexpectedly, we found that miR-122 was not essential for replication,
since a monocistronic construct could replicate in miR-122 deficient Hep3B cells, if
translation was uncoupled from the HCV IRES, in this case by insertion of a Polio IRES
(PI-luc-ubi, fig. 5.16C). Importantly, the HCV IRES used in this setting lacked the
cis-acting element of the core coding region and was thus not able to initiate translation,
but contained only the sequences needed for RNA replication. This phenotype could
also be found for both tested bicistronic replicons, which harbored an EMCV IRES
proximal to the viral ORF (PI-luc and luc, respectively). Hence, miR-122 independent
replication was independent of the nature of the IRES element driving translation of
the viral proteins, as long as this was not the HCV IRES. These data also assigned a
crucial function of miR-122 to the translation of non-structural proteins, since only the
monocistronic replicon requiring the HCV- IRES for translation of the polyprotein was
replication incompetent in absence of miR-122 (luc-ubi, fig. 5.16C). Of note, enhanced
stability of the viral genomes mediated by miR-122 binding could likely be excluded
as a factor in this approach, since all replicons contain the same 5’ UTR sequence.
However, addition of miR-122 could still enhance translation and replication in the
bicistroic, as well as in the Polio-IRES dependent monocistronic replicon, albeit to a
lower extent compared to the monocistronic replicon (luc-ubi), which did not replicate
at all in absence of miR-122. This stimulating effect on miR-independent replicons could
be attributed to the published RNA stabilizing effect.
To gain a more quantitative view on the role of miR-122 in different parts of the viral
RNA metabolism, bicistronic replicons were constructed, in which elements necessary
for replication and translation were separated by duplication of the HCV 5’ UTR and
could thus be directly compared (fig. 5.17A). The first copy of the 5’UTR (i1) was
required for regulation of viral RNA replication and to maintain stability of the viral
genome, but had no function in translation. To monitor replication independently of
miR-122 activity, a Polio-IRES driven renilla luciferase gene was inserted. Translation
of the second cistron was dependent on the HCV IRES, bearing a firefly luciferase re-
porter to visualize translation of the viral proteins (fig. 5.17A). The architecture of
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Figure 5.16.: Importance of translation of HCV NS proteins for replication. A |
Schematic representation of the different replicons used. The functional RNA elements re-
sponsible for RNA replication or translation of the viral proteins are indicated in the boxes
on the right. B | Initial translation, as measured by firefly luciferase activity (RLU), 4 h post
electroporation. Shown are the comparisons between miR-122 WT and A4U supplementation
in the different classes of replicons. Polymerase-dead variants (∆GDD) of the replicons were
used in these experiments to exclude potential influences of early replication. C | Kinetics of
replication, measured by luciferase expression over a time course of 72 h post electroporation.
Shown are the comparisons between miR-122 WT and A4U supplementation in the different
classes of replicons. A polymerase-dead mutant (∆GDD) was used as negative control. Values
represent means of three independent experiments with S.D..
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this construct therefore allowed to independently mutate the miR-122 binding sites in
both copies of the HCV 5’UTR to assess the functional role of miR-122 in viral repli-
cation/stability and IRES-function/translation, respectively. The functionality of the
construct was tested in different cell lines, and in presence or absence of miR-122. In
Hep3B cells, functional miR-122 had to be co-electroporated or stably expressed to fa-
cilitate translation/replication of the construct. Without miR addition, no replication
was detectable.Surprisingly, renilla luciferase activity was significantly lower, and only
distinctly detectable in the highly permissive Huh7.5 cells (fig. 5.17B). However, a
robust increase in firefly luciferase activity of approximately 100-fold was achieved by
addition of miR-122 in Hep3B cells (fig. 5.17B). In Huh7.5 cells, the peak luciferase
activity was around 10 to 20-fold higher than in Hep3B cells expressing miR-122 WT.
Thus, the firefly values were initially used for quantification. Furthermore, single point
mutants disrupting the miR-122 binding to its recognition sequences were introduced to
each of the IRES elements separately or in combination. In addition, miRNAs with com-
plementary mutations were used for rescue experiments. By this approach, individual
functions of the miRNA could be probed separately. While the wild type replicon did
only replicate in presence of wild type miRNA, but not with A4U, the control replicon
with mutations in both UTRs exhibited the inverse phenotype. Surprisingly, abrogation
of the interaction of miR-122 at the 5’ end (i1 m1,2) only had a slight negative effect
on replication, which could be restored by addition of the rescue miR. In contrast, the
mutations in i2 affected replication more dramatically. In presence of wild type miRNA
only basal levels of replication could be achieved. However, the replication of this mutant
could be rescued by co-transfection of the mutant miR-122. The replication kinetics of
the dual luciferase replicons, as measured by firefly luciferase expression, differed from
those observed with other bicistronic replicons in earlier experiments . Therefore, di-
rect detection of the viral RNA was performed by northern blotting, in order to see
whether RNA integrity or replication were affected. Also at the RNA level, the dual
luciferase reporters exhibited slightly delayed kinetics, and a lower replication efficiency
compared to a monocistronic replicon (fig. 5.17D). In addition, it was noted that a
lower molecular weight band appeared after 48 h, which was approximately the size of a
monocistronic construct (fig. 5.17D, asterisks). Over the course of 72 h this truncated
RNA gained intensity in the wild type replicon, and became the dominant fraction. Both
point mutants showed lower maximal luciferase activities in the previous assays, which
was also reflected in decreased RNA levels. However, the lower band was also detectable
at 48-72 h in the i1 m1,2 and at 48 h in the i2 m1,2 mutant (fig. 5.17D). This could
83
5. Results
Figure 5.17.: Quantification of miR-dependent translation and replication. A |
Schematic representation of the dual luciferase replicon. B | Renilla and firefly expression after
electroporation in Huh7.5 or Hep3B cells. C | Replication capacity of dual IRES replicons upon
miR-binding site mutation of IRES 1 (i1 m1,2) and 2 (i2 m1,2)in Hep3B cells stably expressing
miR-122 WT (green squares) or A4U (red squares). To define the maximal replication capacity
for the single IRES mutants, miR-122 A4U duplex was co-electroporated into miR-122 WT
producing cells (black triangles). D | Northern blot detection of viral RNA over 72 h in Hep3B
cells, supplemented with miR-122 WT. Body-labeled radioactive RNA probes directed against
the coding region of the NS-proteins was used to detect HCV RNA. β-Actin served as a loading
control. Upper panels: RNA amounts of wild type and point mutants of the dual- luciferase
construct. Truncated RNAs, which appeared for the RF replicons after 48 h, are marked with
an asterisk. Lower panels: monocistronic replicon (luc-ubi) wild type and ∆GDD were used as
controls. Fixed amounts of in vitro transcribed replicon RNA were loaded as standard. Mock
electroporated Hep3B cells were used as negative control.
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hint towards a recombination event, which occurred at early time points (4-24 h), and
gave rise to a monocistronic fragment, likely consisting of the second cistron. Possible
mechanisms would be a homologous recombination at SLI, or internal initiation of the
viral RdRP at the start of the second cistron during (+)-strand synthesis. In both cases,
the renilla luciferase gene would have been removed in the majority of replicating RNAs,
which consequently accounted for the strong differences of firefly and renilla activities.
Overall, the results of the comparison between the different mono- and bicistronic
replicons showed that HCV can only replicate in absence of miR-122, if translation
is not mediated by the HCV IRES. This finding emphasized the importance of initial
translation during the HCV replication cycle. However, a detailed quantification was
not yet possible, due to recombination events within the used dual luciferase replicon.
5.2.2. Sequences and Structures in Domain I of the 5’ UTR
Necessary for Translation
As the results of the previous experiments pointed towards a strongly translation-
associated effect, we asked, how miR-122 can enhance translation efficiency by binding
to domain I of the IRES. However, removal of domain I has no negative effect on IRES
function240. Furthermore, it is known that optimal activity of the HCV IRES depends
on its secondary and tertiary structure247 (fig. 5.18A, B). The complementary 3’(-) re-
gion adopts a well-described and functionally relevant fold244 (fig. 5.18D). Particularly
the region containing the terminal 150 nt is essential for replication, and disruption of
the secondary structure leads to severe loss of viral fitness. Therefore, the highly struc-
tured shape of the complementary region (SL-IIz’) opposes the paradigm of a completely
relaxed state on the (+)-strand. Consequently, domain I might adopt a fold, which in-
terferes with the formation of essential structures in the IRES. Especially the adjacent
SLII could be affected, resulting in a dysfunctional IRES. Based on this hypothesis in
silico folding of the first 120 nucleotides was performed, which include domain I and
II. Interestingly, all tested algorithms predicted a stem-loop, encompassing nucleotides
21-105, which are exactly the borders of the 3’(-) SL-IIz’ as energetically most favorable
option (fig. 5.18C). Obvious similarities were observed between the base (nts 21 - 35,
85 - 105) and tip regions (nts 48 - 65) of the hypothesized domain I/II stem-loop and
the corresponding structure on the 3’(-) end (fig. 5.18C, E). This is not particularly
surprising, since it can be assumed that complementary sequences will likely adopt sim-
ilar shapes, except for parts where U:G base paring occurs. Strikingly, all five U:G base
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pairs within the 3’ terminal 120 nucleotides are clustered within a 9-base pair stretch
(fig. 5.18E). Accordingly, this central part of the (+)-strand counterfeit of SLIIz’ is
strongly destabilized and expected to assume a single stranded conformation. It is also
worth noting that this segment overlaps exactly with the second seed binding region for
miR-122. The reported fold of domain II (fig. 5.18A, B) could not be obtained, unless
additional constraints were applied. Strikingly, disallowing the nucleotides involved in
miR-122 binding to form base pairs, prevented the domain I structure and yielded the
functional fold of the IRES. These predictions indeed suggested that miR-122 binding
to the 5’ UTR of the HCV positive strand might contribute to the correct folding of the
IRES. As mentioned above, the in silico model predicts a fold closely related to the 3’(-)
Figure 5.18.: In silico analysis of domain I/II of the HCV 5’ UTR. A | Schematic
representation of the complete 5’ UTR and IRES of HCV. The two miR-122 binding sites
within domain I are indicated. The region of domain I and II, which was used for in silico
prediction is colored in red. B | mfold prediction of the first 120 nt of the HCV (+)-strand,
when both seed binding sequences (indicated by red lines) were prohibited from forming base
pairs. C | The same sequence as in B, but without constraints. Seed binding sequences are
again marked with red lines. D | Schematic representation of the complementary sequence to
the 5’ UTR at the 3’(-) end. The region, which was used for in silico prediction is colored
in red. E | mfold predicted structure of the 3’ 105 nt of the (-)s-strand. U:G base pairs are
depicted in blue.
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end structures. Therefore, the results obtained in the in silico analysis conflicted with
the commonly proposed structural model of domain I/II. Hence, the structure of this
region was examined in greater detail. In order to experimentally address the structure
of the 5’ 120 or 389 nt, these RNA fragments were in vitro transcribed and gel purified.
The purity and integrity of the resulting RNA was checked by urea PAGE, and staining
with methylene blue. The obtained RNA was free of appreciable contamination and
could be isolated in satisfactory yields (fig. 5.19A). Prominent secondary structures,
and hybridization of miR-122-5p to its target under the chosen in vitro conditions, were
investigated by native PAGE, stained with methylene blue. As a non-binding control,
the complementary strand of the miR-122 duplex (3p) was used. It was observed that
miR-122-5p does bind to both fragments, as the target RNA shifted to a higher molecular
weight, and concurrently the miR-122-5p band showed decreased intensity, compared to
the 3p-control (fig. 5.19B, C). Seven distinct bands were observed for the 389 nt frag-
ment, pointing towards a number of secondary structures (fig. 5.19B). Importantly,
no lower molecular weight bands were detected in the denaturing gel, arguing against
truncated/abortive fragments in the preparation. In this setting, no change of the band
pattern was observed between the miR-122-5p or -3p condition. Expectedly, the 120 nt
RNA presented a much cleaner picture in the native gel, since there are fewer options for
intramolecular interactions. However, at high contrast three more bands could be de-
tected (fig. 5.19B). The quantification of bound miR molecules to their target showed
that both miR-binding sites were occupied on the 389 nt, while only one site was bound
efficiently on the 120 nt fragment. This might be a result of the lower miR:template ratio
(≈2:1) , compared to the 389 nt fragment (≈8:1). These data provide evidence that in-
deed the 5’ UTR can fold into several different structures. In addition, miR-association
was possible under the chosen in vitro conditions, and likely both binding sites were rec-
ognized, given a sufficient molar excess of the miR over its respective target. However,
post-folding binding of miR-122 seemed not capable of resolving the non-canonical folds
of the 5’ UTR.
A more sophisticated approach was applied with the help of our collaboration partners
in Grenoble, where the smaller fragments should be analyzed by NMR. This technique
is able to discern dynamic states of a macromolecule in solution. The general principle
is the measurement of energy transfer from an external magnetic field to atomic nuclei.
Nuclei of 1H, 13C or 15N can be excited, due to their specific spin and energy properties.
When these atoms relapse into their basal energy state after application of the force field,
the emitted energy can be recorded. The exact energy that acts upon a specific nucleus is
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Figure 5.19.: Characterization of HCV 5’UTR fragments. A | Denaturing urea PAGE
with ∼1µg of in vitro transcribed RNA, before and after gel purification. B | Native PAGE
using 1.5µg of the 389 nt (≈12 pmol) and 120 nt (≈40 pmol) fragment after denaturation and
refolding for 15 min at 37◦C in presence of 100 pmol miR-122-5p or -3p (non-binding control).
C | Quantification of miR molecules bound to the respective target RNA. Calculation was
done by comparing the density of miR-122 signals between the binding and the non-binding
control.
dependent on the surroundings, i.e. other nuclei and electrons, which influence the local
magnetic field. Therefore, the excitation state and consequently the emitted frequencies
vary between different atoms in a higher order structure, and give an individual spectrum
for each molecule.
First, we optimized the RNA production to generate large amounts of highly pure
RNA. Apart from the full-length IRES (389 nt), three truncations were generated: the
first 120 nucleotides, comprising domain I and II, only the SLII sequence (40-120) and
one harboring the predicted alternative structure (1-105). These samples were used to
record 1D 1H spectra. In this case, only the hydrogen atoms engaged in the imino bonds
between the bases were specifically activated by the magnetic field. Therefore, each peak
in the obtained spectrum should theoretically represent one imino bond. However, only
the hydrogens of U:G and C:G base pairs (and some non-Watson-Crick pairings), are
easily detectable. U:G pairs will result in a double peak, while C:G only gives a single
peak. The experiments were performed at 6.6 mM MgCl2, and several temperatures from
5 to 30◦C. Strikingly, while the linewidth usually is reduced at low temperatures, in the
case of the 120 nt and 105 nt fragments, the spectrum became very noisy. This can be due
to different conformers, which are trapped in their current state at low temperatures,
when the available energy is increased the most stable structure is favored, and thus
becomes the dominant spectrum. This hypothesis was further supported by the fact
that this temperature dependence was not seen for the SLII fragment (40-120), which
is predicted to strongly favor a particular secondary structure (fig. 5.20A). After the
determination of optimal recording conditions, the 1D spectra of each fragment was
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Figure 5.20.: 1D NMR spectra of HCV 5’UTR domain I and II. A | To assess the
optimal temperature for the following experiments, 1D 1H spectra of the first 120 nt of the HCV
5’ UTR were recorded at 5 to 30◦C. The RNA concentrations used in this initial experiment
were 0.8 to 1.2 mM. B |. Comparison of 1D 1H spectra recorded of three truncations of
the HCV 5’ UTR, 1-105 (1.2 mM), 40-120 (0.8 mM) and 1-120 (0.3 mM) at 30◦C. C | While
some mismatches remain, the combination of peaks generated in B fit the 1-120 spectrum
considerably better than the ones obtained for the individual sub-fragments. Mismatched peaks
are marked with a line. The corresponding predicted folds for each construct are depicted at
the respective spectra. Since the 120 nt fragment is likely present as ensemble of conformers,
the predicted and the canonical structure are shown.
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compared. There was no strong overlap between each individual peak map. However,
several peaks missing in the 120 nt spectrum, as compared to the others could be restored
by addition of both fragments, even though not all signals could be matched (fig. 5.20B,
C). While the 1D spectra are a good indicator whether two structures are identical, it
is not possible to assign a peak to a specific base pair. This means, even closely related
structures can have very different spectra. In order to determine specific secondary
structural elements, 2D NMR was performed (fig. 5.21 and fig. 5.22). The optimal
temperature for the 120 nt construct was determined to be at 30◦C, while in contrast to
the 1D spectrum, the 105 nt fragment gave varying signals, the strongest one at 15◦C,
which was used for analysis in this experiment.
Here, the signals come from the imino bonds (ω1), and the magnetization transfer
between hydrogen atoms in close proximity (ω2). As expected, several characteristic
peaks for the SLII stem-loop were detected, in the 120 nt fragment as well as in 40-
120 nt truncation. There were only few peaks that were missing in the 40-120 template,
which are likely representative of the SLI stem. This is corroborated by the fact that the
105 nt RNA did not present the SLII peaks, however, the signals absent in the 40-120 nt
fragment could be seen. The rest of the cross-peaks did not show any overlap, which is
in line with the predicted abolishment of SLII in this mutant (fig. 5.22).
Overall, these experiments in conjunction with the native gel analysis could provide
further evidence for the existence of an ensemble of structures in solution, which could be
influenced by association of miR-122 to the RNA. Moreover, it seems that the alternative
states are not defined as one or two stable conformations, but rather the dynamic tran-
sition of a number of structures, with the canonical fold as a dominant fraction. Only
such a model would explain the fact that most of the signal is lost in the background.
In parallel, SHAPE was used as an approach (fig. 5.23) to verify the architecture
of domain I and II biochemically305. This type of structure probing relies on stochastic
chemical labeling (acylation) of flexible nucleotides. In a subsequent reverse transcrip-
tion reaction, the polymerase stalls at these modified residues, giving rise to several
fragments, which can be separated on a denaturing gel. Each band will thus represent a
nucleotide not engaged in a higher order structure. Since most complex RNAs in solution
can adopt numerous folds, depending on the thermal energy of the surroundings, this will
also be reflected in the band pattern. Therefore, the SFold algorithm was used, which
can produce a histogram plot with the probabilities of a nucleotide being free, based on
the 1000 thermodynamically most favorable structures of a given RNA306. Interestingly,
while the overall SHAPE pattern was similar to previously published data, the mapping
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Figure 5.21.: 2D 1H-1H-NOESY spectrum of HCV 5’UTR fragments. 2D 1H-1H-
NOESY spectra were recorded for the 120 (top) and 105 nt (bottom) fragments. The temper-
atures at which the measurement was performed is indicated. The mfold predicted structures
are shown as inset. Since the 120 nt fragment is likely present as ensemble of conformers, the
predicted and the canonical structure are shown.
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Figure 5.22.: Comparison of 2D NMR spectra of the different fragments. Overlay of
the 40-120 nt part, resembling SLII, with the full 120 nt fragment (top). Mismatched singular
peaks are marked with a red box. Characteristic cross-peaks, which indicate the presence of
SLII (arrows) are indicated. The inset shows the corresponding region of the original publi-
cation, in which they were first described (Lukavsky et al. 250). The lower panel shows the
overlay of the 120 nt and 105 nt fragments. The mfold predicted structures are shown on the
right. Since the 120 nt fragment is likely present as ensemble of conformers, the predicted and
the canonical structure are shown.
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of reactive nucleotides against the current folding model revealed significant mismatches
(fig. 5.23A,B). Some of these could be resolved by fitting to our predicted alternative
structural element, especially the lack of reactivity of residues 20-35 and 61-65, whereas
some inconsistencies remained. The most striking unresolved peak in reactivity (nts
49-51) was included as a constraint in the following prediction refinement(fig. 5.23C-
E). This small change was sufficient to favor a structure even more closely resembling
the SLIIz’ stem loop, with a much smaller central bulge, however, still containing the
complete seed binding region. Moreover, this led to a better overall fit of experimental
data and predicted structure. The final structure only contains minor regions (<=4 nt)
which are not reactive. Only the region between nt 90-98 shows no labeling, while it
should be accessible in the predicted, as well as in the published fold. This could also
be a result of tertiary structure or intra-/intermolecular interactions.
To further test the involvement of domain I in the IRES formation, we created a panel
of mutants to stabilize or destroy SLII of the IRES. Hence, all mutants had at least one
defective miR-binding site. The structures of all designed constructs were tested by
in silico predictions. In addition, some were tested for the predicted fold using native
PAGE analysis and SHAPE chemistry. An obvious approach to disrupt the putative
interactions of the miR-binding region (MBR) with other downstream sequences is to
delete it completely (fig. 5.25). It is also an approximation of the canonical IRES
element, which additionally lacks SLI. Further increments of shorter deletions were also
created (∆15, ∆10), all starting at nt 21, to functionally map relevant sequences in this
region in more detail. Besides the deletion variants, several mutations were designed:
One class was modified by changing short sequences within domain I to adenine, thereby
preventing their original bonding with other sequences. Either five ( pA5) or ten (pA10)
adenines were inserted starting from position 21. Another method was the introduction
of stable stems in the supposedly relaxed region of domain I. This was either achieved by
changing nts 31-40 to the reverse complement sequence (C(omplementary) mutant, fig.
5.26), or by replacing the sequence between nt 21 to 35 with a C:G-hairpin. All of these
sequences stabilized the canonical SLII fold, according to mfold prediction. Also, two
negative controls were created. The M25 mutant was predicted to destroy the alternative
fold, but not stabilize SLII. The ISL construct (inhibitory stem-loop) was modified in
the region of the U:G cluster, to eliminate the central bulge in the proposed alternative
structure, and therefore stabilize this form (fig. 5.27). In the following, a set of three
mutants (∆20, C, and ISL), which will be in the focus of this study, is described in more
detail.
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Figure 5.23.: SHAPE analysis of domain I/II of the HCV 5’ UTR. A | Schematic
of the SHAPE method. NAI can transfer its leaving group to flexible nucleotides. Modified
residues will terminate the following RT reaction with a radioactively labeled primer. The
resulting fragments were visualized by auto-radiography after urea PAGE. B | Representative
auto-radiography image for the WT sequence at 1 mM MgCl2. Marker (M) shows all A residues.
C | Plot of SHAPE reactivities (red line) against the predicted probability of the respective
residue being single stranded (gray line, generated by SFold). Shown are means with S.E.M.
of 3 independent experiments. D | Overlay of SHAPE reactivity with the canonical model of
the first 120 nt of the HCV positive strand. Nucleotides are colored white to red, according
to their average normalized SHAPE reactivity. In silico folding was performed with the mfold
online tool. E | Structure prediction of the 3’(-) SLIIz’. U:G base pairs are depicted in blue
(U:G cluster). F | Predicted 2D structure with incorporation of SHAPE-based constraints in
the folding prediction.
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First, it was tested, whether the mutants also showed the extensive range of secondary
structures, which was observed in the wild type RNA. The mutations were designed to
stabilize a specific form of the structure, which should result in a suppression of the
additional bands in the gel. Indeed, the mutant RNAs presented themselves as a single
band, without appreciable alternative forms on a native gel (fig. 5.24B). Quantification
of the major “top” band and the lower bands could however not detect a difference in
the band pattern between incubation with the non-binding (3p) or binding (5p) strand
of miR-122 (fig. 5.24B).
Figure 5.24.: Characterization of HCV 5’UTR fragments. A | Denaturing urea PAGE
with ∼1µg of different variants of the in vitro transcribed 389 nt HCV 5’ UTR/IRES fragments,
stained with methylene blue. Shown are wild type, ∆20, C and ISL RNA after gel purification.
Below are the mfold predictions for the first 120 nt of the respective construct. B | Native
PAGE of the 389 nt fragment after denaturation and refolding for 15 min at 37◦C in presence
of miR-122-5p or -3p (non-binding control). RNA was stained with methylene blue. C |
Quantification of “top” and “bottom” bands as indicated in B. Densities were normalized to
wild type and miR-122-3p. Error bars represent SD from quantification of two gels from the
same sample.
∆20
∆20 mutant was designed as approximation of the canonical IRES sequence, omitting
possible interactions of domain I with downstream sequences. Only the small stem-loop
SLI was retained, and nucleotides 21-41 were deleted. Via SHAPE structure probing,
the construct was tested for its correct fold. This construct was predicted to strongly
favor SLII formation, while completely lacking any miR-122 recognition sites. fig. 5.25
shows the rationale of mutant design and structural probing by SHAPE. Most predicted
free nucleotides were detected, with the exception of two small bulge regions around nt
65 and 73 (fig. 5.25A, B). In the secondary structure view, the nucleotides are colored
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according to their SHAPE reactivity (fig. 5.25C). The predicted fold of SLII is identical
between the mutant and wild type (fig. 5.25D).
Figure 5.25.: Characterization of the ∆20 mutant. A | Representative autoradiogra-
phy image of the SHAPE pattern at 1 mM MgCl2. Marker (M) shows all A residues. B |
The corresponding histogram plot with the average normalized reactivities of 2 independent
experiments. Error bars represent S.E.M. C | Secondary structure prediction of the first 120 nt
of HCV in the native state and impact of the deletion. Region of the mutation is marked with
a red box. D | Canonical fold of the HCV 5’UTR domains I and II. SHAPE reactivities as
determined in fig. 5.23 are indicated.
C
The C mutant was designed following a different scheme, in order to keep length and
complexity of the sequence constant. A small stem-loop was introduced into the MBR
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by exchanging the region predicted to be involved in the alternative structures, includ-
ing parts of miR-binding site #2, by its complementary sequence (fig. 5.26C). This
should force a strong interaction, which would compete with the translation attenuating
conformations, thereby also favoring the SLII fold. Importantly, site #1 remains intact,
but is also engaged in a stem-loop, as it is predicted for the wild type (fig. 5.26C). The
SHAPE data mostly confirmed the predicted fold, while again the region around nt 70
was not efficiently labeled, as seen for the wild type and ∆20 alike (fig. 5.26B). The
loop of SLI was hardly visible in this mutant, but detectable (fig. 5.26A). Also for this
mutant, the predicted structure of domain II was in agreement with the functional SLII
fold (fig. 5.26D).
ISL
The inhibitory stem-loop mutant was generated to serve as a negative control. Since
a stem-loop resembling the 3’(-) fold was predicted to be the energetically most stable
conformation, however, bearing a large bulge in the central region of the stem, nucleotide
exchanges were introduced in this segment to stabilize this structure (fig. 5.27C). This
intervention destroys site #2, site #1 remains unaffected. Since this mutant should not
be able to form SLII efficiently, it is expected that translation will be greatly diminished.
The SHAPE pattern showed a high reactivity between nt 90 and 120, which correlated
very well with the predicted fold. However, the RT reaction was much less efficient for
the subsequent nucleotides. Most predicted regions showed some reactivity on the gel,
but due to the following normalization process these could not be appreciated in the
histogram plot (fig. 5.27A, B). Still, the qualitative pattern supported the desired fold
of this mutant.
In summary, the native gel analysis as well as SHAPE data argued for the desired fold
of the tested mutants, even though some regions were not as efficiently labeled as ex-
pected. In particular, the mutants seemed to suppress the various secondary structures,
which could be detected in the wild type. Therefore, domain I seemed to participate in
folding of the HCV IRES.
Functional Characterization of Domain I Mutants
Overall, the experimentally determined structures of the mutants seemed to be in good
agreement with the calculated ones. In a subsequent effort to functionally characterize
the mutants, their replication capacity was tested in a monocistronic context(fig. 5.28).
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Figure 5.26.: Characterization of the C mutant. A | Representative autoradiography
image of the SHAPE pattern at 1 mM MgCl2. Marker (M) shows all A residues. B | The
corresponding histogram plot with normalized reactivities. C | Secondary structure prediction
of the first 120 nt of HCV in the native state and impact of the mutation. Region of the
mutation is marked with a red box. D | Canonical fold of the HCV 5’UTR domains I and II.
SHAPE reactivities as determined in fig. 5.23 are indicated.
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Figure 5.27.: Characterization of the ISL mutant. A | Representative autoradiography
image of the SHAPE pattern at 1 mM MgCl2. Marker (M) shows all A residues. B | The
corresponding histogram plot with the average normalized reactivities of 2 independent exper-
iments. Error bars represent S.E.M. C | Secondary structure prediction of the first 120 nt of
HCV in the native state and impact of the mutation. Region of the mutation is marked with
a red box. D | Fold of the complementary 3’UTR stem-loops I and II.
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Mutations in domain I likely disrupt structure elements in the 3’(-) end, which are
critical for replication. All but one of the mutants were replication deficient. Only the
pA5 mutant could replicate to low levels even in absence of miR-122 (fig. 5.28pA5),
and will be investigated further in future experiments. Preliminary in silico analysis
suggested that this mutant leaves a significant part of the structural elements of the
3’(-) end intact, which might be sufficient to explain this phenotype.
Figure 5.28.: Replication capacity of domain I mutants. Hep3B cells were electropo-
rated with JFH-1 monocistronic replicons in presence of synthetic miR-122 WT or A4U. Cells
were lysed and luciferase activity (RLU) was measured after 4 h (input control, not shown),
and 48 h at the peak of replication activity. The replication deficient ∆GDD (deletion in the
catalytic center of NS5B) mutant served as negative control. The upper panels of the table
show the location and type of mutation for each construct, as well as the thermodynamically
most stable structure calculated with mfold.
The mutants, which were predicted to abolish alternative structures interfering with
IRES function, and instead form the SLII stem-loop, were chosen for translation ex-
periments (fig. 5.29A). To this end, all mutant IRES elements were introduced into a
replication deficient monocistronic replicon, transfected into Hep3B cells, in presence of
wild type or A4U miR-122. In parallel, a capped RNA coding for renilla luciferase was
transfected, to assess transfection efficiency. Translation was quantified at early time
points after transfection via the ratio of firefly to renilla activity. This allowed to measure
the combined impact of translation and stability. Importantly, all SLII-forming mutants
showed increased translation at early time points, without any measurable effect of miR-
122 addition. The most striking phenotype was observed for the ∆20 mutant, devoid of
the complete miR-binding region. Here, the translation activity 1 h post electroporation
was enhanced to several fold above the wild type replicon in presence of miR-122. This
effect proportionally declined with the size of the deletion (∆15, ∆10). While the ∆20
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mutant showed up to 5-fold increased translation activity, excision of 15 nt could only
raise the luciferase levels by approximately 3-fold. Finally, the 10 nt deletion mutant
showed 1 h values close to the wild type in presence of miR-122 (fig. 5.29B, ∆10 - 20).
Similarly, introduction of short adenylate stretches in the base of the predicted alter-
native structure enhanced translation at 1 h post electroporation. These mutants should
be structurally identical to the wild type with bound miRNA. Indeed, also the initial
translation efficiency was comparable to wild-type. Interestingly, the pA5 mutant was
even more efficient at 1 h post electroporation, than pA10 and the wild type control (fig.
5.29B, pA5, pA10).
In another approach, the MBR was mutated to form stable secondary structures (fig.
5.29B, C, SL), which would also abolish the interactions with downstream sequences.
As for the other mutations, early phase translation was enhanced to positive control
levels. There was no difference in the behavior between these mutants.
Both controls showed the expected behavior, the random mutation control (fig.
5.29B, M25) could not increase translation significantly over the level of wild type
without miR-122. This phenotype could not be rescued by addition of miR-122 WT.
Moreover, the SLII disrupting ISL mutant decreased translation efficiency even further
(fig. 5.29B, ISL). The observed reduction of luciferase activity was possibly due to
changes in translation efficiency, or reduced stability upon degradation by exonucleases.
To assess the quantitative effect of the reported miR-122 mediated protection from the
exonucleases Xrn1 and Xrn2, short term northern blot kinetics of selected mutants were
performed. Importantly, the reported stabilization of the wild type RNA could also be
detected in Hep3B cells. However, correlation could be observed between stability of
each construct and its translation efficiency (fig. 5.30). Indeed, the ∆20 mutant with
the strongest translation phenotype was the least stable. In contrast, the ISL mutant was
very stable, but could not be translated efficiently. This anti-proportional phenotypes
could argue for a translation-dependent decay mechanism in absence of RISC binding.
In summary, in these experiments the predicted and partially validated stabilization
of SLII correlated strongly with increased translation. In contrast, mutants which did
not form SLII or even actively disturbed this structure, could not enhance translation,
or even reduced it, respectively. Therefore, it was concluded that the structure played
a significant role in the process. Moreover, the influence of stability on wild type HCV
RNA could be reproduced in Hep3B cells. However, the increased translation of the
mutants seemed to be independent from this effect, because mutants, which lacked miR-
122 binding, and at the same time showed enhanced translation activity, were degraded
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Figure 5.29.: Role of domain I in translation. A | Proposed structural switch by miR-122
in the context of WT, and design of mutants, which should stabilize the translation stimulating
fold without the need for miR-122. In silico folding was used to predict the most stable
conformation of all mutants. The mutations were then introduced into replication deficient
replicons (luc-ubi ∆GDD). B | Overview of the HCV 5’ UTR and IRES. The box indicates
the first 120 nt, containing domain I and II in the reported fold. The red line indicates the
region harboring the mutations. The upper panels of the table show the location and type of
mutation for each construct, as well as the thermodynamically most stable structure calculated
with mfold. The mutants were subsequently tested for their translation capability in luciferase
assays. The reporter replicons were electroporated into Hep3B cells wit A4U or WT miR-122.
A capped renilla luciferase mRNA was co-electroporated as internal control. After 1, 2 and
4 h, cells were lysed and firefly and renilla luciferase activity were measured. The ratio of FLuc
and RLuc was calculated in order to normalize the results. Values represent means with S.D.
of at least 3 independent experiments.
102
5. Results
Figure 5.30.: RNA stability of selected domain I mutants. A | The stability of several
domain I mutants was compared with the WT replicon via northern blot, in presence of either
wild type or mutant miR-122. B | Quantification of northern blot data. The values represent
means with S.D. from 3 independent experiments. C | Respective luciferase data for all time
points. Values represent means with S.D. of at least 3 independent experiments.
as fast or even faster than the wild type RNA.
These observations led to the conclusion that translation of the IRES was influenced
by domain I, likely due to formation of alternative secondary structures. Prevention of
such interactions, by mutation or deletion of sequences within this region significantly
augmented the first round(s) of translation, which could not be explained by enhanced
RNA stability.
Xrn1 and Xrn2 Involvement in HCV RNA Decay
Xrn1 and 2 have been implicated as key regulators of HCV RNA decay. Therefore, pre-
liminary knock-down experiments were performed using transient siRNA transfection.
48 h later, monocistronic replicons were electroporated with miR-122 WT or A4U. After
4 h, translation of the input RNA was measured by luciferase assay. Overall, the stim-
ulation after miR-122 addition was slightly lower than in previous assays, which might
be a result of the preceding transfection procedure. The knock-down efficiencies in both
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transfections were determined by western blotting and quantified. The protein levels
of Xrn1 were reduced by 80%, and 70% in case of Xrn2, suggesting that Xrn2 was not
involved in HCV RNA degradation in this experimental setting. Xrn1 k.d. resulted in
an overall increase in luciferase activity, arguing for increased RNA stability. Moreover,
the difference between wild type and A4U miR-122 was decreased to around 1.5-fold 4 h
after electroporation, compared to 4-fold in case of the control transfection. Increased
stability of the input RNA will likely lead to prolonged production of protein, albeit to
lower levels. Therefore, the overall difference after 4 h was smaller. In contrast, no differ-
ence could be seen in the enhancement of translation after Xrn2 knock-down, compared
to a non-targeting control miRNA.
Figure 5.31.: Influence of Xrn1 and 2 knock-down on HCV translation. A Xrn1 and
2 were knocked down by siRNA and their expression levels after 48 h were detected by western
blot. B The detected bands were quantified relative to HSP90 levels, in order to determine the
relative knock-down efficiencies. C The siRNA transfected Hep3B cells were electroporated
with replication deficient reporter replicons (luc-ubi ∆GDD). Luciferase activity (RLU) was
measured 4 h after electroporation.
Another interesting observation was that, in spite of the initial boost of translation, the
protein production did not seem to be sustained over multiple rounds. Calculating the
slope of the firefly/renilla ratio, relative to the 1 h value, all mutants, and also the wild
type in absence of miR-122, showed a significant decrease over time. However, addition
of miRNA duplex was sufficient to stabilize the levels of luciferase activity significantly
(fig. 5.32A). In case of the Xrn1 k.d. a similar effect on the kinetics of luciferase
activity were noted. While overall luciferase activity was increased, the stimulation by
miR-122 was as pronounced as in the siONT control.
In essence, Xrn1, but not Xrn2, controlled HCV RNA degradation at early time points
after electroporation. However, neither the mutants, nor Xrn1 depletion could compen-
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Figure 5.32.: Faster decay of translational activity in absence of miR-122. A |
Hep3B cells were electroporated with replication deficient reporter replicons (luc-ubi ∆GDD),
containing the previously described domain I mutations. Luciferase activity (RLU) was mea-
sured 1, 2 and 4 h after electroporation. After normalization of all samples to the 1 h value,
the linear regression of the luciferase activity in all mutants and the wild type was calculated.
Selected mutants are depicted in color. B | siONT or siXrn1 transfected Hep3B cells were
electroporated with replication deficient reporter replicons (luc-ubi ∆GDD). Luciferase activ-
ity (RLU) was measured 1, 2 and 4 h after electroporation. After normalization of all samples
to the 1 h value, the linear regression of the luciferase activity in all mutants and the wild type
was calculated.
sate for all functions of the bound RISC, as the production of new protein seized after
a short initial burst. This was deduced from the fact that the luciferase activity after
1 h decayed approximately with the half life of the firefly luciferase protein (t1/2 ≈2 h).
Therefore, stability and translational enhancement were dependent on separate mecha-
nisms.
Impact of Mg2+ and miR-122 Binding on the Secondary Structure of Domain I
and II
Since we hypothesized that miR-122 alters the secondary structure of the IRES, the in-
fluence miR-122 annealing was investigated. It is known, that the concentration of Mg2+
is an important variable for the folding of the HCV IRES307, and also for RNA:RNA
hybridization. Several studies have examined the influence of metal ions on the ultra-
structural properties by means of gel-shift and atomic force microscopy, however, there
has not been any in-depth biochemical analysis of the secondary structure. It has been
described that significant rearrangements occur in the concentration range of 2-3 mM
MgCl2. This is close to the predicted intracellular free magnesium levels, which are
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believed to be around 0.5-3.5 mM. Most SHAPE experiments done so far, used much
higher concentrations for folding, which might bias the result. Especially the folding of
SLII can be influenced, since the hinge of SLII coordinates three Mg2+ ions, which gives
this stem-loop its characteristic, and functionally relevant L-shaped appearance. There-
fore, experiments were performed using 0, 1 or 6.6 mM MgCl2 in the folding buffer. The
5’ proximal 389 nt of JFH-1 were used either in their wild type sequence pre-incubated
with the 3p- or 5p-arm of miR-122, or the mutants ∆20, C and ISL. DMSO controls
were loaded for each condition for normalization. As expected, the MBR is significantly
reduced in reactivity only if miR-122-5p was supplemented (fig. 5.33A). This confirms
that AGO-less binding of miR-122 occurs under these conditions. However, since some
regions, especially at the first binding site, are not reactive in either condition, no claims
can be made, as to whether both sites are bound. The peak at nt 21 is likely an artifact,
since it appeared only irregularly. It is directly in front of SLI, which is a very stable
structure and might terminate the RT reaction. As expected the band patterns differed
in several positions between the three conditions (fig. 5.33A, B). Interestingly, the re-
activity of the predicted tip of the SLII stem-loop, was strongly affected by magnesium
concentration. At low levels all of the nucleotides gave a clear signal, which waned with
increasing concentrations. This might hint towards a tertiary structure component, or
another Mg2+ organizing loop, where the flexibility of the participating nucleotides is
affected. The band representing U103 was only detectable at higher Mg2+ concentra-
tions. The mutants however presented the nt 103 band even in absence of miR-122,
arguing for a shift towards functional fold even under physiological levels of magnesium,
and in absence of miR-122. While free nucleotides are only predicted at this position
in the canonical fold, the nucleotides 114-116 should in contrast only be reactive when
SLII is not efficiently formed, as they are part of the small predicted stem at the 3’
terminal portion of domain II(fig. 5.33C). Indeed, the latter ones were only labeled
in the lower range of MgCl2 concentration. Instead, reactivity was shifted towards nts
119-120, which are located just 3’ of the SLII base. Also miR-122 annealing efficiency
was impaired at lower concentrations, which is an indication that the hybridization en-
ergy alone might not suffice to fully reconstitute the processes in the cell in this system.
An interesting observation was the fact that at 0 mM as well as at the highest concen-
trations no significant impact of miR-122 binding was apparent, resulting likely from
reduced hybridization of target and miRNA, and maximal shift towards the “active”
conformation, respectively (fig. 5.33A,B). At intermediate magnesium levels, however,
several bands were quantitatively affected. Intriguingly, U103 became stronger at 1 mM
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Figure 5.33.: A | Auto-radiography image of the results obtained for the WT sequence at 0 -
6.6 mM MgCl2. Marker (M) shows all A residues. B | Histogram plots of nucleotide reactivities
at different magnesium levels and in presence of miR-122-5p (green) or a control (miR-122-3p,
red). Shown are means with S.E.M. of 3 independent experiments. C | Magnification of miR-
122 responsive regions downstream of the MBR. At 1 mM MgCl2 the band corresponding to
nucleotide position 103 is intensified, while position 115 is decreased. D | Characteristic bands
from C, affected by Mg2+ levels. The shift of intensities at higher concentrations resembles
the situation after addition of miR-122-5p. E | Comparison of U103 SHAPE reactivities in
wild type RNA and selected domain I mutants.
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MgCl2, and the reactivity of the 114-116 bands were shifted to a greater proportion at
this concentration (fig. 5.33C). Of note, also the translation enhancing mutants ∆20
and C showed increased reactivity at this residue (fig. 5.33E). This argues for a dy-
namic equilibrium of structures, which can be biased by miR-122 binding, favoring the
canonical IRES structure. It can be assumed that miR-122 incorporated into the RISC
is much more efficient in binding to the HCV RNA under low divalent cation conditions.
Moreover, the quite large protein complex might also facilitate state conversion. So the
changes that are occurring in the natural infection might be more drastic.
All in all, the effects of Mg2+ concentration were quite drastic, and superseded those
of miR-122 addition. Only at concentrations of 1 mM, which is close to intracellular
free magnesium levels, differences at specific nucleotides were observed in the SHAPE
pattern upon miR-122 annealing. Assuming an array of different structures in solution,
these data suggest a magnesium-dependent shift of this equilibrium, which could be
supported by miR-122 association at low Mg2+ levels.
Conclusively, these experiments could show that translation is a key feature of the
miR-dependent activity, which stimulates HCV propagation. Phenotypical data, gen-
erated with domain I mutants, supported the notion that the MBR could take part in
translation-abrogating structures within domain I and II. Moreover, it was confirmed
that the structure of the IRES in solution was strongly affected by magnesium concen-
tration. Under specific conditions, this effect was also moderately enhanced by annealing
of miR-122.
5.2.3. In Search for a Host Factor
While our results so far pointed to a significant contribution of miR-122 to stabilizing the
IRES and preventing alternative secondary structures. However, based on the prolonged
translation activity during the first 4 h after electroporation of HCV RNA, we wanted
to evaluate the impact of recruiting host proteins by miR-122. The RISC complex is
a highly dynamic RNP, which can be reconfigured for a variety of purposes, where the
central Argonaute protein acts as a hub to recruit different auxiliary factors. Hence, it is
conceivable that binding of the RISC to the HCV RNA is necessary to assemble a trans-
lation enhancing and -sustaining protein complex at the IRES. This could for instance
join the 5’ and 3’ ends of the genome to circularize the RNA, which is a prerequisite
for efficient polysome assembly and steady state translation. In order to find candidate
proteins, a literature search was performed, which brought to light two studies: one
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examined AGO-associated protein complexes308, the other determined factors binding
to the HCV RNA309. In a first approach, these lists host factors were compared, and a
Figure 5.34.: Comparison of
factors associated to HCV
and AGO complexes. Venn
diagram of the proteins found
in pull-down experiments to in-
teract with HCV RNA (Upad-
hyay et al. 309 , blue) or present in
different AGO complexes (Ho¨ck
et al. 308 , yellow). Ten pro-
teins were detected in both ap-
proaches, and are therefore vi-
able candidates in HCV transla-
tion regulation (see tab. 5.1).
roster of matching proteins was generated (fig. 5.34 and tab. 5.1,tab. 5.2). Known
cellular elongation factors and ribosomal proteins were excluded, since these are motile
on the RNA and therefore unlikely to act as linkers between genome ends. A curious
result, which was found in this analysis was the strong enrichment of known relevant
proteins for HCV IRES-mediated translation in AGO1 complex III (IGF2BP1, NF45,
MOV10 in tab. 5.1; HuR, HSP90, hnRNPC/L, NSAP-1 in tab. 5.2). Some of these
were not found in association with AGO2, which is thought to be the key regulator
of miR-122-mediated HCV stimulation. In contrast, AGO2 was found to bind several
regulators of replication/assembly, such as YB-1, DDX3/5/6, and NF45. Intruigingly,
DDX5 could only be found in complex II of AGO2, which also includes YB-1 and NF45.
This might point towards a possible influence of the bound AGO protein on the func-
tional impact. According to this data, 5’-bound AGO1 could stimulate translation, while
AGO2 rather enhances replication. Some factors were only present in of the two lists,
but well known to be involved in HCV translation and replication, as determined by
other studies. These are summarized in tab. 5.2.
To attain the composition of the specific RNP for the 5’ binding sites of HCV, biotiny-
lated miR-122 was used to capture HCV RNA, and the associated proteins. Since any
duplex miRNA is expected to be incorporated into a RISC, and thus will pull down many
associated proteins, we used the mutated miR-122 and the corresponding replicon. This
increases specificity, since canonical miR-122 targets will not be efficiently targeted, and
3’ binding sites in the HCV genome are also excluded. Thus, using either wild type or a
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Table 5.1.: Proteins identified in association with HCV and Argonaute complexes. Given are
functions in the viral life cycle and location of their respective binding sites, if known. The
containing AGO complexes are named according to Ho¨ck et al. 308 .
Protein Accession HCV function HCV RNA
binding
AGO complex
YB-1 181486/55451 Replication/
Assembly
? AGO1: II
AGO2: II, III
HSP60 306890 ? ? AGO1: I
AGO2: I
Upf1 1575536 ? ? AGO1: III
AGO2: -
DDX5 226021 Replication ? AGO1: -
AGO2: II
hnRNP U 32358 ? ? AGO1: II, III
AGO2: II, III
hnRNP H 5031512 ? ? AGO1: II
AGO2: -
PABPN1 693937 ? ? AGO1: III
AGO2: II, III
IGF2BP-1 7141072/
56237027
Translation 3’UTR AGO1: II, III
AGO2: III
NF45 532313 Translation/
Replication
5’+3’UTR AGO1: II, III
AGO2: II, III
MOV10 14424568 Translation 5’UTR AGO1: III
AGO2: III
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mutant replicon, any additional proteins detected in the mutant pull-down are potential
candidates for further evaluation.
Table 5.2.: Additional proteins identified in complex with either HCV genome or Argonaute
only found in one list, but linked to the respective other in separate reports.
Protein Accession HCV function HCV RNA
binding
AGO complex
DDX3 698980011 Replication310 ? AGO1,
AGO2311
DDX6 574957069 Replication312 ? AGO1,
AGO2313
HuR 1022961 Translation 3’ UTR AGO1: III
AGO2: -
NF90 1082856/5006602 Translation/
Replication
5’+3’UTR ?
HSP90 153792589 Translation284 ? AGO1: II, III
AGO2: -
hnRNP C 117189974 Translation 3’ UTR276 AGO1: II, III
AGO2: II, III
hnRNP L 52632382 Translation271 5’ UTR AGO1: III
AGO2: -
hnRNP D 52632382 Translation314 5’ UTR314 AGO1-3315,316
NSAP1 5031511 Translation265 5’ CDS AGO1: II, III
AGO2: -
In a first approach electroprations of Hep3B cells were performed with wild type
or m1,2 replicon and 3’-biotinylated miR-122 A4U. Unbiotinylated miR-122 was used
as background control (fig. 5.35A). After 72 h the cells were harvested and RNA
and protein were extracted from the pulled down material. To validate the assay, the
presence of RISC components as well as known interactors with the viral genome were
verified by western blotting. In subsequent experiments, co-precipitated HCV RNA
was quantified by Taqman qPCR. As for the protein fraction, the pull-down yielded
small, but detectable amounts of AGO2, HSP90 and DDX6, while the control IP with
unbiotinylated miRNA was devoid of protein. The common RISC proteins DDX6 and
AGO2 were enriched around 10-fold compared to the control. HSP90 was also present
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in the pull-down, albeit to a lesser amount (fig. 5.35B, C).
To determine the influence of miR-122 binding on the pulled down protein fraction,
biotinylated miR was co-electroplated with the corresponding mutant (binding) or wild
type (non-binding) replicon. No significant difference could be detected between the
HCV-binding or non-binding miRNA, for the tested RISC proteins. This was within
the expectation, since RISC incorporation of the biotinylated miRNA should be largely
independent of HCV (fig. 5.35D-F). In contrast to AGO2 and DDX6, proteins that
associate to HCV, but not to the RISC should be enriched. Quantification of the western
blot gave the expected result (fig. 5.35G). Because the overall quantity of pulled-
down protein was rather low (around 0.5% of input), in the following approach the
number of electroporations used for pull-down was doubled, and the amount of input
was reduced to 0.1%, resulting in more equal loading of input and pull-down fractions.
The first tested candidate was a subunit of the eIF3 complex (eIF3η) . This protein
is a part of the preinitiation complex, interacting with the 40S ribosomal subunit, and
therefore a marker for active translation. Since the RISC mainly inhibits translation,
and triggers disassembly of the initiation complex, eIF3 should not co-purify significantly
with microRNPs. In parallel to Hep3B cells, these pull-downs were also performed in
Huh7.5 cells. Indeed, the pull-down from both cell lines showed a significant enrichment
of eIF3η, when miR-122 was able to bind the co-electroporated replicon RNA, compared
to the non-binding control (fig. 5.35H, I). Subsequently, the the pull-down material
was subjected to mass spectrometry, to gain high-throughput data on all differentially
enriched proteins. However, the results were not yet available at the time of submission
of this thesis.
Overall, our results so far pointed towards a substantial role of miR-122 in stimulating
translation of the HCV polyprotein, probably by stabilizing the secondary structure of
the IRES: Firstly, the results with mono- and bicistronic replicons showed the impor-
tance of translation. Secondly, mutants lacking miR-122 binding sites, but stabilized
the IRES structure, showed enhanced translation. However, since these mutants were
not replication competent, it was difficult to assign the quantitative impact of trans-
lation stimulation on overall replication efficiency. In particular, since previous studies
suggested that each HCV genome is translated ca 10.000 times prior to replication45.
Thus, even a moderate change in translation efficiency might have a massive impact on
overall replication efficiency. Moreover, the enhancement of the domain I mutants only
lasted over a short time period, leading to the assumption that additional mechanisms,
such as recruitment of host factors by the RISC might support ongoing translation. To
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Figure 5.35.: Pull-down of specific HCV:miRNPs with biotinylated miRNA. A4U
miR-122 (red) was used for these experiments to reduce background due to canonical miR-122
target binding. A | The background of the assay was assessed by comparison of proteins pulled
down with biotinylated versus unbiotinylated miR-122. B | While the absolute amount of
protein detected by western blot is low,C | a significant enrichment of miR-associated proteins
was achieved. D | Since RISC assembly should be equally efficient, independent of target
binding. E | Western blot analysis of the processed samples showed detectable amounts of
protein. F | Quantification confirmed that RISC members AGO2 and DDX6 are pulled down
with similar efficiency in both conditions. G | Non-RISC binding, but HCV associated proteins
should only be co-purified via HCV-bound RISC. H | Western blot against eIF3η showed a
marked increase in pull-down efficacy with a matching miR:HCV pair. I | Normalized to input,
a more than 3-fold enrichment was detected in both, Hep3B and Huh7.5 cells
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investigate this further, have established a system, which allowed us to pull down miR-
122 bound HCV molecules. This technique can be used in future studies to identify host
factors, which facilitate RISC-dependent translation stimulation.
5.2.4. Evaluating The Role of miR-122 in Replication
Since it was already established that the role of miR-122 in replication is important, in
addition to its effect on translation, the mechanism of action on this regulatory level
was also being investigated. During the search for possible mechanisms of miR-122
induced activation of replication, a peculiar fact was noted. The 3’ terminal nucleotides
of the major fraction of miR-122 molecules are identical with the ones at the 3’ end
of the HCV genome (UGU). Since the rate limiting step of de novo RNA synthesis by
the viral RdRP is the initiation, which requires the generation of a 2-nt primer. The
single stranded nature of the miR-122 overhang, as opposed to the stable stem at the
3’(+) end, and the concomitant close association with the viral genome, could support
a model of a trans-priming mechanism (fig. 5.36A). The 3’ nucleotide of the initiation
dimer is essential in the progression from initiation to elongation. Thus, we designed
a miR-122 mutant with a 3’ terminal CU, instead of GU, as well as a corresponding
HCV replicon. In the mutant replicon, the structural integrity of the 3’ terminal stem
was maintained by introduction of a compensatory mutation on the other arm of the
hairpin. If the hypothesis were true, the primer generated from the mutated miR would
be AG, and could therefore not initiate on a 3’-UG template, and would consequently
abolish replication. The generated replicons were electroporated into Hep3B cells, with
either wild type or mutant miR-122. The replication of the GC mutant was completely
abolished in Hep3B cells, and could not be rescued by the addition of the GC miR-
122. Concurrently, the wild type replicon was not impaired by addition of GC miR-122,
compared to the wild type molecule (fig. 5.36B). While there seems to be no priming
at the end of miR-122, it also became apparent that binding of miR-122 and probably
the associated RISC is the most important feature of any miR-related mechanism. The
3’ unpaired sequence might indeed be fully exchangeable. To further investigate any
potential role of unpaired regions of miR-122, more mutants were designed, with more
severe sequence alterations (fig. 5.36C). All mutants were tested for their replication
stimulating activity with wild type JFH-1 replicons. Only two of the mutants showed
any attenuating effect. A moderate 3-fold repression of replication, but not on the level
of translation, was noted in case the overhang was exchanged for the complementary
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Figure 5.36.: Effects of altered miR-122 sequences on HCV replication.A | Model
of a trans-priming mechanism at the 3’ end of miR-122 to initiate replication. The overhang
of miR-122 at the 5’ end might be recognized by NS5B, and used as a template for generation
of an AC-primer. After translocation to the 3’ end, RNA synthesis is initiated. When the
penultimate nucleotide of the miR is modified, the resulting di-nucleotide should not be able
to serve as primer for replication. B | Luciferase assay with miR and HCV 3’-GC mutants.
Alteration of the penultimate nucleotide of miR-122 has no effect on HCV replication and
cannot rescue a replication-dead replicon with the same mutation in the 3’ SL3. A | Sequences
of the miR-122 mutants. Base-paired regions are colored in red, mutated bases are underlined.
D | Test of additional mutants. Most variants do not exhibit any change in HCV stimulation,
only significant changes in nucleotide composition or switch of entire regions are deleterious.
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sequence (OC). Interestingly, the replacement with the 3’ sequence of miR-26a (3’26a)
had no effect. This might be an indication that certain sequence features are indeed
needed, the terminal U, or a UG rich region in general, albeit they are not supposed
to directly bind to the HCV genome. A more striking impairment was observed for
the variant, in which the central bulge was switched with the 3’ overhang (BOS). Here,
translation, as well as replication, was significantly lower than for the wild type (fig.
5.36D). These changes, however, are drastic, and might affect additional processes,
including RISC-dependent strand selection, or simply binding efficiency. Therefore, the
primary sequence of miR-122 3’ of the seed region seems not to be the most important
feature for HCV replication, although drastic sequence modifications can significantly
impair miR-122 functions.
Another possible way of increasing replication, would be the active translocation of
genomic RNA by the RISC to the replication sites. At some point, translation needs
to be terminated in order to assemble the replicase complex on the HCV RNA. The
determinants for this process are widely unknown. A recent publication stated that
PCBP2, a trans-activating factor of the HCV IRES, might be displaced by the RISC207.
Assuming such a model, the RNA would be associated to the RISC after termination of
translation. The miRNA-mediated RNA processing also involves intracellular transport
mechanisms, leading to accumulation of the miRNPs in P-Bodies. Together with the fact
that several P-Body proteins are also recruited to these viral factories317,318, it seemed
a plausible hypothesis that the RISC could in that way play a role in recruiting the
viral RNA to the replication sites after translation. Assuming a highly dynamic RISC
composition, bound AGO complexes could, possibly in collaboration with NS proteins,
shift the viral RNA from translation to replication. To test this hypothesis, imaging
experiments were performed in Hep3B cells electroporated with JFH-1 replicons. After
48 h, the cells were fixed and HCV RNA was visualized by in situ hybridization, followed
by immuno-staining of AGO2 and Hsp90. Both proteins have been shown to influence
several parts of the viral life cycle. Surprisingly, very little co-localization was observed
between the proteins and the HCV genome (fig. 5.37). Instead, several signals of AGO2
and HCV RNA were directly apposed to each other.
In summary, these data could confirm that the binding of a miRNP to the HCV 5’
UTR is of utmost importance, whereas the sequence of the miR plays a minor role.
Only drastic changes of the primary sequence, which potentially disrupted the proper
annealing to the target RNA impaired HCV replication. At the peak of replication,
48 h post electroporation of an HCV replicon, no co-localization of AGO2 and the HCV
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Figure 5.37.: Localization of HCV RNA and host proteins. Hep3B cells were electro-
porated with HCV replicon and wild type miR-122. 48 h later they were fixed and stained for
HCV (+)-RNA (red), AGO2 (green) and Hsp90 (blue), both proteins involved in viral trans-
lation. Little co-localization was observed for these host factors with HCV RNA. However,
clustering of AGO2 around HCV RNA or vice versa was observed. White arrowheads indicate
regions where HCV RNA and host proteins accumulate.
(+)-strand could be detected in the microscopic analysis. Also, studies have found
that the dependence on miR-122 decreases, after replication has been established. This
observation could point towards the exclusion of AGO complexes from replication sites.
5.2.5. Identification and Characterization of Additional miR-binding
Sites in the HCV Genome
So far, the analysis focused on the two well-characterized mir-122 binding sites at the
5’ end of the genome. However, it has been published that the HCV genome contains
more than the two best described seed binding sites, which are conserved over several
genotypes. However, these sites remain poorly characterized. Therefore, we aimed to
determine, whether these exhibit any functionality. Additionally, it was attempted to
identify possible new miR-122 sites. In this approach, we screened the genomes of several
genotypes for the central seed binding hexamer CACUCC. Three novel binding sites in
the coding region of NS5B were successfully identified (fig. 5.38A). One of these (4)
was found to be conserved throughout all tested sequences, the two others (3 and 4*)
were only partly conserved. Genotype 2a harbored a miR-binding site only at position
(3), while sequences of genotype 1a and 3a contained site 4*. Genotypes 1b, 4, 5 and 6
were positive for both. It was also noted that the novel miR-binding sites 3 and 4 of gt2a
and 4 are very close to each other (˜60 nt), and might act in a synergistic way. Since
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Table 5.3.: Identification of miR-122 binding sites in the HCV genome. The reported
MBRs are indicated by the citation. Nucleotides in bold were targeted by mutations.
no. start end MBR Sequence gt published
1 23 28 CCCCUAAUAGGGGCGACACUCCG all Jopling et al. 153
2 38 43 ACACUCCGCCAUGAAUCACUCCC all Jopling 319
3 8778 8784 UGACCAGAGACCCAACCACUCCA 2, 4,
5, 6
4 8815 8821 CUGGGAAACAGUUAGACACUCCC all
5 9219 9225 AGACCAAGCUCAAACUCACUCCA all Nasheri et al. 320
6 9406 9412 CGGCACACACUAGGUACACUCCA all Jopling et al. 153
the main aim of this part was to investigate the functional involvement of these sites
in the complete viral life cycle, it was necessary to use a system capable of replication
and virion production. However, most genotypes do not efficiently produce infectious
particles in cell culture. The chimeric genotype 2a virus (JcR2A) is the exception,
therefore only the sequences of gt2a were examined in this approach. The location,
primary sequences and references for the MBRs are summarized in tab. 5.3. To
assess the quality of the binding site, several features, such as conservation, location and
sequence similarity were examined by in silico analysis(fig. 5.38A). Moreover, it is well
established that structure elements within the binding region can strongly influence RISC
association and activity. Hence, the structural conformation of the putative binding
sites and the resulting hybridization energies were predicted with SFold/StarmiR (fig.
5.38A). It was observed, that certain features of the primary sequence were prominently
appearing. Site 3 was overall very C/G rich, a C(U)GUU motif was found in most
sequences. For site 4 the most apparent feature was a GGGAAA cluster. Site 5 contained
the most highly conserved 5’ flanking sequence. Notably, this site is located directly
upstream of the secondary structure element 5BSL, which is critical for HCV replication.
Therefore, the primary sequence might be more important in this region. Site 6 lies in the
variable region of the HCV 3’ UTR, therefore only little sequence homology was detected.
Notably, most sequences contained a 3’-terminal adenine or guanine, and an upstream
nucleotide triplet which could mediate secondary interactions of miR-122 nucleotides 14-
16 (5’-GGU-3’). Such sequence attributes have been shown to improve miRNA annealing
and activity. This, and the fact that most of the surrounding sequence was not conserved
at all, could indicate that all these sites have functional relevance (fig. 5.38A). Hence,
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we first tested the canonical functionality of the individual and combinations of the sites
(fig. 5.38B, C). In line with the following genetic experiments, the sequences present in
genotype 2a were used. A simple way of testing the physical and functional interaction of
a miRNA with a putative target sequence, is to introduce the binding site downstream
of a reporter gene, and assess whether the expression of the protein is regulated by
transfection of the miRNA. Three copies of the MBR, spanning approximately 40 nt
upstream of the seed binding sequence, were cloned behind a renilla luciferase gene,
a firefly reporter plasmid was used as transfection control. The canonical function of
miRNAs is the translational inhibition of their respective target RNA. Therefore, a
functional interaction would lead to reduced renilla luciferase expression in this assay. In
these reporter based experiments, it was found that site 3 and 6 were able to efficiently
repress the renilla luciferase activity. Possible synergistic effects were addressed by
combining a single copy of each of the four sites, however, no additional repression could
be achieved. Next, we asked how these sites might act on the viral life cycle. Thus, single
point mutants and combinations thereof were introduced into JFH-1 reporter replicons
(fig. 5.39A). For the sites in the coding region, special attention was paid not to disrupt
the amino acid sequence, while still being able to target all sites with the same rescue
miRNA. Only for site 4 a mutation on the protein level had to be introduced, which led
to a Ser to Thr exchange. These mutants were electroporated into Huh7 Lunet, which
are highly permissive for HCV replication, or Hep3B cells, in order to check for cell
type specific phenotypes. The latter were supplemented with synthetic miR-122 WT to
facilitate HCV replication. The 4 h values, representing translation of input RNA, were
increased to a certain extent for some mutants. All effects on translation were more
pronounced in the Huh7 cells, but similar in Hep3B cells. (fig. 5.39B). However, these
mutations had only little effect on replication in this setting. In Huh7 Lunet cells, the
mutations manifested in a slightly decreased replication of 60-90% of wild-type. The
combination of mutations in sites 3-5 led to a 3-fold drop of viral RNA amplification. In
Hep3B cells, the mutations had practically no influence on replication, with the exception
of the 3-5 mutant, which was reduced to around 60% of wild type replication capacity
(fig. 5.39C). Since no negative influence of binding site mutations could be observed at
the stage of viral replication, these studies were then extended to full-length JcR2A (fig.
5.40A), to test a possible involvement in subsequent steps of the viral life cycle. These
experiments were performed in Huh7.5 cells, with or without co-electroporation of the
A4U miR-122, which is able to bind the mutated sequences. Replication of the JcR2A
constructs was tested as for the replicons. The relative replication values were similar to
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Figure 5.38.: Identification and characterization of additional miR-122 binding
sites. A | Seed binding hexamers were searched within the HCV genome of different genotypes.
The 5’ flanking regions of the identified seed-binding sequences were tested for conservation
between genotypes (black bars). StarmiR was used to calculate binding structures and hy-
bridization energies. gt2a sequences were used as a template for the prediction. B | Reporter
constructs for the assessment of canonical activity of the putative MBRs. Three copies of an
approximately 40 nt region harboring the MBR were cloned 3’ of a renilla luciferase gene. A
control vector with firefly luciferase was co-transfected. C | Renilla activity values were nor-
malized to the corresponding firefly expression. Ratios of all constructs were then normalized
to the control vector, without miR-122 binding sites. Values represent means with S.D. of 5
independent experiments. *: p≤0.05, **: p≤0.01.
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Figure 5.39.: Effect of additional miR-122 binding sites on replication. A | Schematic
of a monocistronic JFH-1 reporter replicon. Black arrow heads indicate the position of the
mutated miR-binding sites. B | Mutant JFH-1 replicons were electroporated into Huh7 Lunet
or Hep3B cells, to test for cell type specific effects. The latter were co-transfected with miR-
122 duplex. To determine translation efficiencies, the cells were lysed, and firefly luciferase
activity was measured 4 h post electroporation. The luciferase activities of the mutants was
normalized to wild type. C | To probe the replication capacity, electroporated cells were lysed
after 48 h, and firefly luciferase activity was measured. The luciferase activities of the mutants
was normalized to wild type. Values represent means with S.D. of 2 independent experiments.
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those obtained in the replicon experiments, and did, with the exception of the 3-5 mutant,
not vary significantly from the wild type construct. Interestingly, addition of miR-122
A4U reduced the replication capacity of several mutants by approximately 2-fold. The
most profound effect was seen for the 3-6 mutant, in which all sites are A4U responsive
(fig. 5.40C). After 72 h, supernatants were transferred to a new batch of Huh7.5 cells,
and incubated for another 72 h. Then, the ratio of luciferase activity obtained from
the electroporated and infected cells was calculated to determine the relative release of
specific infectivity. The mutant with nucleotide exchanges in all 3’ binding sites (3-6)
replicated as efficiently as wild type, but was strongly impaired in particle production
(5 to 10-fold reduction). This was also the case for the single site mutants targeting
position 3 and 6. Addition of the miRNA with a compensatory mutation, however,
could not reproducibly restore the relative amounts of released infectivity. Interestingly,
for the mutants targeting site 4 and 5 alone, no strong effect could be observed (fig.
5.40D). This was in coherence with the functional assays (fig. 5.38C), in which site 4
and 5 also did not appear to be functional in isolation. The 4+5 mutant, in contrast,
had a strong impact on assembly/release, which might suggest a cooperative function of
these sites.
The results obtained in these experiments argue for a functional involvement of the
miR-122 binding sites within the coding region and 3’ UTR during the production of
viral progeny. While the stage of replication was largely unaffected, initial translation
seemed to be increased by abrogation of miR-binding to these sites. Overall, this could be
indicative of a regulatory switch, in which RNA leaving the replication is either targeted
for translation (5’ sites) or packaging into virions (CDS/3’ sites). Moreover, the strong
replication and assembly phenotype of mutations in sites 3-5, and the intermediate
suppression of both processes mediated by the 4-6 mutant, suggest a highly complex
regulation, which requires all binding sites in conjunction.
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Figure 5.40.: Effect of additional miR-122 binding sites on replication, assembly
and release. A | Representation of a JcR2A full-length reporter virus. Black arrow heads
indicate the position of the mutated miR-binding sites. B | To address a potential role in
assembly and release, the same mutations were introduced into a JcR2A reporter virus, and
the constructs electroporated into Huh7.5 cells. The cells were lysed 4 and 72 h post electropo-
ration and luciferase activity was measured, as described before. The supernatant of the 72 h
time point was collected, and used to inoculate na¨ıve Huh7.5 cells. These infected cells were
incubated at 37◦C for another 72 h, lysed, and luciferase activity determined. The luciferase
activities of the infected cells after 72 h was normalized to the corresponding values of the
electroporated cells. This ratio was assumed as the efficiency of infectious particle release.
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The hepatitis C virus is a widespread pathogen, and one of the main etiological agents
for liver disease. The replication within the cell is entirely cytoplasmic, and driven by
the viral proteins NS3-5B. Three of these proteins were investigated in this study: NS3
acts as a protease/helicase, that recruits the small peptide NS4A as co-factor. The
phosphoprotein NS5A interacts with several host and viral factors but has no enzymatic
function. NS5B is the viral polymerase. Most of the highly efficient antiviral drugs
developed during the last decade target components of this complex14–17, called the
viral replicase. However, only limited information is available about the determinants
for the interplay between these proteins, and the involvement of specific RNA signals,
so called cis acting replication elements (CRE), that modulate RNA amplification. In
particular, the mechanism of (-)-strand synthesis remains enigmatic, since the 3’ end of
the plus strand is not a suitable platform for initiation of NS5B107. In particular, the
helicase function of NS3 was of interest, since it might be required to remove unfavorable
RNA structures, ultimately leading to enhanced initiation. Hence, this study aimed to
establish in vitro tools to investigate these questions in a controlled way.
Another goal was to clarify the mechanism of action of the liver specific miR-122 on
the life cycle of HCV. While miRNAs usually repress bound target RNAs, in case of
HCV two binding sites in the 5’ UTR strongly increase translation209, replication207
and RNA stability203. However, the mechanistic details and quantitative contribution
of these functions have remained unclear. Thus, we established tools to investigate each
of the proposed functions. Moreover, we searched for additional miR-binding sites in
the HCV genome and characterized their influence in the complete infectious cycle of
HCV.
124
6. Discussion
6.1. Functional characterization of purified HCV
proteins
The first part of the thesis aimed to generate an in vitro model assessing the contribution
of the NS3 helicase and NS5A to initiation of RNA synthesis. To this end, proteins were
individually expressed, purified and relevant enzymatic activities were tested to ensure
their functionality. In the established DNA unwinding assay, based on the study of Zhang
et al. 62 , it was confirmed that the protease domain is a vital component for helicase
activity. This concurs with previously published data, which state that the RNA binding,
as well as contact to NS5B were facilitated by the protease62,321. Proteolytic activity
was, however, not a prerequisite for its influence on RNA unwinding capability. This was
clearly demonstrated by addition of the protease inhibitor VX950 at a concentration of
100µM, which entirely inhibited protein cleavage by NS314. Even under these conditions,
there was no discernible effect on helicase activity, while manoalide (MNLD)63 strongly
impaired duplex dissociation at the same molarity (fig. 5.5).
In agreement with these results, also the absence of the protease co-factor NS4A did
not impair helicase activity. However, the data showed that the properties of the holo-
enzyme differed from those of NS3 alone, especially in terms of their individual pH
optima (fig. 5.6). This could also be observed in an earlier study of Kyono et al. 322 . In
the in vitro setting, the lack of lipid membranes might have led to aberrant folding of
NS4A, which interfered with protein activity. The lower pH could have compensated for
this by altering the charge of the protein, and thereby inducing a functional conforma-
tion. Lam et al. 323 found that nucleic acid binding properties of the holo-enzyme and
the helicase domain were in fact improved at low pH. Moreover, a recent publication also
reported a pH dependent structural shift of the protein, which modulated its NTPase
and helicase function324. Therefore, it is also possible that this effect was not an artifact
of in vitro conditions, but rather a property that enables alternative functions of the
enzyme in different environments. In this context it might be interesting to address the
in cellulo pH of replicase compartments, to probe for a physiological relevance of an
acidic environment. A lowered pH could argue for a protonation-dependent functional
switch, possibly between protease and helicase activity. The fact that addition of NS5B
rescued helicase activity of NS3 in suboptimal buffer conditions (fig. 5.7) could also be
interpreted as a result of conformational changes. The main interaction site is located
in the protease domain, which was able to modulate helicase function and RNA bind-
ing62. A stabilizing effect of a favorable conformation might explain the observed effect.
125
6. Discussion
Another possibility arises from the fact that nucleic acid binding also activates NS3325.
Therefore, merely enhanced recruitment of NS3:5B complexes to the template could be
the underlying mechanism for this activating phenotype.
6.2. Role of NS3 helicase in replication
The main hypothesis of this part of the study, was a possible unwinding activity of
NS3, exerted on the extensive 3’-X-tail structures of the HCV positive strand. These
stable stem-loops impair RdRP initiation. Transformation of the helical regions to single
stranded RNA would create optimal initiation sites for the viral polymerase NS5B.
Conversion of stable stem-loop formations by NS3 has been demonstrated in vitro 326.
The in vitro replication data gained in this study by comparing NS5B performance on
a hetero- and a homo-polymeric template showed that the polymerase was functionally
enhanced on a structured RNA (fig. 5.8). In addition, the level of activation was
strongly dependent on the nature of the 3’ end of the template. If the RNA terminus
was engaged in a stem, the stimulatory effect of NS3 is even more pronounced than
in the context of a single stranded region at the initiation site. Also, inactive mutants,
either ATPase deficient (Q460H)327, or impaired in RNA binding (∆P) were not capable
of increasing polymerase activity (fig. 5.8 and fig. 5.9). Overall, these data argue for a
major role of the NS3 helicase function in initiation, which is the rate limiting step during
viral replication108. An auxiliary role in elongation might be exerted by increasing overall
processivity of the viral polymerase. A similar approach to study the effect of NS3 on
viral RNA replication has been taken by Piccininni et al. 64 , who were not able to observe
template-sized product in their assay. In their experiments, addition of NS3 stimulated
NS5B activity, but resulted in the generation of a significantly larger RNA. However,
no functional analysis of helicase activity was performed in this study. Along those
lines, it is interesting to note that a similar phenotype could be observed in our hands,
when the NS3 inhibitor MNLD at effective concentrations, or high doses of spermidine
were added (fig. 5.10). Polyamines are potent inhibitors of NS3 helicase activity,
but strongly activate NS5B303. MNLD also seemed to inhibit NS5B terminal de novo
initiation, however, using a combination of both proteins, the higher molecular weight
band was strongly increased. At the same time, the template-sized product was markedly
reduced. This is indicative of an “unspecific” RdRP-stimulatory function of NS3, which
was not associated with RNA helicase activity. While this apparently conflicted with
the data obtained in this study and by Piccininni et al. 64 , using a helicase dead mutant,
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which was unable to exert any stimulatory effect, there was one hint towards a possible
explanation. While the inhibitory concentration of MNLD was at around 1µM, the IC50
for the NTPase was significantly higher (70µM according to Salam et al. 63). Therefore,
a profound residual NTPase activity was retained at 100µM63. Both mutants were
however ATPase defective, as determined by Piccininni et al. 64 for their variant, and
for the Q460H mutant in the study of Kim et al. 327 . While the exact mode of action
remains elusive, the potential involvement of the NTPase activity provides grounds for
further experiments, using other NS3 mutants, which leave the ATPase intact.
Moreover, a tight physical and functional association of the replicase proteins has been
described earlier62, and could also be confirmed in this study. It is conceivable that this
is a prerequisite for optimal protein function. For CSFV this was already shown by
mutational analysis of NS3:NS5B interaction sites65. This might simply be achieved by
bringing the replicase components into close proximity, or potentially through induction
of a certain conformational state. Intriguingly, our data showed that there were recipro-
cal effects of temperature on the interplay between viral helicase and polymerase (fig.
5.9). At lower temperatures it is likely that protein:protein, as well as protein:RNA
interactions were stabilized. In this case, a very specific effect on terminal de novo initi-
ation was apparent, which even surpassed the general boost of the RdRP. In line with a
potentially stronger interaction, these effects were present even at low NS3:NS5B ratios.
With increasing temperature, the strongest effect could be observed at equimolar pro-
tein amounts. Of note, while the average stimulation of terminal de novo product was
around 3-4-fold for all temperatures, unspecific RdRP initiation was increased propor-
tionally. This might be attributed to several reasons. The most obvious would be the
observed higher catalytic velocity of NS3 at higher temperatures, which in turn led to
more dissociation of secondary structures on the template, accounting for more internal
initiation, as more single stranded regions became available. Alternatively, these could
represent abortive elongation products, resulting from decreased processivity of NS5B
at higher temperatures299.
These data showed that NS3 and NS5B are sufficient for the assembly of a functional
replicase in vitro. The helicase activity of NS3 enabled NS5B de novo initiation on
a difficult template and moderately increases its processivity. On an ideal template,
like the 3’(-) end107, the effects are less pronounced, which corroborates the notion
that NS3 mostly acts at the stage from initiation to elongation of NS5B. On the other
hand, NS5B also significantly stimulated NS3 activity in vitro 67. This means that both
enzymes depend to some extent on their interaction to function efficiently.
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6.2.1. Involvement of NS5A
The role of NS5A in replication is not fully understood. It participates in a wide network
of protein:protein interactions, involving host and viral factors. One host factor used
for viral replication is replication protein A328. It is recruited by NS5A, and supports
the attachment of NS5B to the HCV genome. It is known that the protein binds RNA,
importantly it shows a strong affinity for the poly U tract in the HCV 3’ UTR77,78. It
also interacts with NS3329 and NS5B330,331, which could hint towards a role as a hub for
recruitment of the replication machinery. Its different phosphorylation states might also
define the subset of interaction partners needed for the various functions in the viral
life cycle. It has been shown that NS5A can increase the RdRP activity of NS5B in a
template-dependent manner332. In this study, the role of NS5A in initiation of (-)-strand
synthesis was addressed. As shown in fig. 5.11, the contribution of NS5A seemed to be
a general stimulatory effect on NS5B. This could be deduced from the fact that terminal
de novo initiation was not favored, but the overall activity of the RdRP was increased.
The effect was weaker than the one exerted by NS3. The combination of NS3 and NS5A
augmented the effect of NS3, and facilitated terminal de novo product formation. This
is in line with a recent study that used a rolling circle RNA polymerization model.
Mani et al. 328 found that NS5A exploited the host protein replication factor A to tie a
preexisting NS3:NS5B complex to the template. While the used template was poorly
amplified by the replicase, addition of NS5A and RPA could markedly increase initiation
and polymerization. However, the importance of RPA in cellulo has not been determined
so far. Generally, the impact of RPA might point to a requirement for a single stranded
binding protein, a role which might be served by other viral proteins like core or NS4B,
both being shown to bind RNA, or differentially phosphorylated NS5A isoforms, which
cannot be generated in vitro.
In addition, numerous cellular RNA binding proteins have been identified in previous
studies to contribute to HCV replication, which might serve this function in vivo 88,333–338.
In contrast to our study, the helicase domain of NS3 was sufficient to stimulate NS5B,
which might be a result of the specific assay conditions (i.e. salts, pH). One remaining
substantial concern is the post-translational modification of NS5A. Since the protein was
produced in bacteria, the way of interaction with either of the other non-structural pro-
teins might be affected. Therefore, future experiments will need to address the influence
of NS5A in different phosphorylation states on the RdRP, either alone, or in concert
with NS3. Such approaches will need to make use of NS5A produced in mammalian
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cells, or phosphorylated in vitro.
6.2.2. Remaining Technical Challenges And Perspectives
While the overall trend in most experiments was reproducible, the results showed a high
variation, depending on the batch of protein and RNA used. Therefore, different issues
arose in the course of this study (supplementary fig. 5.12). Foremost, the strength of
the NS3-mediated activation of NS5B was very inconsistent, ranging from almost none to
20-fold. Then, a template-sized band could sometimes be seen with NS5B alone, which
might be due to contaminating proteins, or aberrant RNA folding. In some experiments,
the appearance of a second band very close to template size made it difficult to judge
which one was the true de novo product. Also, the used marker (either generated
by hot in vitro transcription, or end-labeled) did show several truncated fragments,
arguing for abortive T7 products, or RNAse contamination. Since these fragments likely
represent templates for NS5B, the presence of unspecified smaller RNAs in the reaction
was a major concern for the interpretation of any phenotype produced in this assay. It
was therefore clear that the major flaw was the variable quality of RNA and protein
preparations, which need to be addressed in the future. Subsequent studies will have to
make use of higher quality template, to generate more consistent phenotypes. A robust
assay could then be used for different applications, such as the functional specification
of template and protein regions in the context of replication. Moreover, this method
could be applied to clarify the mechanism of action for different antiviral drugs which
target replicase components.
6.3. miR-122 Promotes Viral Translation
The liver specific miR-122 is an important host factor for HCV, contributing to the
viral tropism in a non-canonical mode of action, by enhancing viral propagation. Sev-
eral paradigms exist, which aim to explain the stimulatory effects exerted by miR-122
on the life cycle of HCV. The currently favored model is the direct shielding of the
viral genome against host exonucleases (specifically Xrn1)339,203. Only the elongation
phase of RNA replication seems not to be affected206. Moreover, mechanistically con-
flicting roles in translation and replication have been proposed. While Henke et al. 198
claimed that miR-122 association facilitates 40S ribosomal subunit binding, another re-
cent report suggested a translation abrogating effect, through the displacement of ITAFs
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(PCBP2)207. Moreover, a recent study suggested that miR-122 function is specifically
altered during HCV replication340. This shaping of the cellular environment could be
of relevance for the balance between viral replication and translation, since several fac-
tors associated with HCV are themselves predicted or validated targets of miR-122, e.g.
PACT304, OCLN341, IGF2BP1 (predicted by TargetScan).
Others have used non-hepatic HeLa cells342 or rabbit reticulocyte lysates209 to study
HCV translation. Obviously, such systems pose a high risk of in vitro artifacts. In
particular, there is no functional RISC loading of introduced duplex miRNA in the RRL
system, so pre-annealing of the miR-122 guide strand to the genome becomes necessary,
which represents a very artificial system209,198. In fact, in vitro and in cellulo translation
activation has already been shown to rely on functionally distinct mechanisms342. All of
these factors have made it difficult to evaluate the biological relevance or quantitative role
in the natural infection. Therefore, in our studies we interrogated the effect of transient
miR-122 supplementation on different reporter replicon constructs in Hep3B cells, a
hepatic cell line, which does not express miR-122 natively343. We found that, in line
with published data155, the miRNA was able to support replication of a monocistronic
replicon in these cells (fig. 5.15). In addition, bicistronic replicons could partially
overcome the dependence on this host-factor (fig. 5.16), which has also been described
by others for one of the tested constructs155. In addition, we could show that this effect
was also achieved, when protein expression of a monocistronic replicon was put under the
control of a PV IRES. While substantial replication was observed without miR-122 in
these translationally uncoupled HCV reporters, addition of miR-122 could still increase
the maximal replication and initial translation levels. This might be due to either the
published shielding of the genome, faster progression towards replication, or possibly
recruitment of translation-activating factors in the course of RISC association to the
HCV IRES, which could then be passed along to the upstream IRES elements. A similar
capturing mechanism has also been described for picornaviral IRES structures, which
have been shown to enhance translation of upstream cistrons344. In any case, these
data very clearly favored a role of miR-122 in promoting translation above a certain
threshold level, which in turn led to efficient replication. If this was achieved by other
means, this was sufficient for active replication in absence of miR, arguing that other
possible activities, i.e. enhanced genome stability203, or initiation of replication207, were
advantageous, but not essential. Moreover, the use of a mutant miR-122 (A4U) could
stimulate translation and replication of a corresponding mutant replicon (fig. 5.15).
Since this miRNA could not efficiently bind to canonical miR-122 target sequences, the
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regulatory properties of miR-122 seemed to be of little importance to HCV replication,
at least in the transient cell culture setting.
To quantify all possible contributions in the context of replication, a bicistronic repli-
con was created, which should allow for a distinction between phenotypes arising from
replication/stability, or translation. However, recombination of the replicon RNA after
electroporation precluded the generation of quantitative data (fig. 5.17).
Conclusively, it was shown that increased translation, rather than RNA stabil-
ity/replication was the initial step for the action of miR-122. Nonetheless, subsequent
events were also enhanced by miR-122 supplementation, arguing for additive effects
during the course of HCV replication.
6.4. The impact of domain I on IRES function
In an approach to find the mechanism of miR-122 in HCV translation, we were address-
ing the question, whether binding of the RISC complex could act as an RNA chaperone,
to invoke a structural switch in the 5’ UTR of HCV, which regulates translation ac-
tivity. In previous studies focusing on IRES structure domain I was omitted in most
cases, since it was deemed functionally irrelevant240. In our model, however, we propose
that while it likely does not enhance translation, it rather negatively regulates IRES
function241,242, by interacting with other sequences. A functionally related mechanism
has been proposed before, in which a sequence within the core coding region beyond
domain IV, was suggested to interact with domain I. This interaction was supposed
to involve the miR-122 binding region and would be disrupted by RISC association345.
This hypothesis was later falsified by introduction of specific mutations introduced in
the interacting sequence346. Also, the fact that the 389 nt IRES element used in mono-
cistronic replicons is fully translation competent, and responsive to miR-122 stimulation,
precludes a relevant involvement of this stem-loop in miR-122 dependent activation of
IRES function. Hence, we focused on the local structure adjacent to the miR-binding
region. Several structural features of the IRES have been proposed to play important
roles in binding and positioning host translation machinery to initiate cap-independent
translation259,347,256,257,348,291. We envision that, by preventing translation attenuating
conformations in domain I, miR-122 binding creates a bias towards the local structure,
which has been described as SLII of the HCV IRES (fig. 5.18). The aforementioned
attenuating elements have been predicted by different RNA structure algorithms, and
the complementary strand is known to form a stem-loop at this position. Moreover, we
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could observe that the translation efficacy of an HCV IRES dependent construct was
increased by >5-fold at early time points after HCV RNA transfection by the addition
of miR-122. Accordingly, we designed mutants, which should fold into the SLII con-
firmation natively, circumventing the need for miR-122. Indeed, all mutants designed
that way could stimulate translation at least to the level of wild type in presence of
miR-122. Some even exceeded the translation activity of the positive control by up to
3-fold, whilst specific controls were not able to enhance translation. The observed effect
was limited to the time points up to 2 h post electroporation, since there seemed to be a
block at the stage of re-initiation for all mutants. The luciferase activity decayed roughly
with the half life of the protein, which is around 2 h. Only in the case of the wild type
positive control, the levels remained nearly unaltered even at 4 h post transfection. This
effect cannot be attributed to RNA stability, in spite of the fact that the decay of wild
type RNA was indeed slowed by miR-122. This point can be exemplified by focusing on
the C mutant (fig. 5.29, fig. 5.30). Here, the initial 1 h values of luciferase activity
closely resembled the wild type levels (3.5-fold RLuc for WT and 4.3-fold for C). Also,
the RNA decay kinetics were very similar (with and without miR-122) with a half life
of approximately 30 minutes (fig. 5.30). The reason for this increased stability of the
mutant without miR-122 has not been investigated, but might be due to the introduced
stem-loop structure. In any case, initial translation and RNA breakdown were nearly
identical, still the rate of protein decay was accelerated. This is, precluding any effect
on protein stability itself, indicative of a large protein amount generated in one or two
rounds of translation, followed by ribosome drop-off.
In addition, the influence of Xrn1 and 2 on HCV translation was investigated by
knock-down experiments. It has been established that Xrn1 knock-down protects HCV
RNA from degradation203. Indeed, silencing of Xrn1 could also significantly enhance
luciferase activity in the translation assay (fig. 5.31). However, luciferase expression
over time was still enhanced by miR-122 WT compared to A4U (fig. 5.32). Therefore,
the effects of miR-122 on stability of the RNA and translation activity rely on separate
mechanisms. In addition, knock-down of Xrn2 had no effect on luciferase expression,
which argues against a role in HCV RNA degradation, as proposed by204.
The obtained data, based on the domain I mutants, support the initial hypothesis
that the IRES structure is influenced by miR-122 association, which in turn leads to
more efficient translation initiation. However, the fast decay of translation activity
of all mutants, compared to the wild type with bound RNA, suggested an additional
mechanism, which depends on the miRISC itself. Moreover, stability and translation
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activity were shown to be mechanistically independent.
6.4.1. Influence of miR-122 and Mg2+ on IRES Structure
The marked effect on first-round translation activity, even though it was not sustained,
correlated with structural constraints introduced by specific mutations (fig. 5.29). The
biochemical approach to validate the secondary structure via SHAPE chemistry could
not detect a significant fraction of a single alternative structure fig. 5.23. Accordingly,
the native gel analysis showed several secondary structures of the wild type RNA, but
none for the domain I mutants fig. 5.24. Also the obtained NMR data indicated the
presence of a number of conformers (fig. 5.20), which may be intermediate folding
states. The RNA also seemed to progress from one state to the other dynamically, since
at low temperatures, the obtained NMR peaks were broadened and the noise increased,
arguing for a number of structurally diverse forms. As shown in fig. 5.23, the region
around the second miR-122 binding site (nt 38-43) was unpaired in almost all predicted
structures (calculated probability 0.65 - 1), and was highly reactive. In contrast, the
signal for the directly adjacent nucleotides 21-35 was severely decreased. Precluding a
technical error only occurring in this particular region, this phenotype contradicted the
notion, that this part is entirely relaxed. The fact that this was seen for the 120 nt long
fragment as well (supplementary fig. C.4), can be interpreted to conclude that these
nucleotides are engaged in some way with other sequences in this region. Secondly, the
experimental validation of all tested domain I mutant structures showed high degrees
of conformity with the prediction (fig. 5.25-fig. 5.27). This increased the overall
confidence in the in silico data.
The native gel, NMR and SHAPE experiments did confirm that a fraction of the RNA
natively adopts the canonical fold. This was in line with the predictions derived from
the phenotypical data shown in fig. 5.29: translationally active RNA is formed even in
absence of miR-122, so a significant fraction probably contains SLII.
The structure of the complete 5’ 389 nt of HCV was then investigated by means of
SHAPE analysis under different ion conditions and in presence or absence of miR-122.
MgCl2 is known to have a significant impact on the folding of the HCV IRES and
miR-122 hybridization, as has been reported by several groups349,307,350. Moreover, the
exact ion-dependent secondary structure has not been established for the 5’ terminal
part. Thus, we performed folding experiments using different Mg2+ concentrations, and
some mutants enhancing or reducing translational activity. For the wild type IRES,
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there were marked changes that appeared with increasing ion availability. A phenotype
also observed by Mortimer and Doudna 349 (supplementary data). In the intermediate
condition (1 mM), which should be close to cellular free magnesium levels, miR depen-
dent changes could be observed, which seemed to alter the structure in a way similar to
the highest magnesium levels. This might also be a limitation of studies performed on
RNA structure before, since mostly unphysiologically high magnesium concentrations
were used, which improves folding, but also introduces a source of in vitro artifacts.
Translation initiation, measured by sucrose density fractionation, is also increased at
concentrations of 5 mM MgCl2, as compared to 2.5 mM
347. While this study claimed
to use intracellular concentrations of magnesium, no distinction was made between free,
ionized Mg2+, which only constitutes around 1-5% of the total amount351, while the vast
majority is complexed with nucleotides/nucleic acids and proteins351,352, and is thus not
available for the HCV IRES. This leaves a “usable” intracellular concentration of only
0.1-3.5 mM in a normal cell. This is a range at which the HCV IRES was seemingly
impaired in initiating translation, according to the data of Lancaster et al. 347 .
Finally, the appearance of certain reactivity peaks in presence of high MgCl2 or excess
miR-122-5p, was indicative of fixation of certain structures under these conditions (fig.
5.33, U103). In agreement with the hypothesis that at these high concentrations of
divalent cations the HCV IRES folds spontaneously, no changes could be achieved by
miR-122 at 6.6 mM magnesium, albeit very efficient binding to its target, as indicated
by a marked loss in reactivity within the MBR (fig. 5.33A). That would mean, a
maximally folded equilibrium was already established, which was also corroborated by
the NMR data, gathered under high magnesium concentrations.
These data support a model, in which the RNA structure was stabilized by mir-
122, reducing the dependence on Mg2+ ions, or poising the structure to coordinate the
available ions more efficiently. Moreover, the presence of a functional RISC in the cell
might be needed to exert the strongest possible effect on its target, which cannot be
attained by mere hybridization.
6.4.2. A pioneer round of translation at the IRES?
Cap-dependent translation in eukaryotic cells is usually split in two distinct phases, char-
acterized by discernible RNPs associated to the mRNA215,218,213,217. The first round of
translation is usually dependent on the cap binding complex CBP20/80, which interacts
with polyA binding proteins and initiation factors. CBP20/80 and PABPN1 are only
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found on mRNAs in this pioneer round of translation218. Likewise, if the transcript is
spliced, the exon-junction complex remains associated during this stage217. When the
first ribosome has assembled and encounters an EJC before it has reached a stop codon,
this is recognized as a signal for an aberrant transcript. This triggers a quality control
mechanism called non-sense mediated decay216. For a correctly spliced message, after the
first ribosome has run through the coding region, a major change in RNP composition
is induced in order to form the polysome and start steady-state translation218.
The phenotype in the case of the HCV domain I mutants was quite reminiscent of the
proceedings taking place during non-sense mediated decay. In particular, only active
translation triggers this type of RNA decay, which could also be interpreted from the re-
sults at hand: the most strongly translated ∆20 mutant RNA was degraded at a rate even
faster than wild type in absence of miR-122, while the ISL mutant abolishing translation
near completely was as stable as wild-type with miR (fig. 5.30 ∆20, ISL). Generally,
one would not easily assume a role of NMD in HCV RNA turnover, since the HCV
genome is not spliced, and mammalian intronless genes are usually NMD resistant353.
To date, there have been no reports so far implicating the EJC/NMD machinery with
HCV translation, but some peculiar facts hint towards a possible connection. Firstly,
several NMD components, including the central factor Upf1, which is essential for re-
cruitment and activation of the effector endonucleases, have been found in proteomic
approaches to be present on HCV RNA, and to interact with viral proteins309,354. Also,
Xrn1 the nuclease claimed to be responsible for HCV degradation, is the enzyme that
eliminates the 5’-uncapped RNA fragments resulting from NMD cleavage355. Further-
more, it is known that IRES-mediated translation can trigger NMD, without the need
for CBP-components356, while AGO2 binding to a given mRNA can actively inhibit
NMD357,358. Recently, two studies also showed a direct antiviral effect of NMD by limit-
ing translation of (+)-sense RNA viruses in plants and mammals. The effects were seen
to be dependent on central effector components Upf1, SMG5 and SMG7359,360.
In conclusion, a putative inhibitory effect of NMD on the viral RNA, and hijacking of
AGO2 by HCV, in order to prevent degradation of its genome, is a plausible hypothesis,
which might be promising a starting point for further studies. Especially the determi-
nation of the translation-associated RNP could hold novel insights into the regulation
of the HCV IRES.
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6.4.3. Potential candidates for a translation-activating host factor
The observation that alterations in domain I, which natively stabilize SLII were still
not able to induce translation over a longer time period (fig. 5.32A), argues for a
specific function of miR-binding. This will in the cell always be accompanied by the
RISC complex, and an array of auxiliary factors. It is very likely, that one of these
proteins stimulates steady state translation. Considering the notion that the first round
of translation could obviously be initiated without the need for a RISC complex in the
domain I mutants (fig. 5.29), it follows that re-initiation is the step where the miR-
guided RNP might act. For efficient multi-round translation, mRNAs need to adopt a
circular form. It has been shown in fact that regions of the 3’UTR are essential for full
translation activity. Thus, the function of the factor in question, could be responsible to
bridge both ends of the viral genome. This could either be AGO itself, or an interacting
protein, binding to the 3’ UTR of HCV.
One of the few occasions, where miRNA-mediated up-regulation of translation has
been described in human cells, is TNFα. Here, a complex containing AGO2 and FXR1
is required for activation of protein synthesis361,362. FXR1 is known to bind to AU-rich
elements in the 3’ UTR of the tnfa-mRNA, and during starvation it can interact with
AGO2 to stimulate TNFα expression. The detailed mechanism that promotes the switch
of the AGO2-dependent machinery from RNA decay to translation activation is however
still elusive. FXR1 itself would rather be unlikely as the interaction-partner in suspicion,
since the translation stimulating complexes were shown to form during cell cycle arrest,
while the HCV IRES is most active in the mitotic G2/M stages363. Moreover, in the
mouse, Tsai et al. 364 found that the polysome assembled more efficiently on RIP140
mRNA, after binding of miR-346 to a binding site in the 5’ UTR. While the exact
mechanism has not been elucidated in this case, AGO2 knockdown did not significantly
impair this effect, which could hint towards a role of the other AGO-members364. Thus,
the proof-of-principle has been established that the RISC can participate in translation
activation under specific conditions.
In the following, some factors will be discussed, which could be promising candidates
for a translation enhancing/sustaining function for the HCV IRES. To reiterate, assum-
ing a bridging function between the 3’ and 5’ end, the factor in question needs to interact
with the 3’ UTR, and a component of the RISC, likely an AGO protein. An indirect
interaction might also be possible, however, only direct interactions will be assumed here
to minimize the complexity of the initial model.
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Nuclear Factors Associated with dsRNA
NF90 and NF45 are dsRNA binding proteins which cooperate functionally with each
other and further proteins and regulatory RNAs to regulate gene expression and stabi-
lize mRNAs. Furthermore, both factors are commonly found in Argonaute-containing
complexes, which make them appealing candidates for being the bridging component
needed for efficient HCV translation. The interaction of both has been shown to stimu-
late gene expression of cellular proteins, and activate cell proliferation365,366. In respect
to cellular mRNA, it has been described that NF90 is also involved in RNA transport
processes367, which could also play a role in delivering viral RNA to the sites of partic-
ular processes, be it replication or translation. NF90 has already been implicated in the
replication cycle of the HCV related pestivirus BVDV368, and binding sites for NF90
and NF45 were detected in both UTRs of HCV369,268.
Insulin-like growth factor-2 mRNA-binding proteins
IGF2BP-1 is a member of the ZIP-code like protein family, with two more homologs,
accordingly termed IGF2BP-2 and -3. The family name is derived from the drosophila
homologue which targets specific mRNAs to certain sites. These proteins are exclusively
localized in the cytoplasm and form RNPs with a variety of mRNAs370,371. Many of those
are important oncogenes, i.e. KRAS, c-MYC372, therefore dysregulation of IGF2BPs is
associated with tumor metastasis373,374. A hallmark feature of target association is the
recognition of naked RNAs, which are likely protected from premature decay IGF2BPs.
IGF2BP1 binds the poly-U region of the HCV genome121 and is a known interactor of
RISC complexes375. IGF2BP-2 and -3 are found either associated to HCV or the RISC,
respectively308. It cannot be excluded that these might also be involved in translation
modulation in the context of HCV. Interestingly, an interaction with the protease (Npro)
of the related pestivirus family has been shown376.
Y-Box protein 1
YB1 is a DNA and RNA binding protein, which resides in the nucleus and the cyto-
plasm377. Its major functions include transcription, splicing and translation regulation.
The name is deduced from its Y-Box-promoter affinity, which regulates HLA class II
genes, among others378–380. It stabilizes exported mRNA (e.g. GMCSF, c-MYC) by se-
quence specific interaction381,382. A secreted version of the protein acts as strong mitogen
and can influence proliferation and migration of neighboring cells383. An involvement in
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the non-coding RNA machinery has been claimed as well384. YB1 has been described
as a dependency factor of HCV replication, while it restricts virion assembly. Mechanis-
tically, it is known that YB1 exerts its effects on the viral life cycle in part by binding
to NS3285,385.
PolyA-binding protein N1
The class of poly-A binding proteins regulate translation initiation, by associating to
the 3’ poly A element of mRNAs in the nucleus. PABPN1 can recruit and stimulate the
poly A polymerase activity, thereby stabilizing target transcripts through the elongation
of their poly A tail386. The protein is shuttled to the cytoplasm in complex with the
mRNA387. During the pioneer round of translation, it modulates NMD, and is removed
from the RNP in a translation-dependent manner218. Steady-state translation requires
only PABPC1218,355. It has been found to be associated with the HCV genome309,
but there has been no report of functional interaction with HCV so far. However, the
fact that several other factors included in the pioneer round of translation and the
associated NMD pathway have also been found to bind HCV RNA might suggest a
possible functional link309,354.
Human antigen R
HuR is a predominantly nuclear RNA-binding protein, which preferentially targets the
3’ UTR of mRNAs. Especially poly U and AU-rich elements are avidly bound388. It can
regulate the nuclear export of its target messages, and thereby influence gene expres-
sion. Prominent targets are the proto-oncogenes survivin and p53389,390. Deregulation of
HuR has been implicated in tumor growth and metastasis391–393. Moreover it interferes
with miR-122-binding to the CAT-1 mRNA and relieves its repression182. Sindbis virus
recruits HuR to a U-rich region in its 3’ UTR, stabilizing the viral genome. This is
accompanied by a translocation of HuR into the cytoplasm, which also leads to impair-
ment of its cellular functions394,395. An AU-rich element present in the CSFV genome is
also targeted396. HuR has been linked to HCV translation stimulation, which is achieved
by binding to the viral polyU element in the 3’ UTR120. The exact mechanism has not
been clarified so far.
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The role of AGO1
The comparison of HCV and RISC associated factors led to the striking observation
that most proteins, which play a role in IRES mediated translation, are actually in a
complex assembled around AGO1 (“complex III“ from Ho¨ck et al. 308). The few studies
that looked at the different Argonaute proteins apart from AGO2 in HCV modulation
yielded controversial results. While some reports found that AGO2 is the key player
boosting HCV RNA accumulation397,339, another group saw all Argonaute proteins (and
many other components of the RNAi machinery) as important host factors in their
siRNA approach152. Curiously, in this case the knockdown of AGO4 was the most
effective in inhibiting HCV replication. A more recent study also showed direct, miR-
dependent association of AGO1 to HCV RNA, albeit AGO2 was still more efficiently
bound208. It is important to consider a likely interaction between the Argonaute proteins
and their respective complexes. Moreover, little is known about the determinants of
miRNP-assembly. This might again be dependent on the cell-type and environmental
factors, so that the study of Ho¨ck et al. 308 , which was performed in HeLa lysates, might
be a good starting point, but could fail to describe the situation in the liver. Thus, the
proteins found only in AGO1 complexes by Ho¨ck et al. 308 , could also be associated to
AGO2 in liver cells. Alternatively, different functions in the viral life cycle might be
performed by different AGO-species.
The review of the literature brought to light several candidate proteins, which interact
with the HCV 3’ UTR, as well as the RISC. Hence, these factors could join the 5’ and 3’
end of the viral genome during translation, to facilitate polysome formation. Notably,
AGO1 was found to bind many of the factors known to modulate HCV IRES-mediated
translation, which could imply that AGO2 is not the only Argonaute protein involved
in HCV regulation.
6.5. The effect of miR-122 in HCV replication
The annealing of miR-122 to the 5’ end of the HCV genome is characterized by a 6-
nucleotide U-rich overhang. This is thought to prevent recognition of the uncapped viral
5’ terminus by exonucleases, like Xrn1203. Moreover, it has been shown that deletion
of the 3’ nucleotides can severely affect miR-122-dependent HCV stimulation202. This
might have been be a result of inefficient incorporation into the RISC, which is strongly
selective for correctly sized RNA duplexes. Another study has also found that either
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shortened or elongated synthetic miR molecules were impaired in their influence on
HCV208. While some work has been done in the context of translation, using short
luciferase reporter constructs346, we wanted to study the miR-122 sequence determinants
for replication in more detail. A central hypothesis was the possible primer generation
of NS5B at the single-stranded portion of the bound microRNA, since the 3’ UG dimer
at the end of the miR would be a perfect primer template (fig. 5.36). Moreover,
the structural appearance, a short pyrimidine-rich region, close to a helical element,
resembles an ideal initiation template for NS5B107. Also, the genome is circularized to
facilitate replication, which brings the 5’ and 3’ termini in close proximity398. Thus,
primer generation at the microRNA would be an elegant solution to effectively initiate
(-)-strand synthesis. However, we could show that at least the supplementation of a
synthetic duplex could not rescue a corresponding mutant in Hep3B cells, arguing against
an initiation at the bound miR-122. Importantly, this phenotype strongly favors a
primer generation site apart from the 3’ terminus, since the priming would otherwise
be unaffected by the mutation of the penultimate nucleotide. Furthermore, we tested
a panel of other mutants to assess their influence on HCV replication. The general
phenotype of different mutations introduced in the overhang and bulged regions of the
miRNA was also investigated. Most perturbations of the non-binding miR-regions were
tolerated without impairing HCV replication. The exchange of all overhang nucleotides
to their complementary counterparts resulted in a 70% reduction of replication, while
translation remained seemingly unaffected. A terminal UG-rich sequence might therefore
have some impact on miR-122 activity. This might also explain why addition of the
miR-26a 3’ region has no effect, as it also harbors 3 pyrimidines and two gunaines.
Importantly, a recent report suggests binding of hnRNP K to flexible, pyrimidine-rich
sequences in mature miR-122399. While hnRNPK does not influence replication400, a
similar mechanism involving another miR-binding protein might be responsible for the
observed effect. A switch of the bulged and overhang region massively affected replication
(100-fold reduction), and initial translation (4-fold reduction). This could also be due to
the 1 nt difference in length between the two regions, making the bulge slightly smaller,
which might affect the target binding affinity in general.
Furthermore, RNA localization may be influenced by RISC binding. Since several
components of the miR-silencing pathway are involved in HCV replication318,401,317, we
asked whether these could recruit the AGO-bound genome to the sites of viral replication.
In an imaging based approach, electroporated HCV (+)-strand RNA was stained in situ,
and in parallel to AGO2 and Hsp90, a chaperone involved in many steps of the HCV
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life cycle402,403,284. Unexpectedly, while the signals for protein and RNA were in close
proximity in some regions, no direct co-localization was observed (fig. 5.37). It was not
clear, if this was due to a very transient interaction, a suboptimal time point (48 h post
electroporation), or technical limitations. Therefore, no definitive conclusions could be
drawn from this experiment.
Recent studies performed by Masaki et al. 207 suggest that part of the mechanism could
be the displacement of PCBP2, a host factor that stimulates translation. The authors
claimed that this leads to a shift of the fraction of HCV RNA engaged in translation
towards replication.
Unfortunately, the mechanisms of miR-122 supporting viral RNA replication could
not be elucidated further in this study.
6.6. Effects of miR-122 binding to sites in the CDS and
3’ UTR
In the same report that found the first binding site in the 5’ UTR, an additional one
has been described within the variable region of the 3’ UTR153. While this region is not
essential for RNA replication in vivo 404, deletions impaired viral propagation in the repli-
con system by an unknown mechanism118, which might be linked to miR-122. Later on,
another site was identified in the coding region of NS5B320. However, these additional
sites have only been poorly characterized, likely because of their negligible effect on viral
replication. In our study, possible additional binding sites were investigated by searching
the full-length genomes of six genotypes for the core hexamer CACUCC. Indeed, several
putative miR binding sites were detected in the sequences, two of them were also con-
served among genotypes. Insertion of point mutations had only limited effects on RNA
amplification kinetics of HCV replicons in Huh7 Lunet, as well as in Hep3B cells with ex-
ogenously supplemented miR-122 (0.3-fold to 1.5-fold of wild type). Interestingly, some
mutants showed enhanced translation (up to 6-fold), which could imply directly oppos-
ing effects of miR-binding to either end of the genome, which has been described for the
known sites 5 and 6320. For site 6, this could also be deduced from a reporter assays, in
which this MBR could significantly lower the expression of a preceding renilla luciferase
gene. All other sites, except site 3, could hardly act as translational repressors. Also, no
synergistic effects were detected using all sites in conjunction. However, the results ob-
tained with the artificial reporters did not correlate completely with the phenotype seen
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in the replicons. For instance, point mutations within sites 4 and 5 could enhance initial
translation to a certain degree, which could argue for additional influence of the flanking
sequences, or effects dependent on certain combinations of binding sites not tested so
far. In any case, these sites seem to be functional, and their conservation speaks for
a relevant role in the HCV life cycle. The restricting effects on translation/replication
would suggest distinct and position-dependent complexes, which are recruited to exert
a specific function.
To date, an impact of miR-122 on assembly and release has been proposed only once,
and focusing on the 5’ UTR sites405. Since replication kinetics were only moderately
affected by the identified 3’ sites, these were also tested for a function in later stages
of viral propagation. The mutant sites were cloned into JcR2A reporter viruses and
Huh7.5 cells were electroporated with or without the matching miR-122 mutant. For
the single mutants, as in the replicon context, no notable effect could be seen. However,
supplementation of miR-122 A4U lowered the replication capacity of mutant 6. Notably,
this phenotype was dominant in all mutants harboring a defective site 6. This corrobo-
rates the reporter assays and the previous report of Nasheri et al. 320 , which showed that
this site could function to repress the upstream ORF to some extent. The supernatants
containing the released virions were used to inoculate fresh Huh7.5 cells, and luciferase
activity was measured 72 h later. The replication of the electroporated cells after 72 h
was used as baseline to normalize the amount of reinfection (fig. 5.40). All viruses,
except for the single mutations site 4 and 5, were severely impaired in their relative re-
lease of infectivity, compared to wild type. However, the addition of synthetic miR-122
A4U duplex during electroporation could not rescue the assembly/release phenotype.
This could be in part due to the experimental setup. One has to take into account that
exogenously delivered duplex RNA in high doses will be incorporated in a different fash-
ion than intracellularly expressed miRNA. In an earlier publication NS3 was observed
to form a complex with YB1, which modulates virus production and replication285,385.
YB1 is also an interaction partner of AGO1 and 2. Therefore, the assembled RISC-
complexes might be different and dependent on viral proteins. In that case, the bound
complexes formed by synthetic miR might not be able to act synergistically. Follow- up
experiments will be performed using Huh7.5 cells, stably expressing miR-122 A4U, to
circumvent these potential pitfalls. Furthermore, nothing is known about the regulatory
events that dictate where miR-122 binds on the HCV genome. Finally, it cannot be
excluded that miR-122 wild type is needed for activation of assembly/release. A possi-
ble explanation might be the significant effect of HCV replication on miR-122 function,
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which has been described by Luna et al. 340 . The authors saw a marked upregulation of
miR-122 target genes. One of these might play a role in assembly, packaging or release
of the virion. Assuming that sequestration of miR-122 might be dependent on the con-
certed action of all binding sites in the genome, the introduced mutations would disturb
this function. Therefore, no rescue can be achieved by miR-122 A4U addition. In this
case, specific inhibition of miR-122 might be a way to rescue assembly in these mutants.
Also it will have to be clarified whether the defect lies in the actual assembly step, or
whether infectious virions are only retained within the cell.
In summary, the characterization of additional miR-122 binding sites in the HCV
genome showed that at least two of these sites have an impact on assembly/release.
These findings led to the discovery of a complex regulatory mechanism, which should be
explored in more depth in the future.
6.7. Towards a comprehensive model of miR-122:HCV
interaction
In the course of this study, we have shown that miR-122 is indispensable for HCV
replication, and have quantified the influence at individual steps of the viral life cycle.
Mutants lacking miR-122 binding sites, but stabilizing the IRES structure were equally
or more efficient at what appears to be a pioneer round of translation, as the wild
type with bound miR-122. Thus, the stabilization of essential structures by miR-122
association might be the first step of poising the RNA for translation. Suppression of
adverse conformations and favoring of SLII formation would provide a surface for 40S
docking254,247,259, which is the basis of preinitiation complex formation. The recruitment
of the first ribosome is therefore accelerated in these mutants even in absence of RISC
binding. However, further rounds of translation were not efficiently initiated. This led
to the conclusion that the AGO-associated complex itself is essential at the stage of
polysome assembly. This might be facilitated through an interaction of the RISC with
a factor binding to the 3’ UTR, leading to genome circularization. This end-joining has
been proposed to be an essential step for induction of steady-state translation406. The
aspects of genome stability and initiation of replication were found to play subordinate
roles, and support the life cycle through an additive mechanism. The RNA stabilizing
effect of the miR could be reproduced in this study, could however not account for the
effects seen on viral propagation. While point mutations in the 5’ miR-122 binding
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Figure 6.1.: Model of miR-122:HCV interaction A | Initially, miR-122 association to
the 5’ terminus of HCV might stabilize a translation-competent conformation of the IRES.
Thereby, the miRISC enables enhanced binding of the 40S ribosomal subunit and initiation
factors (i.e. eIF3). B | After the initial round of translation, genome circularization is required
for efficient reinitiation of the ribosome. This seemed to be impaired, when miR-122 and the
associated RNP is not present. Therfore, recruitment of host/viral factors might interact with
the RISC to create a bridge between the genome termini. C | In later stages of viral replication,
HCV needs to shunt some of the genomic RNA towards packaging to generate progeny virions.
Binding of miRISC to 3’ recognition sites seemed to suppress translation/replication, while
increasing the fraction of RNA available for virion assembly.
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sites are detrimental for viral translation, targeting of newly discovered 3’ located sites
could increase translation. This was accompanied by a marked decrease in viral progeny
generation. Therefore, we propose a dynamic shift of HCV associated RISCs which
might differ in protein composition. The modulatory effect of NS3 in complex with
YB1285 imply that HCV might actively modify RISCs in the course of infection.
The miRNP-based determinants for the translation/replication/assembly-switches will
be of particular interest for subsequent studies. More efforts will have to be invested
into localization studies and biochemical approaches to unravel the mechanism by which
miR-122 augments replication. Overall, this study provides several new perspectives,
and the basis for a deeper understanding of this unique virus-host interaction.
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HCV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . hepatitis C virus, p. 5
gt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . genotype, p. 5
HCC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . hepatocellular carcinoma, p. 6
IFN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . interferon, p. 6
DAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . direct acting antiviral, p. 7
LNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . locked nucleic acid, p. 7
(+)ss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .positive single-stranded, p. 7
NS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . non-structural, p. 8
IRES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . internal ribosomal entry site, p. 8
UTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . untranslated region, p. 8
SR-B1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . scavenger receptor B1, p. 8
CLDN1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . claudin-1, p. 8
OCLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . occludin, p. 8
mt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . microtubuli, p. 10
DMV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . double membrane vesicles, p. 12
MW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . membranous web, p. 12
MAVS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .mitochondrial antiviral-signaling protein, p. 13
RIG-I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . retinoic acid inducible gene I, p. 13
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MAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .mitochondria-associated membranes, p. 13
RNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .ribonucleic acid-associated proteins, p. 14
RdRp . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . RNA-dependent RNA polymerase, p. 15
CRE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . cis-acting replication element, p. 16
RNAi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .RNA interference, p. 20
siRNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . short interfering RNA, p. 20
PolII . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . DNA polymerase II, p. 20
PolIII . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . DNA polymerase III, p. 20
DGCR8 . . . . . . . . . . . . . . . . . . . . . . . . . . DiGeorge Syndrome Critical Region Gene 8, p. 20
pre-miRNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . precursor microRNA, p. 20
RISC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .RNA-induced silencing complex, p. 21
AGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Argonaut protein, p. 21
TRBP . . . . . . . . . . . . . . . . . . . . . . . . trans-activation response RNA-binding protein , p. 21
GW182 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Glycine-tryptophan protein of 182 kDa, p. 21
P-body . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . processing body, p. 21
JFH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . japanese fulminant hepatitis, p. 19
EJC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . exon junction complex, p. 24
CTIF . . . . . . . . . . . . . . . . . . . . . .CBP80/20-dependent Translation Initiation Factor, p. 24
NMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . nonsense-mediated decay, p. 24
PABP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . polyA-binding protein, p. 24
eIF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . eukaryotic initiation factor, p. 25
ITAF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IRES-specific cellular transacting factors, p. 26
miRNA or miR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . microRNA, p. 27
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PKR . . . . . . . . . . . . . . . . . . . . . . . . . double stranded RNA-dependent protein kinase, p. 29
EDTA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ethylenediaminetetraacetic acid, p. 33
MOPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-(N-morpholino)propansulfonic acid, p. 33
TRIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tris(hydroxymethyl)aminomethane, p. 34
EtBr . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Etidium bromide, p. 41
LB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lysogeny Broth, p. 41
DMEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dulbecco’S modified eagle medium, p. 43
PEI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Polyethyleneimin, p. 43
SDS PAGE . . . . . . . . . . Sodiumdodecylsulfate polyacrylamide gel electrophoresis, p. 47
HRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Horse radish peroxidase, p. 47
RT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . reverse transcription, p. 50
qPCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . quantitative PCR, p. 52
CT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .threshold cycle, p. 52
PFA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . paraformaldehyde, p. 54
Sf9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Spodoptera frugiperda 9, p. 62
BSRT7 . . . . . . . . . . .Baby Hamster Kidney cells expressing T7 RNA polymerase, p. 62
MNLD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Manoalide, p. 64
SPDN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Spermidine, p. 72
MBR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . miR-binding region, p. 93
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C.1. Influence of VX950 on NS3 Unwinding Kinetics
Besides the end point values shown in fig. 5.5, also kinetic data of the NS3 helicase
activity with or without effective concentrations of the protease inhibitor VX950. Inhi-
bition of the NS3 protease has no effect on kinetics or maximal template unwinding in
this assay. These data suggest that inhibition of the protease activity did not impair
Figure C.1.: Impact of protease inhibition on NS3 helicase function. A | Structure
of VX950. B | Native gels showing the NS3 activity over a time frame of 30 minutes, either
with or without the compound.
helicase activity or RNA binding capability of NS3.
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C.2. Growth Inhibition of miR-122 Expressing Hep3B
Cells
miR-122 has been shown to have anti-proliferative effects on tumor cell lines. To validate
the physiologic activity of miR-122 in the stably transduced Hep3B cell lines, these cells
were tested for their growth kinetics by WST-1 assay (Promega, Madison, WI, USA).
The experiments show that miR-122 was active and exerted all described effects in Hep3B
cells. The cell growth of Hep3B cells was slightly impaired after introduction of wild type
miR-122, compared to miR-122 A4U. Addition of the miR-122 inhibitor miRVANA R©
(Thermo Fischer Scientific, Waltham, MA, USA) alleviates the effect. Importantly, the
A4U mutant did not affect cell proliferation.
Figure C.2.: Growth kinetics of Hep3B cells
stably expressing miR-122. Cell growth estima-
tion was performed by WST assay. Approximately
10,000 cells were seeded in hexaplicate per time-
point on 96-Well plates. The initial cell number was
determined 4-6 h after seeding, to allow settling of
the cells. This value was used for normalization.
Subsequent measurements were performed after 24-
72 h. The individual points are means of 2 experi-
ments, error bars represent S.D.
The apparent growth inhibition after miR-122 overexpression in Hep3B cells was in
line with previously published data for other hepatoma cell lines154. These data provide
further evidence for a physiological function of exogenously expressed miR-122 in Hep3B
cells.
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C.3. Generation of a Hep3B GFP-AGO2 Cell Line
To enable a live tracking of AGO2 containing complexes in future experiments, a Hep3B
cell line with AGO2 knock-down and simultaneous overexpression of a GFP-tagged sub-
stitute (pWPI-GFP-AGO2) was generated. The shRNA sequence was designed to target
the 3’ UTR of the endogenous mRNA, to avoid interference with the exogenous version.
shRNA mediated knock-down and expression of GFP-AGO2 were successful and the
Figure C.3.: Establishment of a Hep3B cell line with GFP-AGO2. A | Western blot
against AGO2 and α-Tubulin in the parental and transduced Hep3B cells. B | Quantification
of western blot data. AGO-Protein amounts were normalized to α-Tubulin.
relative levels of the tagged protein were comparable to the endogenous levels of the
parental cell line. The used primer sequences can be found in tab. C.1. The successful
Table C.1.: shRNA stem-loop oligos.
Label Sequence
S-shAGO2-3001 TCGAGAAGGT ATATTGCTGT TGCTCAAACT AGCTGT-
GAAT CTCGAAAGAT TCACAGCTAG
A-shAGO2-3001 AATTCCGAGG GACAGCCAGC ATCGAACATG ATTCGT-
CATG TTCGATGCTG GCTGTCAACA
generation of this cell line provides a tool for live imaging based approaches, e.g. to
follow AGO2 relocalization after HCV infection.
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C.4. mfold Prediction of Domain I Mutants
In the following, the mfold predictions with the lowest ∆G for the designed domain I
mutants are listed. The structure is given in VIENNA format.
WT
gaccugcccc uaauaggggc gacacuccgc caugaaucac uccccuguga ggaacuacug
.....((((( .....))))) (((((((((( ((((...... ......(((( (((.(....)
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
)))))))... ....((.... .))))))))) .......))) )))).....( ((....))).
WT (w/ miR-122)
gaccugcccc uaauaggggc gacacuccgc caugaaucac uccccuguga ggaacuacug
....(((((( .....)))))) ......... .......... ...((((.(( ((.....(((
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
(...(((.((. ..((((((. ......)))) ))....)).)) )....)))) ))))))))..
∆10 (21-30)
gaccugcccc uaauaggggc caugaaucac uccccuguga ggaacuacug ucuucacgca
.....((((( .....))))) .......... ...((((.(( ((.....((( (...(((.((
gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
...((((((. ......)))) ))....)).) ))....)))) ))))))))..
∆15 (21-35)
gaccugcccc uaauaggggc aucacucccc ugugaggaac uacugucuuc acgcagaaag
((..(((((( .....))))) ))).....(( ((.((((... ..((((...( ((.((...((
cgccuagcca uggcguuagu augagugucg uacagccucc aggcc
((((...... .))))))... .)).)))... .))))))))) )))..
∆20 (21-40)
gaccugcccc uaauaggggc gccccuguga ggaacuacug ucuucacgca gaaagcgccu
.....((((( .....))))) ...((((.(( ((.....((( (...(((.(( ...((((((.
agccauggcg uuaguaugag ugucguacag ccuccaggcc
......))))) )....)).)) )....)))) ))))))))..
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SL (26-37)
gaccugcccc uaauaggggc gacacgggga aaacccccac uccccuguga ggaacuacug
....(((((( .....))))) )....((((. ....)))).. ...((((.(( ((.....(((
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
(...(((.(( ...((((((. ......)))) ))....)).) ))....)))) ))))))))..
C (31-40)
gaccugcccc uaauaggggc gacacuccgc guacuuagug uccccuguga ggaacuacug
.....((((( .....))))) ((((((.... ......)))) )).((((.(( ((.....(((
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
(...(((.(( ...((((((. ......)))) ))....)).) ))....)))) ))))))))..
pA5 (25-29)
gaccugcccc uaauaggggc gacaaaaaac caugaaucac uccccuguga ggaacuacug
....(((((( .....))))) )......... .......... ...((((.(( ((.....(((
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
(...(((.(( ...((((((. ......)))) ))....)).) ))....)))) ))))))))..
pA10 (21-30)
gaccugcccc uaauaggggc aaaaaaaaaa caugaaucac uccccuguga ggaacuacug
....(((((( .....))))) )......... .......... ...((((.(( ((.....(((
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
(...(((.(( ...((((((. ......)))) ))....)).) ))....)))) ))))))))..
ISL
gaccugcccc uaauaggggc gacacuccgc cauggaucgc uuuccuguga ggaacuacug
.....((((( .....))))) (((((((((( (((((..((( ((((.((((( (((.(....)
ucuucacgca gaaagcgccu agccauggcg uuaguaugag ugucguacag ccuccaggcc
)))))))).. )))))))... ..)))))))) .......))) )))).....( ((....))).
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C.5. SHAPE Analysis of 5’ UTR Fragments
Besides the 389 nt fragment, also the first 120 nt of the HCV 5’ UTR, from the wild
type, and the ∆20 mutant were assessed by SHAPE. It could be observed that the band
pattern of the truncated variants was very similar to the full-length IRES (fig. C.4,
fig. 5.23). Also, the binding of miR-122 was clearly visible in the wild type, whereas
no change was detected in the ∆20 mutant.
Figure C.4.: SHAPE analysis of the 120 nt wild-
type and 100 nt ∆20 fragments. Auto-radiography
image of the SHAPE results obtained for the WT and
∆20 sequences at 6.6 mM MgCl2. The marker (M) shows
all A residues. NAI indicates addition of the electrophile,
and DMSO represents the cotrol reactions. “-” stands
for the addition of miR-122-3p as non-binding control.
Lanes marked with a “+” show reactions with the bind-
ing miR-122-5p strand.
In conclusion, the 120 nt fragment seemed to adopt a similar conformation as the
389 nt RNA. Therefore, most of the observed conformers in fig. 5.19 can be assumed
to be based upon local structures in this region.
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C.6. Interaction of HCV Non-structural Proteins to the
HCV 5’ UTR and RISC Components
In preliminary experiments, it was investigated, whether non-structural proteins show
any affinity for the 5’ UTR. It was previously reported that NS3 can bind to SLIII of
the HCV IRES, and displace the La protein, in order to prime the genome for RNA
replication68. For the 5’ terminal portion it is not known, whether HCV non-structural
proteins can bind to modulate translation or replication. Thus, filter-binding assays were
performed with purified HCV proteins. A significant enrichment could be achieved with
NS3, while the helicase domain alone was not able to retain the radioactively labeled
120 nt fragment. Interestingly, NS5B in its full length variant showed a modest but clear
enrichment for the HCV IRES RNA (fig. C.5A). These results were validated using
electro-mobility shift assays. Incubation of labeled RNA with RRL and also with NS5B
yielded a shift band, while the BSA control did not (fig. C.5B). Addition of NS3 lead to
retention of most radioactive signal in the pocket of the gel (not shown). The normalized
intensity suggested that around 5-10% of input RNA are bound to NS5B under the
used conditions. To support a role of non-structural proteins in RNP remodeling to
perform the switch from translation to replication, putative interactions of the viral
proteins with components of the RISC were explored. To date, only indirect links to
AGO-containing complexes have been established. To assess the physical interactions
between the HCV proteins of interest and the RISC, co-immunoprecipitation assays were
performed. For this purpose, the NS3-NS5B polyprotein was overexpressed in Huh7
“Lunet” cells (expressing T7 polymerase), and AGO2, NS3 or 5A were pulled down
with specific antibodies. The material was analyzed by western blot to identify host
and viral interaction partners. As a control, the interaction of NS3 and 5A, and AGO2
with DDX6 was tested. As reported, NS3 and 5A strongly interact and precipitating
NS5A shows a considerable amount of pulled down NS3. Of note, NS3 was readily
detected after NS5A pull-down(fig. C.5D), in contrast, an antibody against NS3 could
not co-immunopreciptate NS5A ( picrefEMSAE). Since the epitope of the used antibody
lies in the helicase domain, is might be deduced that the NS5A interaction site is also
located there. A small fraction of NS3 (∼3-5% of input), but not NS5A or β-Actin was
co-immunoprecipitated with AGO2.
In summary, NS3 can bind the 5’ UTR of HCV, and shows affinity for the RISC,
which make the protein a possible candidate to perform RNP remodeling. Additionally,
binding of NS5B to the first 120 nt was noted, while association with AGO2 has yet to
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Figure C.5.: Determination of domain I and RISC binding viral proteins. A |
Quantification and assessment of purity of E. coli expressed NS-proteins. B | Filter binding
assay performed with 400 ng of purified NS-proteins and 1 fmol of 3’-labeled RNA. BSA was
used as baseline control. Only NS3 and NS5BFL can bind to the 5’ 120 nt of HCV. C |
Validation of the filter binding assay by electric mobility shift assay. Translation competent
rabbit reticulocyte lysate (RRL) was used as positive control. D | Western blot of nonstructural
proteins co-immunoprecipitated with AGO2 after overexpression in “Lunet” T7 cells. T: total
lysate (10%). The asterisk indicates the heavy chain of the mouse antibody. Some aggregation
was visible in the pocket of the T lane for the DDX6 panel. E | Pull-down of viral and cellular
proteins with NS3 and AGO2. The AGO2:NS3 interaction was verified by western blotting,
Actin was used as control. F | Quantification of pull-down efficiency. Actin was used as
negative control.
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be tested.
C.7. Primers
Table C.2.: Cloning of His-tagged NS proteins
Label Sequence
SIN3H6 GCGGCCGCTC ATCATCACCA TCACCATTCG CGACCCATCA
CTGCTTATGC
AIN3H6 GGTCGCGAAT GGTGATGGTG ATGATGAGCG GCCGCACCAC
CGCGGAGACG
SIN4BH6 CATTTAAATC ATCATCACCA TCACCATATT AATATGCAGG
CTTCATGG
AIN4BH6 ATTAATATGG TGATGGTGAT GATGATTTAA ATGAGCGGGT
TGTATGTC
AIN5AH6 CAGGCCGGCC ATGGTGATGG TGATGATGCT TAAGACCGCT
CGAGGGGGGC
SIN5AH6 TCTTAAGCAT CATCACCATC ACCATGGCCG GCCTGATGCA
GGCTCGTCCA
SIN5BH6 GATCGCCATC ATCACCATCA CCATGGTACC GCCTTCACGG AG-
GCC
AIN5BH6 GGTACCATGG TGATGGTGAT GATGGCGATC GCTCAGGTTC
CGCTCGT
Table C.3.: Cloning of NS3 variants
Label Sequence
SOUTQ460H ACCCCCCGGG TCAGTGACAA CC
AINQ460H CCCGCGGCGG TGACTGCGTG AGACAGCGTC TTGTGGGA
AOUTQ460H TCGATAAGCT TTAATGCGGT AGT
SINQ460H CACGCAGTCA CCGCCGCGGG CGCACAGGTA GAGGAAGA
A2ANS3P CGCTTAATTA ATCAGGGAGA CCTTGTAACA ACGTCG
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Table C.4.: Primers for in vitro assay templates
Label Sequence
T7S2A9191
T7S2A9415 TAATACGACT CACTATAGGG AGCTAACTGT TCCTT
T7S2A9507
T7AHCV3(-) TAATACGACT CACTATAGGT GCACGGTCTA CGAGA
A2A3(+)wt ACATGATCTG CAGAGAGACC AG
A2A3(+)C GCATGATCTG CAGAGAGACC AG
A2A3(+)3C GGGACATGAT CTGCAGAGAG ACCAG
A2A3(+)3(-) ACCUGCATGATCTG CAGAGAGACC AG
S2A3(-) GACCTGCCCC TAATAGGGGC G
T7S1B9181 TAATACGACT CACTATAGGG CAGTAAGGAC CAAGCTCAAA
C
S1B3(-) GCCAGCCCCT GATGGGGCGA C
A1B3(+)UGU ACTGGCCTCTCTGCAGATCATGT
A1B3(+)AGU ACTGGCCTCTCTGCAGATCAAGT
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Table C.5.: Oligos for cloning of miR-activity reporter.
Label Sequence
S 5B miR 3 Ban-Not GCACCGCCGC AGATACTACC TGACCAGAGA CC-
CAACCACT CCACTGC
A 5B miR 3 Ban-Not GGCCGCAGTG GAGTGGTTGG GTCTCTGGTC AG-
GTAGTATC TGCGGCG
S 5B miR 4 Ban-Not GCACCACTCG CCCGGGCTGC CTGGGAAACA GTTA-
GACACT CCCCTGC
A 5B miR 4 Ban-Not GGCCGCAGGG GAGTGTCTAA CTGTTTCCCA
GGCAGCCCGG GCGAGTG
S 5B miR 5 Ban-Not GCACCTCAAT TGGGCGGTGA AGACCAAGCT
CAAACTCACT CCATTGC
A 5B miR 5 Ban-Not GGCCGCAATG GAGTGAGTTT GAGCTTGGTC
TTCACCGCCC AATTGAG
S 5B miR 6 Ban-Not GCACCCCCGC TCGGTAGAGC GGTACCCACT AG-
GTACACTC CATAGGC
A 5B miR 6 Ban-Not GGCCGCCTAT GGAGTGTACC TAGTGGGTAC
CGCTCTACCG AGCGGGG
S 5B miR 3 Ban-Ban GCACCGCCGC AGATACTACC TGACCAGAGA CC-
CAACCACT CCACTG
A 5B miR 3 Ban-Ban GTGCCAGTGG AGTGGTTGGG TCTCTGGTCA
GGTAGTATCT GCGGCG
S 5B miR 4 Ban-Ban GCACCACTCG CCCGGGCTGC CTGGGAAACA GTTA-
GACACT CCCCTG
A 5B miR 4 Ban-Ban GTGCCAGGGG AGTGTCTAAC TGTTTCCCAG
GCAGCCCGGG CGAGTG
S 5B miR 5 Ban-Ban GCACCTCAAT TGGGCGGTGA AGACCAAGCT
CAAACTCACT CCATTG
A 5B miR 5 Ban-Ban GTGCCAATGG AGTGAGTTTG AGCTTGGTCT TCAC-
CGCCCA ATTGAG
S 5B miR 6 Ban-Ban GCACCCCCGC TCGGTAGAGC GGTACCCACT AG-
GTACACTC CATAGG
A 5B miR 6 Ban-Ban GTGCCCTATG GAGTGTACCT AGTGGGTACC GCTC-
TACCGA GCGGGG
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Table C.6.: Oligos for cloning of miR-activity reporter (continued)
Label Sequence
S 5B miR 3 Xba-Ban CTAGAGCCGC AGATACTACC TGACCAGAGA CC-
CAACCACT CCACTG
A 5B miR 3 Xba-Ban GTGCCAGTGG AGTGGTTGGG TCTCTGGTCA
GGTAGTATCT GCGGCT
S 5B miR 4 Xba-Ban CTAGAACTCG CCCGGGCTGC CTGGGAAACA GTTA-
GACACT CCCCTG
A 5B miR 4 Xba-Ban GTGCCAGGGG AGTGTCTAAC TGTTTCCCAG
GCAGCCCGGG CGAGTT
S 5B miR 5 Xba-Ban CTAGATCAAT TGGGCGGTGA AGACCAAGCT
CAAACTCACT CCATTG
A 5B miR 5 Xba-Ban GTGCCAATGG AGTGAGTTTG AGCTTGGTCT TCAC-
CGCCCA ATTGAT
S 5B miR 6 Xba-Ban CTAGACCCGC TCGGTAGAGC GGTACCCACT AG-
GTACACTC CATAGG
A 5B miR 6 Xba-Ban GTGCCCTATG GAGTGTACCT AGTGGGTACC GCTC-
TACCGA GCGGGT
Table C.7.: Primers for miR-binding site mutations
Label Sequence
S U26/41A CCCTAATAGG GGCGACACAC CGCCATGAAT CACACCCCTG
TGAGGAACTA C
A U26/41A GTAGTTCCTC ACAGGGGTGT GATTCATGGC GGTGTGTCGC
CCCTATTAGG G
S U8763A ACCCAACCAC ACCACUCGCC CGGG
A U8763A CCCGGGCGAG UGGUGUGGUU GGGU
S U8800A AAACAGUUAG ACACACCCCU AUCA
A U8800A UGAUAGGGGU GUGUCUAACU GUUU
S U9204A GCUCAAACUC ACACCAUUGC CGGA
A U9204A UCCGGCAAUG GUGUGAGUUU GAGC
S U9391A CUAGGUACAC ACCAUAGCUA ACUG
A U9391A CAGUUAGCUA UGGUGUGUAC CUAG
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Table C.8.: Primers for SHAPE RT
Label Sequence
A 105 CGACACTCAT ACTAACGCCA T
A 120 GGGCCTGGAG GCTGTACGAC
A 150 CCGGTGTACT CACCGGTTCC
A 160 CACCGGUUCCGCAGACCACUA
Table C.9.: Primers for cloning of IVTsc templates
Label Sequence
pUC-S/2A/1-T7GG CATAAAGCTT TAATACGACT CACTATAGGA
CCTGCCCCTA ATAGGGGCGA CAC
pUC-S/2A/41-T7GG CATAAAGCTT TAATACGACT CACTATAGGC CC-
CTGTGAGG AACTACTGTC TTCA
pUC-A/2A/105 TAATCCCGGG CGACACTCAT ACTAACGCCA
TGGCT
pUC-A/2A/120 TAATCCCGGG CCTGGAGGCT GTACGACACT
CAT
pUC-S/2A/1-T7GG D20 CATCAAGCTT TAATACGACT CACTATAGGA
CCTGCCCCTA ATAGGGGCTC CC
pUC-S/2A/3’120-T7GG (-) CATCAAGCTT TAATACGACT CACTATAGGC
CTGGAGGCTG TACGACACTC AT
pUC-S/2A/3’105-T7GG (-) CATCAAGCTT TAATACGACT CACTATAGG CGA-
CACTCAT ACTAACGCCA TGGCT
pUC-A/2A/3’(-) TAATCCCGGG ACCTGCCCCT AATAGGGGCG
ACAC
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Table C.10.: Cloning of double IRES replicon
Label Sequence
ARLUCAflII CCTATTAGGG GCAGGTCCTT AAGTAACGTT ACTATTGTTC
ATTTTTGAGA ACTCGC
SHIAflII GCGAGTTCTC AAAAATGAAC AATAGTAACG TTACTTAAGG
ACCTGCCCCT AATAGG
pA5 AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCGACAAAAA
ACCATGAATC ACACCCCTGT
pA10 AflII CTGACTCTTA AGCTGCCCCT AATAGGGGCA AAAAAAAAAC
ATGAATCACA CCCCTGTGAG
D10 AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCCATGAATC
ACACCCCTGT GAGG
D15 AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCATCACACC
CCTGTGAGGA ACTACTGTC
SL AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCGACACGGG
GAAAACCCCC ACACCCCTGT
C AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCGACACACC
GCGTACTTAG TGTCCCCTGT
M25 AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCGACTGAGG
CGGTACAATG CGAGGGATGT
D20 AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCTCCCCTGT
GAGGAACTAC TGTCTTCACG
ISL AflII CTGACTCTTA AGGACCTGCC CCTAATAGGG GCGACACACC
GCCATGGATC GCTTTCCTGT
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